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Hydrogen sulfide (H2S) has relatively recently been added to a list of endogenously 
produced gaseous signalling molecules. Our understanding of the science of H2S has 
advanced rapidly in recent years as exemplified by the fact that, within a mere 10 
years, a range of H2S releasing drugs have already been synthesisied and some indeed 
are entering clinical trials. However, the precise biological roles of endogenous H2S are 
not fully understood. In this respect, slow releasing H2S donors, such as GYY4137, have 
played a part in elucidating the complex roles of this gas in the body and are also 
beginning to show promise as possible therapeutics in inflammation - an area in which 
the function of H2S remains ambiguous.  
This thesis attempts to provide some additional clarity to the biological 
significance of endogenous H2S. The first part of this work examines the release of 
endothelial cell derived H2S in vitro and the consequences of deleting the genetic 
encoding of nitric oxide synthase on tissue H2S biosynthesis in mice. As part of this 
study, I show that the methods currently utilised to measure H2S are insufficiently 
sensitive/reliable to convincingly demonstrate the release of H2S from cells in vitro. In 
addition, data reported herein has demonstrated that knocking out endothelial cell 
nitric oxide synthase (eNOS) results in an increase in tissue H2S synthesising activity, 
which is hypothesised to be a compensatory mechanism as a result of the loss of NOS.  
The second part of this thesis examines the role of H2S in inflammation and 
provides further evidence for its anti-inflammatory activity both in vitro and in vivo. In 
addition, this thesis has shown the ‘added benefit’ of slow-releasing H2S donors (c.f.  
conventional sulfide salt based donors) in that the H2S released from slow-releasing 
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donors is progressive and does not instantaneously expose cells to potentially 
cytotoxic amounts of H2S. In response to the need for additional slow releasing H2S 
donors, attempts were made to examine the H2S releasing ability and antioxidant 
capacity of a library of additional compounds. As a result of this work, a novel 
compound, ZJ802 was shown to exhibit more potent antioxidant ability than the 
current commercially available H2S donors. Furthermore, ZJ802 was shown to exhibit 
anti-inflammatory activity in vivo. 
Overall, the roles of H2S in physiology are not yet clear. There is scope for 
improvement in the current methods available to detect H2S.  Thus, the necessity for 
pharmacological tools, such as slow releasing H2S donors and selective inhibitors of 
enzymes involved in H2S synthesis, cannot be over-emphasised.  Whilst the possible 
use of H2S donors in the clinic has been raised there is still a need for more detailed 
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 1. Introduction  
  
1.1.  Chemistry of h
 
Hydrogen sulfide (H2
rotten eggs. In solution H
dianion (S2-): 
 
The majority of methods used to measure 
2009). Therefore, in this report, the definition of “H
sulfide species. The proportion of H
of the solution. An acidic solution will shift the equilibrium to the left and an alkali 
solution will shift the equilibrium to the right. Intrinsically 
acid dissociation constant 
physiological solution
dissolved H2S spontaneously hydrolys
molecular H2S (Dombkowski, et al. 2004)
with a pH range between 7.1 
ratio of H2S:HS
- is calculated
HS- is capable of conversion to S
present in this form 
existent in biological tissues 
the small intestinal mucosa
stomach acid from pH 1.1
ydrogen sulfide (H2S) 
S) is a colourless and flammable gas with a characteristic smell of 
2S dissociates into the hydrosulfide anion (HS
H2S HS
- + H+ S2- + 2H+ 
H2S, detect molecular H
2S” will include
2S that dissociates into HS
- or S
H2S is a weak acid and 
(pKa) of 6.76 at 37oC (Dombkowski, et al. 2004)
s, such as plasma or extracellular fluid, approximately 80% of the 
es into HS- and the other 20% remains as 
. The cell cytoplasm is slightly more acidic, 
– 7.4 (Bright, et al. 1987). Therefore within the cell, the 
 to be approximately 1:2 (Olson 2009)
2- (pKa2 11.96) but only 2.8 x 10
at pH 7.4 (Ondrias, et al. 2008) therefore making it
(Olson 2009). A larger concentration of S
, where alkali bicarbonate (HCO3
-) is secreted to neutralise 
 – 1.7 (Lui, et al. 1986, Dressman, et al. 1990)
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-) and the sulfide 
2S, HS
- and S2- (Olson 
 the sum of all free 




-3 % of H2S is 
 virtually non-
2- may be found in 
 to an intestinal 
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luminal pH of 5.9 - 7.6 (Bown, et al. 1974, Evans, et al. 1988). However, even then, a 
pH change from 6 to 8 would only increase S2- by a 100 fold (Ondrias, et al. 2008). 
 
1.2. Toxicity of H2S  
 
H2S is found naturally from volcanic emissions, hot springs and from the bacterial 
catabolism of organic matter (Li, et al. 2009a). Micromolar levels of H2S are found in 
the soil of marshes as a result of anaerobic metabolic activities of bacteria that use 
sulfur as electron acceptors (Bouillaud and Blachier 2010). H2S is also synthesised 
during industrial processes such as: the manufacture of pulp in paper mills (Jaakkola, et 
al. 1990); from tanneries during the processing of  leather (Boshoff, et al. 2004); during 
coal liquefaction (Parka, et al. 1998); sewage treatment (Costigan 2003); and oil 
refineries (Kemper 1966). H2S has also been described as a toxin or poison due to its 
association with a number of occupational deaths (Baldelli, et al. 1993).  
In the UK, the current safe occupational exposure for H2S is 5 ppm (8 h time 
weighted average) and 10 ppm (15 min, short term exposure limit) (Costigan 2003). 
The threshold for the perception of the H2S odour is approximately 0.02-0.13 parts per 
million (ppm) (Costigan 2003). An exposure of H2S >100 ppm can lead to the 
impairment of smell, and is a key factor leading to the over exposure and inhalation of 
this gas (Dorman, et al. 2002, Costigan 2003). Exposure to different concentrations of 
H2S can lead to a number of symptoms: H2S >50 ppm can lead to eye and airway 
irritation; H2S 250-500 ppm can lead to pulmonary oedema and headaches; H2S 500-
1000 ppm results in nausea and ataxia; H2S >1000 ppm will lead to inhibition of the 
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central respiratory drive and death (Beauchamp, et al. 1984, Oesterhelweg and 
Puschel 2008). 
Over exposure of this gas is particularly prominent in the oil and gas industry 
where H2S is a large component of natural gas (Baldelli, et al. 1993). Molecular H2S is 
lipid soluble and is capable of crossing biological membranes (Mathai, et al. 2009). 
Once H2S crosses the membrane barrier and dissociates into HS
- and H+, HS- is capable 
of inducing multiple effects in the cell.  
 
1.2.1. H2S and cytochrome c oxidase inhibition 
 
Mitochondria produce chemical energy in the form of adenosine-5'-
triphosphate (ATP) necessary for normal cellular respiration. To produce ATP, 
mitochondria must maintain a membrane potential driven by protons (H+). This H+ 
membrane potential is maintained by the electron transport chain in the 
mitochondria. The generation of an electrochemical H+ gradient in the mitochondrial 
membrane drives the phosphorylation of adenosine diphosphate (ADP) into ATP 
(Bouillaud and Blachier 2010). The primary mechanism by which H2S induces its toxic 
effects is thought to be through direct inhibition of cytochrome c oxidase (complex IV), 
the ultimate enzyme in the electron transport chain of mitochondria (Beauchamp, et 
al. 1984). Cytochrome c oxidase is composed of two haem groups (a and a3) and two 
copper centers (CuA and CuB) (Pietri, et al. 2010). Haem a3 and CuB make up the 
catalytic centre of cytochrome c oxidase, and H2S has been demonstrated to modify 
these two catalytic subunits, leading to the (reversible) inhibition of cytochrome c 
oxidase (Pietri, et al. 2010). Moreover, exposing rats to a sublethal concentrations of 
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H2S (50-400 ppm) for 4 h can lead to a significant reduction in the activity of lung 
cytochrome c oxidase (Khan, et al. 1990). 
In addition, H2S has been demonstrated to induce apoptosis in a number of cell 
types: H2S (200 µM) human aortic smooth muscle cells (Yang, et al. 2004), H2S (100 
µM) INS-1E insulin-secreting β-cells (Yang, et al. 2007), H2S donor sodium hydrogen 
sulfide (NaHS, 10 µM) pancreatic acinar cells (Cao, et al. 2006), H2S donor sodium 
sulfide (Na2S, 500 µM) periodontal cells (Zhang, et al. 2009), and NaHS (250 µM) 
lymphocytes (Mirandola, et al. 2007). Several mechanism for H2S-induced apoptosis 
have been proposed including: activation of p38 MAPK (mitogen activated protein 
kinase) (Yang, et al. 2007), activation of ERK1/2 (extracellular signal-regulated kinase 
1/2) (Yang, et al. 2004), activation of caspase-3, -8, or -9 (Yang, et al. 2004, Cao, et al. 
2006, Li, et al. 2009c), the induction of Bax expression (Cao, et al. 2006), inhibition of 
Bcl-2 expression (Li, et al. 2009c), and endoplasmic reticulum stress (Yang, et al. 2007). 
Remarkably, H2S is also capable of inhibiting apoptosis: NaHS (1 mM) HCT116 
colon cancer cells (Rose, et al. 2005), NaHS (100 µM) pancreatic β-cells with (Taniguchi, 
et al. 2010), NaHS (1 – 300 µM) SHSY5Y neuroblastoma cell line (Hu, et al. 2009), H2S 
inhalation (80 ppm) retinal cells (Biermann, et al. 2011), NaHS (100 µM) MC3T3-E1 
osteoblastic cells (Xu, et al. 2011), NaHS (1 – 100 µM) cardiomyocytes (Hu, et al. 
2008b), Na2S (1 mg/kg) hepatocytes (Jha, et al. 2008) and NaHS (1.83 mM) neutrophils 
(Rinaldi, et al. 2006). Suggested protective anti-apoptotic mechanisms include: 
preservation of mitochondrial function (Hu, et al. 2009), inhibition of p38 MAPK (Hu, et 
al. 2009, Sivarajah, et al. 2009, Xu, et al. 2011), inhibition of JNK (c-jun N-terminal 
kinase)  (Hu, et al. 2009, Biermann, et al. 2011, Xu, et al. 2011), activation of ERK1/2 
(Hu, et al. 2008b, Biermann, et al. 2011), inhibition of ERK1/2 (Xu, et al. 2011), 
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activation of PI3K/Akt (phosphatidylinositol 3-kinase/protein kinase B) (Hu, et al. 
2008b), KATP channel activation (Hu, et al. 2008b, Sivarajah, et al. 2009), attenuation of 
caspase-3, -9 activity (Sivarajah, et al. 2009, Biermann, et al. 2011), increasing HSP-90 
(heat shock protein-90) expression (Jha, et al. 2008, Biermann, et al. 2011), and 
increasing Bcl-2 expression (Jha, et al. 2008). 
Indeed the reason for the disparity between H2S induced apoptosis through the 
ERK1/2 pathway is unclear. However this is not a H2S specific phenomenon. ERK1/2 
activation has been demonstrated to have anti-apoptotic effects in response to TNF-α 
(Tran, et al. 2001), hypoxia (Buckley, et al. 1999), sodium nitroprusside (Kim, et al. 
2002), radiation (Park, et al. 1999) and other types of stimuli (Lu and Xu 2006). In 
contrast, ERK1/2 activation has also been demonstrated to promote apoptosis in 
response to a number of stimuli including ultra violet and ionising irradiation (Tang, et 
al. 2002), glutamate (Stanciu, et al. 2000), TNF-α (Cheng, et al. 2008), sodium 
nitroprusside (Gomez-Sarosi, et al. 2009) and others (Cagnol and Chambard 2009). The 
reason behind the difference may be dependent on the length of time of its activation 
(that is, transient or prolonged activation), cell type, the stimuli and/or cell culture 
conditions. Indeed, the mechanism by which ERK1/2 activation promotes or inhibits 
apoptosis requires additional clarity.  
Although H2S is thought to exert its toxic effects through inhibiting cytochrome 
c oxidase, interestingly, this is also thought to be the mechanism by which H2S induces 
suspended animation in mice (Blackstone, et al. 2005). Mice exposed to H2S have a 
reduction in core temperature and metabolic rate compared to control (Blackstone, et 
al. 2005, Volpato, et al. 2008). Moreover, mice pre-conditioned with H2S (150 ppm, 20 
min) are capable of surviving for several hours in lethal hypoxia (5% v/v O2) compared 
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to control mice which die within 20 min (Blackstone and Roth 2007). However, the 
relevance of these finding to larger mammalian species is uncertain, as most are 
unable to dramatically drop their core body temperature within a short period of time. 
In anesthetised, mechanically ventilated piglets (Li, et al. 2008a) and sedated 
spontaneously breathing sheep (Derwall, et al. 2011), inhalation of H2S (20 – 80 ppm) 
did not reduce total carbon dioxide production or increase oxygen consumption 
(endpoint markers for aerobic respiration), suggesting H2S does not alter metabolism 
in larger animals.  
Interestingly, low micromolar (<2 μM) concentrations of H2S are capable of 
energising the mitochondria by donating electrons to the respiratory chain (Goubern, 
et al. 2007). This is thought to occur during the oxidation and detoxification of sulfide 
to sufate (see later) (Hildebrandt and Grieshaber 2008). 
 
1.3. Endogenous detoxification mechanisms for H2S 
 
Although H2S can inhibit mitochondrial activity, mitochondria are sites where the 
detoxification and removal of H2S takes place. In the body, the process of H2S oxidation 
and detoxification occurs predominantly in the liver and colon, and subsequently 
excreted in the urine  (Levitt, et al. 1999).  The primary route by which H2S is removed 
in cells is through oxidation to sulfate (SO4
2-) or thiosulfate (S2O3
2−) (Hildebrandt and 
Grieshaber 2008). In mitochondria, sulfide (S2
-) is oxidised to elemental sulfur (So) via 
sulfide quinine oxidoreductase (SQR) a mitochondrial membrane flavoprotein, 
resulting in the formation of SQR-persulfide (SQR-SSH) (Hildebrandt and Grieshaber 
2008). During this process, electrons released from this process are fed into 
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ubiquinone pool further driving the generation of ATP from oxidative phosphorylation 
(Hildebrandt and Grieshaber 2008). Persufide groups (e.g. SQR-SSH or reduced 
glutathione (GSSH)) are further oxidised to sulfite (SO3
2-) by sulfur dioxygenase present 
in the mitochondrial matrix (Hildebrandt and Grieshaber 2008, Kabil and Banerjee 
2010). Sulfite is then directly oxidised to sulfate by sulfite oxidase and excreted in the 
urine (Kabil and Banerjee 2010). Alternatively, sulfite is converted to thiosulfate by 
sulfur transferase, and excreted or further converted to sulfate by thiosulfate 
reductase (Hildebrandt and Grieshaber 2008). 
A secondary route for H2S detoxification is though cytosolic methylation by 
thio-methyltransferase to form methanethiol (CH3SH) and dimethylsulfide (CH3SCH3) 
(Beauchamp, et al. 1984). This reaction occurs prominently in the liver and the 
intestinal mucosa (Beauchamp, et al. 1984). 
Other miscellaneous ways of removing free H2S is through binding to metals or 
reacting with free radicals. H2S is capable of reacting with a number of metals to form 
metal sulfides. It is therefore likely H2S may also react with a number proteins that 
contain metal complexes, for example metalloproteins, such as haem and cytochrome 
c oxidase (Peterson, et al. 1995). Oyxgen (O2) can be metabolised to give rise to a 
number of chemically reactive compounds including both free radicals and non-radical 
forms (Halliwell 1987), collectively known as reactive oxygen species (ROS). H2S is 
capable of reacting with a number of ROS such as peroxynitrite (ONOO-) (Whiteman, et 
al. 2004), nitric oxide (•NO) (Whiteman, et al. 2006),  hydrogen peroxide (H2O2) 
(Laggner, et al. 2007), and hypochlorous acid (HOCl) (Whiteman, et al. 2005, Laggner, 
et al. 2007). However, the rate constants for these reactions are currently unknown. It 
has also been suggested that activated neutrophils are capable of metabolising H2S to 
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sulfite as a result of ROS formation from activated NADPH oxidase (NOX) (Mitsuhashi, 
et al. 2005). 
 
1.4.  Existence of endogenous H2S 
 
Interestingly, despite the toxicological profile of H2S, this gas is endogenously 
synthesised and utilised by a number of prokaryotic and eukaryotic cells. In the deep 
sea where there is limited oxygen and sunlight is absent, bacteria oxidise sulfur 
compounds to obtain energy (Bouillaud and Blachier 2010). 
In the human large intestine, millimolar concentrations of H2S (1 – 2.4  mM) 
have been reported, thought to be the result of the breakdown of sulfurous 
compounds in the diet by gut flora (Macfarlane, et al. 1992). Sulfur is also a vital 
component of human dietary intake. Dietary intake of sulfur-containing amino acids is 
essential for the normal function of a number of proteins. L-cysteine, L-methionine, 
and L-taurine are sulfur-containing amino acids (Brosnan and Brosnan 2006). However, 
only L-cysteine and L-methionine are incorporated into proteins (Brosnan and Brosnan 
2006).  
Taurine is the most abundant free amino acid and acts as an antioxidant 
through a mechanism that is neither through scavenging free radicals or modulating 
antioxidant defense systems (Jong, et al. 2011). Interestingly, depleting taurine in 
neonatal cardiomyocytes results in impared electron transport and increased 
superoxide production by mitochondira, hypothesisied to be as a result of impairing 
the synthesis of mitochondrial proteins essential in assembling respiratory chain 
complexes (Jong, et al. 2011).    
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L-methionine is a hydrophobic essential amino acid and is the initiating amino-
acid in protein synthesis for most eukaryotic proteins (Brosnan and Brosnan 2006).  L-
methionine can also be irreversibly converted to L-cysteine via the transulfuration 
pathway (Brosnan and Brosnan 2006).  L-cysteine is essential in maintaining tertiary 
structure of proteins through forming disulfide bonds between adjacent cysteine 
residues (Brosnan and Brosnan 2006). Apart from protein structure and function, L-
cysteine is also important for the generation of endogenous H2S and glutathione (GSH) 
(Williamson, et al. 1982, Griffith 1999). 
Research on cysteine desulfuration and the formation of H2S in the liver and 
kidney have been ongoing for several decades (Stipanuk and Beck 1982). Warenycia 
and colleagues (1989) (Warenycia, et al. 1989) were the first to discover that H2S was 
produced endogenously in rat brain with levels of 1.57 ng/mg brain tissue.  A decade 
later it was demonstrated that endogenous H2S production is not restricted to the 
central nervous system but also occurs in the cardiovascular system (Hosoki, et al. 
1997). A few years later, others confirmed their observations, that H2S is produced 
endogenously within blood vessels, and research on vascular H2S was commenced in 
earnest (Zhao, et al. 2001).  
Since 2001 appreciable micromolar concentrations of H2S were described in the 
plasma and in a number of other tissues. Reported plasma levels range from 2 µM 
(Olson 2009) to 280 µM (Han, et al. 2006), with most studies reporting a plasma 
concentration ~30-45 μM H2S (Zhao, et al. 2001, Zhong, et al. 2003, Yang, et al. 2008). 
However, more recently, the development of a new polarographic sensor, that 
measures H2S gas in real time (without the need for harsh chemical modification of 
H2S) suggests that this gas is undetectable in plasma (that is, below the detection limit 
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of 100 nM H2S) (Whitfield, et al. 2008). This finding has recently questioned whether 
H2S exists as a free circulating gasotransmitter. Despite these concerns, H2S is currently 
thought to take part in a number of signalling processes necessary for normal 
physiological function (see later) (Yang, et al. 2008).  
Thus the biological role of H2S bears similarity to the history of 
•NO and carbon 
monoxide (CO), which were initially thought of solely as environmental pollutants and 
toxins and later discovered to be synthesised by mammalian cells and elicit important 
biological effects. Together, H2S, 
•NO and CO belong to a family of gaseous 
endogenous molecules known as gasotransmitters (Wang 2002a). •NO was the first of 
the gasotransmitters to be recognised subsequently followed by CO and then H2S 
(Wang 2002a). Gasotransmitters are signaling molecules, like neurotransmitters and 
other mediators in the body, but have gaseous properties (Wang 2002a). All 
gasotransmitters are small-molecule, cell-permeable gases which are produced 
endogenously and are able to exert functional effects at physiologically relevant 
concentrations (Wang 2002a) and are thought to be synthesised at the sight of action 
(Oess, et al. 2006).  
 
1.5.  Endogenous production of H2S 
 
The endogenous production of H2S occurs enzymatically in the cytosol of cells primarily 
by two pyridoxal-5’-phosphate (P5’P, an active form of vitamin B6) dependent enzymes 
known as cystathionine β-synthase (CBS, Enzyme Commission [EC] number 4.2.1.22) 
and cystathionine γ-lyase (CSE, also known as γ-cystathionase, EC 4.4.1.1).  
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CBS is found on chromosome 21 (21q22.3) in humans (Gene ID: 875), 
chromosome 17 in mice (Gene ID: 12411) and chromosome 20 (20p12) in rats (Gene 
ID: 24250). CBS is a homotetrameric enzyme with at least 5 mRNA isoforms, of which 
isoform 1 and 2 are most abundant (Bao, et al. 1998, Kraus, et al. 1998). Each subunit 
has a molecular mass of 63 kDa and contains prosthetic groups for P5’P, S-
adesosylmethionine (SAM) and haem (Kery, et al. 1994, Kraus, et al. 1998). An 
estimated four P5’P cofactors bind to each subunit, and removal of half results in loss 
of CBS activity (>94%) (Taoka, et al. 1999). The allosteric activator SAM binds to the C-
terminal regulatory domain of each CBS subunit (Kery, et al. 1998), and increases its 
activity by 3 fold (Finkelstein, et al. 1975). The activity of CBS is also redox active, as 
oxidation of haem from Fe(II) to Fe(III) results in a 2-fold increase in activity (Taoka, et 
al. 1998).  
CSE, like CBS, is a homotetrameric enzyme with a P5’P binding site on each 
subunit (Clausen, et al. 1998, Messerschmidt, et al. 2003, Sun, et al. 2009). There are 
approximately 31% (126 amino acids) conserved sequences between CSE and CBS, 
with a total homology of 36% including acceptable amino acid replacements (Belfaiza, 
et al. 1986). In humans, CSE is located on chromosome 1 (1p31.1) (Gene ID: 1491), in 
mouse this enzyme is located on chromosome 3 (Gene ID: 107869) and in rat on 
chromosome 2 (2q45) (Gene ID: 24962). This enzyme has a subunit molecular mass of 
43.6 kDa (Ishii, et al. 2004). At least two isoforms of CSE mRNA have been detected, 
but it is likely these are splice variants rather than products of different genes 
(Levonen, et al. 2000). 
CBS is widely thought to be the primary source of H2S in the brain, whereas CSE 
was thought to be the primary source of H2S in the peripheral tissues. This conclusion 
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has arisen from publications demonstrating relatively low levels of CSE and high levels 
of CBS in brain tissue (Abe and Kimura 1996, Ishii, et al. 2004). Moreover, CSE was 
predominantly found in the liver, kidney, gastrointestinal tract (GIT), smooth muscle 
cells and the vascular endothelium (Zhao, et al. 2001, Ishii, et al. 2004, Yang, et al. 
2008) and as such, CSE is thought to be the predominant enzyme in the cardiovascular 
system.  As such, many publications have focused on CBS in the central nervous 
system, whereas work within the cardiovascular field has predominatly focused on the 
activity and expression of CSE. However, recent data showing CBS and CSE mRNA using 
quantitative PCR (polymerase chain reaction) suggest there are relatively equal 
amounts of both CBS and CSE in mouse brain tissue (Tyagi, et al. 2009a). Indeed, other 
publications have located CBS in the liver, kidney, pancreas (Bao, et al. 1998), lung 
(Kumaraswamy, et al. 2009), fibroblasts, smooth muscle cells (Wallace, et al. 2009) and 
data from this thesis has demonstrated CBS mRNA in human endothelial cells (Chapter 
3). Therefore, CBS and CSE should not be thought of as two separate H2S synthesising 
enzymes within separate body systems. Indeed, it is quite likely that both CSE and CBS 
work together in each organ system to generate H2S (see 1.5.1. generation of H2S from 
the transsulfuration pathway). 
 
1.5.1. Generation of H2S from the transsulfuration pathway 
 
The generation of endogenous H2S is thought to occur predominately during the trans-
sulfuration pathway of L-homocysteine to L-cysteine. The transfer of sulfur between L-
homocysteine and L-cysteine is described as trans-sulfuration, and is one of the means 
by which the toxic L-homocysteine is removed from cells (Persa, et al. 2004). CBS and 
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CSE are an integral part of the trans-sulfuration pathway which is interconnected with 
the transmethylation pathway between L-methionine and L-homocysteine (Figure 
1.4.1) (Riedijk, et al. 2007). In these pathways, L-homocysteine is either catabolised to 
L-cysteine via the transulfuration pathway or remethylated by methionine synthase to 
methionine (Persa, et al. 2004).  Both CSE and CBS can catalyse a number of reactions 
leading to the generation of H2S as described in Table 1.4.1 and Table 1.4.2 
respectively. CSE can catalyse a number of replacement or elimination reactions at the 
α, β or γ carbon in the substrates L-cysteine, L-homocysteine and L-cystathionine 
(Chiku, et al. 2009). In contrast, most of the replacement or elimination reactions 
related to CBS demonstrate a preference at the β-carbon on L-cysteine and L-
homocysteine in vitro (Singh, et al. 2009). Interestingly, it has been demonstrated that 
CBS can contribute up to 68% of the H2S produced whereas CSE contributes to the 
remaining 32%, on assumption of full enzyme activity and equal ratio of both enzymes 
(Table 1.4.3.) (Singh, et al. 2009). However, whether CBS is the predominant source of 
H2S in vivo has not yet been explored. Indeed, the relative concentration for each 
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Table 1.4.1. H2S-generating reactions by CSE. Relative contribution (%) of H2S 
produced in the presence of physiologically relevant concentrations of L-cysteine (100 
µM) and L-homocysteine (10 µM) (Chiku, et al. 2009). 
Reaction Contribution to the 
production of H2S (%) 
a)  L-cysteine + H2O  L-serine + H2S  70% 
b)  L-homocysteine + H2O  L-homoserine + H2S 29% 
c)  L-cysteine + L-cysteine  L-lanthionine + H2S Negligible  
d)  L-homocysteine + L-homocysteine  L-homolanthionine + H2S Negligible 
e)  L-homocysteine + L-cysteine  L-cystathionine + H2S Negligible 
 
 
Table 1.4.2. H2S-generating reactions by CBS. Relative contribution (%) of H2S 
produced in the presence of physiologically relevant concentrations of L-cysteine (100 
µM), L-homocysteine (10 µM) and S-adenosylmethionine (360 µM, SAM) (Singh, et al. 
2009). 
Reaction Contribution to the 
production of H2S (%) 
a)  L-cysteine + H2O   L-serine + H2S 2.6% 
b)  L-cysteine + L-cysteine  L-lanthionine + H2S 1.6%  







Table 1.4.3. Percentage of H2S-generated by CSE or CBS (ratio 1:1) in different 
conditions (Singh, et al. 2009). 
Condition CSE CBS 
a)   L-cysteine (100 µM) + L-homocysteine (10 µM) + SAM (360 µM) 
(full activation of CBS) 
32% 68% 
b)  L-cysteine (100 µM) + L-homocysteine (10 µM)  
(absence of SAM) 
80% 20% 
c)  L-cysteine (100 µM) + L-homocysteine (40 µM) + SAM (360 µM) 
(moderate hyperhomocysteinemia) 
45% 55% 



















1.5.2. Other pathways of endogenous H2S generation 
 
An alternative enzymatic pathway to the transulfuration pathway for the enzymatic 
generation of H2S is the 3-mercaptopyruvate pathway of H2S generation. This pathway 
involves two enzymes 3-mercaptopyruvate sulfurtransferase (3-MST, EC 2.8.1.2) and 
the P5’P dependent enzyme cysteine/aspartate transaminase (CAT, identical enzymes 
EC 2.6.1.3/ EC 2.6.1.1). Currently, the brain (Shibuya, et al. 2009b), rat vascular 
endothelium  (Shibuya, et al. 2009a), and rat retinal neurons (Mikami, et al. 2011b) 
have been demonstrated to synthesise H2S by this pathway. The subcellular location by 
which these enzymes produce H2S is unclear. 3-MST is predominately located in the 
mitochondria, but is also found in the cell cytoplasm in lesser amounts (Kimura 2011). 
In this pathway, CAT catalyses the reaction between L-cysteine and α-ketoglutarate to 
produce 3-mercaptopyruvate and L-glutamate (Nagahara and Sawada 2006, Tanizawa 
2011). 3-MST subsequently catalyses the reaction between 3-mercaptopyruvate and 
sulphurous acid (HSO3
-) resulting in the production of pyruvate and either a thiosulfate 
(Mikami, et al. 2011a, Tanizawa 2011) or a persulfide (R-SSH) (Kabil and Banerjee 
2010).  The persulfide or thiosulfate is subsequently reduced (possibly by another 
sulftransferase) in the presence of reducing agents such as dihydrolipoic acid or 
thioredoxin to release H2S (Mikami, et al. 2011a). The relative contribution of H2S 
generation from the transulfuration pathway and 3-MST/CAT pathway is yet unknown 
and cannot be directly compared as the activities of 3-MST and CAT have been 
characterised at pH >9.5 and in rodents only (Shibuya, et al. 2009b, Kabil and Banerjee 
2010). Interestingly, dithiothreitol is utilised in the methods to measure H2S 
synthesising activity via the 3-MST/CAT pathway (Shibuya, et al. 2009a, Shibuya, et al. 
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2009b).  Dithiothreitol is a strong reducing agent and is capable of inducing the release 
of H2S from protein bound sulfur (Tangerman, et al. 2002). Whether protein 
desulfuration or the 3-MST/CAT pathway is the reason for the H2S generated in the 
former study (Shibuya, et al. 2009b) is yet unclear. 
Rhodanese (also known as thiosulfate sulfurtransferase, EC: 2.8.1.1), another 
mitochondrial enzyme with similar homology to 3-MST, is also capable of producing 
H2S from thiosulfate (Mikami, et al. 2011a). In this reaction, rhodanese catalyses 
thiosulfate in the presence of a reducing agent such as dihydrolipoic acid to form 
sulfite (SO3
2-) and H2S (Koj, et al. 1967, Mikami, et al. 2011a). Interestingly, this enzyme 
has also been proposed to detoxify H2S (Picton, et al. 2002), possibly by catalysing the 
transfer of sulfur from thiosulfate to thiol (-SH) compounds to produce persulfides 
(Schlesinger and Westley 1974). However, the role for rhodanese in H2S detoxification 
has been met with some controversy (Wilson, et al. 2008).  It has been suggested that 
rhodanese does not metabolise sulfide (Wilson, et al. 2008). Instead the reported 
ability of rhodanese to metabolise sulfide is due to the spontaneous conversion of 
sulfide to thiosulfate and/or contamination with a sulfide oxidase (Wilson, et al. 2008). 
Instead, rhodanese is thought to utilise thoisulfate, rather than sulfide, as a substrate 
(Wilson, et al. 2008). 
Other miscellaneous sources of H2S in the body include the blood where 
erythrocytes are also capable of producing H2S by reducing elemental sulfur on 
oxidation of glucose (Searcy and Lee 1998). In the gut, bacterial flora are capable of 





1.6.  Endogenous regulation of H2S synthesising enzymes 
 
1.6.1. Regulation of CBS 
 
H2S synthesising enzymes CSE and CBS are regulated by a number of mechanisms. SAM 
can allosterically activate CBS by binding to the C-terminal regulatory domain (Scott, et 
al. 2004). Furthermore, the haem in CBS is redox-active; and the oxidation of haem 
from Fe2+ to Fe3+ increases CBS activity (Taoka, et al. 1998). H2S donors, NaHS and 
GYY4137 have been demonstrated to down regulate CBS mRNA in human airway 
smooth muscle cells (Perry, et al. 2011), suggesting H2S itself can negatively regulate 
CBS expression.  
Insulin has been shown to inhibit CBS expression at the mRNA level, which 
correlates with increased liver CBS activity in diabetic rats (Ratnam, et al. 2002). 
Glucocorticoids have also been reported to increase CBS mRNA in a rat hepatoma cell 
line, H4IIE (Ratnam, et al. 2002). In astrocytes, CBS protein was up-regulated by 
epidermal growth factor (EGF), transforming growth factor (TGF-α), 8-(4-
chlorophenylthio)-adenosine 3′,5′-cyclic monophosphate (CPT-cAMP) and the 
synthetic glucocorticoid dexamethasone (Enokido, et al. 2005).  
Nuclear factor Y (NF-Y), specificity protein (SP)1, SP3, and upstream stimulatory 
factor 1 (USF-1) are thought to transactivate the CBS promoter (Ge, et al. 2001a). 
Myeloid zinc finger protein 1 (MZF1) has also been demonstrated to stimulate CBS 







1.6.2. Regulation of CSE 
 
Compared to CBS, less is known about the regulation of CSE. Lipopolysaccharide (LPS) 
has been shown to stimulate CSE protein expression in RAW264.7 cells (Zhu, et al. 
2010). Liver and kidney CSE activity and mRNA expression was shown to be up-
regulated in LPS treated mice which may suggest CSE expression is regulated by NF-κB 
(Li, et al. 2005). CSE is regulated by Ca2+/CaM, and endothelial cells produce H2S in 
response to Ca2+ stimulating agents (Yang, et al. 2008). Similar to CBS, NaHS (50 – 500 
μM) has been shown to reduce CSE mRNA expression in mouse aortic smooth muscle 
cells (Wang, et al. 2009b), suggesting H2S exerts a negative feedback mechanism for 
CSE.  
MZF1 and SP1 are thought to increase the basal transcriptional activity of CSE 
in HEK-293 cells (Ishii, et al. 2004). High concentrations of glucose (20 mM) have also 
been demonstrated to down-regulate CSE expression in isolated rat pancreatic islets as 
a result of p38 MAPK activation and SP1 phosphorylation (Zhang, et al. 2011). Acute 
myeloid leukaemia-1a (AML-1a), USF-1 and N-Myc are thought to suppress CSE 
transcriptional activity in HEK-293 cells (Ishii, et al. 2004). Another consensus sequence 
associated with CSE transactivation includes signal transducers and activators of 
transcription x (STATx) (Ishii, et al. 2004).  
Interestingly, both CSE and CBS appear to be regulated by the common 
transcription factors SP1, MZF1 and USF-1, which may suggest these are the universal 





1.6.3. Gasotransmitter-gasotransmitter regulation  
  
Evidence from pharmacological compounds suggests that all three gasotransmitters, 
H2S, 
•NO and CO, are capable of interacting and regulating each other’s activity. The 
H2S donor, NaHS 100 μM, has been shown to attenuate LPS induced iNOS expression 
and nitrate/nitrite production in microglia (Hu, et al. 2007). NaHS (50 – 200 μM) has 
also been demonstrated to reduce nitrate/nitrite production and iNOS expression 
through up-regulating haem-oxygenase-1 (HO-1, the enzyme involved in CO 
biosynthesis) in LPS stimulated RAW264.7 cells (Oh, et al. 2006). Conversely, NaHS 
(100 μM) increases IL-1β induced iNOS protein expression in rat vascular smooth 
muscle cells (Jeong, et al. 2006). Moreover NaHS (100 μM) has been demonstrated to 
reduce eNOS phosphorylation in HUVEC (Geng, et al. 2007), and induce eNOS 
phosphorylation in cardiomyocytes (in a model of ischemia-reperfusion) (Yong, et al. 
2008). H2S has also been suggested to increase cGMP (cyclic 3',5'-guanosine 
monophosphate) levels by inhibiting phosphodiesterase activity in vitro (Bucci, et al. 
2010). In a rat model of recurrent febrile seizures, NaHS was shown to up-regulate HO-
1 in the rat brain (Han, et al. 2006). In a rat model of hemorrhagic shock, a bolus 
injection of NaHS (0.2 mg/kg i.v.) significantly increased HO-1 and HO-2 protein 
expression in heart and aortic tissue (Ganster, et al. 2010). Conversely, DL-
propargylglycine (PAG, 2 mM), an irreversible inhibitor of CSE was shown to increase 
HO-1 expression in rat aortic smooth muscle cells; whereas NaHS (100 μM) decreased 
HO-1 expression in this cell line (Jin, et al. 2006). 
The •NO donor SNAP (S-nitroso-N-acetylpenicillamine, 100 μM) has also been 
demonstrated to increase CSE mRNA expression in cultured vascular smooth muscle 
cells (Zhao, et al. 2001). Moreover, •NO donor, SNP (sodium nitroprusside, 1 μM) was 
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shown to significantly increase H2S synthesising enzyme activity in rat fetal membranes 
(amnion) (Patel, et al. 2009) and increased H2S production in rat aortic homogenates 
(Zhao, et al. 2001). •NO and CO can also directly inhibit CBS activity by binding to the 
haem, with an inhibition constant of 320 ± 60 μM and 5.6 ± 1.9 μM respectively 
(Taoka, et al. 1999, Taoka and Banerjee 2001).  
Apart from “gas-enzyme” interaction, “gas-gas” interaction has also been 
described. Both •NO and H2S have been shown to chemically react to form novel less 
biologically active nitrosothiol (RSNO) (Whiteman, et al. 2006). Incubation of SNP with 
NaHS in cultured RAW264.7 cells did not elevate cGMP levels, compared to SNP alone, 
unless •NO was released in the presence of copper (Cu2+, a reducing agent that cleaves 
the RS-NO bond) (Whiteman, et al. 2006). In anaesthetised rats SNP induced a 
significant reduction in mean arterial blood pressure, whereas co-administration of 
SNP and NaHS abolished this reduction in blood pressure (Ali, et al. 2006). 
Taken as a whole, it appears that H2S donors can both activate and inactivate 
NOS and HO. Currently there does not appear to be data in the literature 
demonstrating whether CO donors also regulate NOS or H2S synthesising activity. 
Overall, this confusing evidence suggests that these gassotransmitters are capable of 
regulating each other’s activity. Indeed, whether this interaction occurs endogenously 








1.7. Insight into the endogenous functions of CSE and CBS from gene alteration  
1.7.1. CBS KO mice 
  
CBS-/- knock out (KO) mice are typically used to model hyperhomocysteinemia. 
However, it is possible that CBS-/- KO mice will also have altered H2S synthesising 
activity.   CBS-/- mice have a typical phenotype of: normal birth weight with hindered 
growth and delayed eye opening compared to WT (wild type) mice (Watanabe, et al. 
1995); hyperhomocysteinemia (total plasma homocysteine 271.1 ± 61.5 µM c.f. 7.4 ± 
2.9 µM); elevated liver SAM (35.6 ± 5.9 nmol/g c.f. 19.1 ± 6.1 nmol/g) 
(Choumenkovitch, et al. 2002);  hypermethioninemia (plasma methionine 2,640 ± 317 
μM c.f. 117 ± 9 μM); a reduction in plasma taurine (165 ± 60 μM c.f. 617 ± 242 μM) 
(Ishii, et al. 2010).  Very few of these mice survive past 5 weeks after birth (Watanabe, 
et al. 1995). Surviving CBS-/- mice display increased collagen deposition in the lung, 
alveolar septal thickening, and air space enlargement associated with increased TGF-β 
(transforming growth factor-β) mRNA (Hamelet, et al. 2007), suggesting a role for CBS 
in airway remodeling. The liver of CBS-/- mice have a light tan colour compared to 
reddish-brown colour of WT mice; and the hepatocytes are multinucleated, enlarged 
and contain fatty deposits (Watanabe, et al. 1995) which indicates a role for CBS in 
normal liver function.  
ApoE-/-/CBS-/- double KO mice have provided insight into the role of CBS in 
atherosclerosis (Wang, et al. 2003). Within 6 months, ApoE-/-/CBS-/- fed on a normal 
diet had significantly (P<0.05) greater number of atherosclerotic lesions compared to 
ApoE-/-/CBS+/+. (Wang, et al. 2003) The increased risk of atherosclerotic lesions in the 
ApoE-/-/CBS-/- were associated with an increased uptake of acetylated-LDL (low density 
39 
 
lipoprotein) by peritoneal macrophages suggesting an altered macrophage lipoprotein 
metabolism (Wang, et al. 2003).  
CBS-/+ heterozygote KO mice have previously been utilised to model mild 
hyperhomocysteinemia. These mice have normal growth but with twice the plasma 
homocysteine compared to WT (13.5 + 3.2 nmol/ml c.f. 6.1 ± 0.8 nmol/ml) (Watanabe, 
et al. 1995) and a reduction in plasma H2S (~55 μM c.f. ~35 μM H2S) (Sen, et al. 2009). 
CBS-/+ mice have increased heart rate (HR, 520 ± 40 beats/min c.f.  435 ± 30 beats/min) 
and increased mean arterial blood pressure (MAP, 130 ± 1 mmHg c.f. 92 ± 1 mmHg) 
compared to WT (Ovechkin, et al. 2006). Moreover, CBS-/+ mice also have impaired 
aortic relaxation in response to acetylcholine (ACh) as a result of endothelial cell 
dysfunction (Eberhardt, et al. 2000). In addition, CBS-/+ mice have increased risk of 
thrombosis thought to result from hyperhomocysteinemia; as both CBS+/+ and CBS-/+ 
mice fed on a high methionine diet (to increase plasma homocysteine) have increased 
risk of thrombosis (Dayal, et al. 2006).  
Overall, it appears that a deficiency in CBS results in cardiovascular dysfunction. 
Whether these effects are due to changes in plasma homocysteine or H2S are currently 
unknown. Indeed, many of the studies investigating the effects of homocystinuria from 
CBS KO mice have not examined the consequences of changes in plasma H2S levels. 
Therefore many of the effects described in those studies may possibly result from an 







1.7.2. CSE KO mice 
 
In contrast to CBS-/- mice, CSE-/- mice have normal growth, fertility and survival (Yang, 
et al. 2008, Ishii, et al. 2010). These mice display significant (P<0.05): increases in 
plasma homocysteine (~18 μM c.f. 1 μM); reduction in plasma H2S (~18 μM c.f. 40 μM); 
a reduction in plasma cysteine (~225 μM c.f. 300 μM) compared to WT (Yang, et al. 
2008); these mice also display lower levels of plasma taurine (190 ± 60 μM c.f. 498 ± 88 
μM) (Ishii, et al. 2010). Unlike CBS-/- mice, CSE-/- mice display cystathioninuria (elevated 
levels of cystathionine in the urine, 33.1 ± 5.3 mM c.f. 0.00) but not 
hypermethioninemia (elevated plasma methionine) (Ishii, et al. 2010) consistent with a 
predominant role for CBS in metabolising methionine and CSE for cystathionine. Unlike 
CBS-/- mice, CSE-/- are free of hepatic steatosis and show no biochemical signs of liver 
damage (no significant difference in aspartate and alanine aminotransferase levels 
compared to WT) (Ishii, et al. 2010). Similar to CBS-/- mice, restricting cysteine in the 
diet of CSE-/- mice led to weight loss, growth retardation, reduced glutathione 
production, muscular atrophy and death within 2 weeks; and injecting NaHS (39 
μmol/kg i.p.) over 10 weeks, not surprisingly, did not reverse these effects (Ishii, et al. 
2004, Mani, et al. 2011).  
Several functions for CSE have recently been described. The effect of CSE on 
blood pressure regulation is controversial: one group has suggested CSE-/- mice 
develop aged dependent hypertension (~135 mmHg c.f. 117 mmHg) (Yang, et al. 
2008); whereas CSE-/- mice from another group did not display altered effects on blood 
pressure compared to WT (Ishii, et al. 2010). Cultured smooth muscle cells isolated 
from the mesenteric arteries of CSE-/- have increased proliferation rate compared to 
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their WT counterparts (Yang, et al. 2010) and may be one reason for the hypertensive 
phenotype described in the former study (Yang, et al. 2008). Indeed, this effect on 
smooth muscle cell proliferation may suggest a role for CSE in vascular remodeling 
(Yang, et al. 2010). Microvessel formation induced by vascular endothelial growth 
factor (VEGF) was significantly reduced in the aortic rings isolated from CSE-/- mice 
compared to WT suggesting a role for CSE in angiogenesis (Papapetropoulos, et al. 
2009). Endogenous CSE may play a role in O2 sensing in the glomus cells of the carotid 
body (Peng, et al. 2010). In this study, CSE-/- mice were impaired of a ventilatory 
response to hypoxia, suggesting the impairment of an O2 sensing system (Peng, et al. 
2010). 
CSE may have an endogenous role in cardiac tissue (Salloum, et al. 2009). The 
phosphodiesterase-5 inhibitor tadalafil (1 mg/kg i.p. pre-treatment) has been 
demonstrated to reduce myocardial infarct size and this drug effect was abolished in 
CSE-/- mice, suggesting a role for endogenous CSE in cardioprotection (Salloum, et al. 
2009).  
Endogenous CSE may also have a role to play in the development of diabetes as 
CSE-/- mice had a delayed onset in a model of streptozotocin (STZ)-induced diabetes 
(Yang, et al. 2011b).  
Similar to CBS-/- mice, CSE-/- mice appear to have cardiovascular dysfunction. 
CBS-/- and CSE-/- mice have both an elevated plasma homocysteine and a reduction in 






1.7.3.  Functions of CBS/CSE – evidence from genetic defects in humans 
 
The incidence of humans displaying CBS deficiency may range from 1:20,000 to 
1:1,000,000 (Naughten, et al. 1998, Gaustadnes, et al. 1999, Moat, et al. 2004). A 
deficiency of CBS in humans results in the hereditary multisystemic disorder 
hyperhomocysteinemia (Miles and Kraus 2004, Qu, et al. 2008).  These patients also 
have an elevated plasma SAM, SAH and methionine (Finkelstein 2006). This autosomal 
recessive phenotype is characterised by: bone deformities, such as osteoporosis and 
scoliosis; effects on the central nervous system e.g. mental retardation and 
abnormalities in the electrocardiogram; increased risk of thrombosis and 
atherosclerosis formation (De Franchis, et al. 1998, Fonseca, et al. 1999). In contrast to 
KO mice studies, patients do not develop lung fibrosis (Maclean, et al. 2010). In 
humans, CBS is located on chromosome 21 and is expressed three times greater in the 
brains of Down’s syndrome (or trisomey 21) patients than in control; and may be a 
cause of the cognitive dysfunction described in Down’s patients (Ichinohe, et al. 2005). 
In contrast to CBS, the incidence of CSE deficiency is much lower. These 
patients have increased cystathionine in the kidney, liver, brain and cerebrospinal 
fluid; and mild to moderate hyperhomocysteinemia (Finkelstein 2006). These patients 
have no obvious symptoms or abnormalities possibly due to a sufficient dietary intake 
of cysteine (Kraus, et al. 2009). Interestingly, no significant difference was found in a 
clinical study assessing the occurrence of single nucleotide polymorphisms in CSE of 
hypertensive patients (n = 503) and normotensive controls (n = 490) of the Northern 
Chinese Han population, which may suggest CSE is not associated with essential 
hypertension (Li, et al. 2008d). Due to low sample numbers in the latter study, further 
work is necessary to confirm this observation.  
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1.7.4. Homocysteine or H2S? 
 
CBS heterozygous KO mice (CBS-/+) mice are commonly used as a model of 
homocysteinemia (Sen, et al. 2009).  However, these mice also display a reduction in 
serum H2S, in addition to elevated levels of homocysteine (Sen, et al. 2009). It is 
interesting to note that in a model of hyperhomocysteinemia, supplementing NaHS (30 
μM) in the drinking of water of CBS-/+ KO mice increased their plasma H2S levels and 
led to a normalisation of urinary protein secretion indicating improved renal function 
(Sen, et al. 2009). The effects of improved renal function as a result of H2S 
supplementation was thought to be a consequence of the prevention of apoptotic 
death in renal cortical tissues, reduced activity of  matrix metalloproteinase-2 and -9 
and a reduction in kidney superoxide levels (Sen, et al. 2009). These authors suggested 
that hyperhomocysteinemia-associated renal damage is due to a reduction in 
endogenous H2S levels (Sen, et al. 2009).  
H2S may be an endogenous regulator of blood pressure (Yang, et al. 2008). 
Interestingly there is no correlation between homocysteine and blood pressure in 
humans (Sundstrom, et al. 2003). In a rat model of hyperhomocysteinemia, induced by 
a high methionine diet, an increased MAP was associated with elevated levels of 
homocysteine and a reduction in plasma H2S (Sowmya, et al. 2010). These authors 
suggested H2S may regulate blood pressure in hyperhomocysteinemia (Sowmya, et al. 
2010). However, in another model, CBS-/+ mice fed 3-deazaadenosine (to inhibit the 
accumulation of homocysteine) resulted in the normalisation of MAP and HR (93 ± 1 
mmHg and 469 ± 27 beats/min) (Ovechkin, et al. 2006), which may suggest 
homocysteine accumulation is the cause of the hypertension. Conversely, increasing 
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homocysteine levels in WT mice by increasing their methionine consumption/intake 
for >6 weeks did not affect blood pressure suggesting that homocysteine is not the 
cause of the rise in blood pressure seen in the CSE-/- mice (Yang, et al. 2008). Instead, 
the latter study suggested that the reduction in plasma H2S was the cause of the 
increase in blood pressure described in the CSE-/- mice (Yang, et al. 2008). Indeed, 
whether H2S and/or homocysteine, regulates blood pressure in rodents is yet unclear. 
The injection of H2S in a rat model of hyperhomocysteinemia induced by 
subcutaneous injection with homocysteine resulted in a reduction in total plasma 
homocysteine (Chang, et al. 2008). Moreover, the oxidative stressed induced by 
homocysteine in the myocardium was associated with the down regulation of CSE, and 
the oxidative stress induced in the myocardium was alleviated upon injection of 
exogenous H2S (Chang, et al. 2008). This suggests that endogenous H2S may have a role 
in the pathology of hyperhomocysteinemia.  
Overall, it is likely that some of the physiological responses described in 
CSE/CBS KO mice are caused by removal of H2S from the system. Whether the 
cardiovascular dysfunction seen with removal of CSE or CBS is as a result of H2S and/or 
homocysteine is an area that requires further investigation. Indeed, many of the 
previous studies utilising CBS KO mice have not examined the effects of H2S. 
 
1.8.  H2S donors and CSE/CBS inhibitors 
  
H2S donating salts and CSE/CBS inhibitors have predominately been used to decipher 
the biological actions of H2S. Although these tools have been of some value, it should 
be noted that both H2S donors and inhibitors have their disadvantages. H2S donors are 
capable of inducing cell death in cell types such as: hepatocytes (NaHS 500 μM, 60 
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min) (Eghbal, et al. 2004), pancreatic acini (NaHS 10 μM, 3 h) (Cao, et al. 2006), aortic 
smooth muscle cells (H2S 200 μM, 2 h ) (Yang, et al. 2004), and INS-1E cells (insulin-
secreting β-cell line, H2S 50 μM, 12 h) (Yang, et al. 2007). However, the role for H2S 
donors in inducing apoptosis is controversial as this gas has also been shown to inhibit 
apoptosis or preserve cell viability: cardiac myocytes (in a model of myocardial 
ischemia/reperfusion, NaHS 3 mg/kg pretreatment) (Sivarajah, et al. 2009), SH-SY5Y 
(human neuroblastoma cell line, rotenone induced apoptosis, NaHS 1 – 300 μM, 24 h) 
(Hu, et al. 2009), hepatocytes (hepatic ischemia/reperfusion model, Na2S 0.3 – 1 mg/kg 
pretreatment)  (Jha, et al. 2008), retinal ganglion cells (model of ischemia/reperfusion, 
H2S inhalation 80 ppm pretreatment) (Biermann, et al. 2011), and HCT116 cells (human 
colon cancer cells, β-phenylethyl isothiocyanate induced apoptosis, NaHS 0.1 – 1 mM) 
(Rose, et al. 2005). Indeed, although the role for H2S donors in apoptosis has met with 
controversy, the potential for H2S donors to induce apoptosis is a possibility and is a 
disadvantage of using H2S salts as a tool to determine the biological actions of H2S. 
Many of the H2S synthesising enzyme inhibitors are thought to be ‘selective’ for 
either CSE or CBS. However, most of these compounds inhibit other P5’P  dependent 
enzymes. DL-Propargylglycine (PAG), irreversible inhibitor of CSE, is capable of 
inhibiting enzymes such as aspartate aminotransferase  (Tanase and Morino 1976), 
alanine transaminase, (Burnett, et al. 1980, Cornell, et al. 1984) and methionine 
gamma-lyase (Lockwood and Coombs 1991). Aminooxyacetate acid (AOAA), a 
reversible inhibitor of CBS, is capable of inhibiting aspartate aminotransferase (Rej 
1977), GABA aminotransferase (Loscher 1981), glutamate decarboxylase (Hamel, et al. 
1982), glutamate transaminase (Seglen and Solheim 1978) and alanine 
aminotransferase (Smith, et al. 1977). Hydroxylamine (HA, inhibitor of CBS) has been 
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reported to inhibit ornithine aminotransferase, aspartate aminotransferase (Kito, et al. 
1978) and alcohol dehydrogenase (Kaplan and Ciotti 1953). The non-selective effects 
of these inhibitors should be kept in mind when analysing the effects of inhibiting 
endogenous H2S synthesis.  
1.9. Biological roles for H2S – evidence from H2S donors and CSE/CBS inhibitors 
Although H2S donors and H2S synthesising enzyme inhibitors have their disadvantages, 
these tools have provided much insight into what is known about the biological actions 
of H2S to date. 
1.9.1. H2S and the nervous system 
In the brain, H2S biosynthesis is predominantly thought to be generated through the 
activation of CBS and there is evidence to suggest that H2S may act as a 
neuromodulator (Abe and Kimura 1996). Exogenous H2S has been demonstrated to 
facilitate long term potentiation via activation of NMDA receptors through increasing 
cAMP, suggesting H2S may be involved in memory formation (Abe and Kimura 1996, 
Kimura 2000). H2S has also been shown to induce Ca
2+ waves in cultured astrocytes 
and hippocampus brain slices through the activation of Ca2+ channels, and was 
suggested to be a mechanism by which H2S induces signals between neurons (Nagai, et 
al. 2004).  
 NaHS (100 - 500 μM) has also been demonstrated to increase intracellular Ca2+ 
in cultured microglia cells, the resident macrophages in the CNS, partially via an 
adenylyl cyclase dependent mechanism (Lee, et al. 2006). This suggests that H2S may 
play a role in neuroinflammation through microglia cell activation (Lee, et al. 2006). 
Interestingly, microglia cells pre-treated with NaHS (100 – 300 μM) caused a significant 
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reduction in LPS-induced nitrite production through inhibiting p38 MAPK 
phosphorylation (Hu, et al. 2007). Similarly, pre-treatment with SAM (100 μM, 
allosteric activator of CBS) significantly reduced LPS-induced nitrite production in 
microglia cells suggesting both exogenous and endogenous H2S is anti-inflammatory 
(Hu, et al. 2007).  
H2S has been shown to protect neurons from oxidative stress induced by 
glutamate in vitro by up-regulating cysteine transport and increasing γ-
glutamylcysteine synthetase activity and thus GSH production (Kimura and Kimura 
2004). Moreover, NaHS (50 μM pretreatment) has been shown to reduce NOX-4 
expression and reduce intracellular ROS production induced by methionine in bEnd3 
cells, a mouse brain endothelial cell line (Tyagi, et al. 2009b). 
In a rat model of recurrent febrile seizures induced by hyperthermia, NaHS (56 
μmol/kg, i.p.) significantly increased γ-aminobutyric acid (GABA) B receptor subunits 
back to control levels (Han, et al. 2005b). This suggests that H2S is capable of regulating 
synaptic excitation/inhibition through regulating GABA subunit expression in the brain 
in this model of febrile seizure (Han, et al. 2005b). 
Mental retardation is a frequent symptom in patients with CBS deficiency  
(Dutta, et al. 2005), which may suggest CBS and/or endogenous H2S production in the 
brain have roles in conscious intellectual activity. In humans, CBS is expressed on 
choromosome 21 (Belardinelli, et al. 2001). Trisomy 21 (Down syndrome) patients are 
often associated with mental retardation and have greater urinary thiosulfate levels 
compared to control possibly as a result of increased H2S production (Belardinelli, et al. 
2001). These controversial outcomes may suggest that CBS/H2S may be an 
independent factor to conscious intellectual activity.  
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 The hypothalamus has a number of brain functions including the regulation of 
the body temperature, hormone secretion, food intake and control of the autonomic 
nervous system. The hypothalamus is capable of secreting hypothalamic-releasing 
hormones such as corticotropin-releasing hormone (CRH) and growth hormone-
releasing hormone (GHRH), which in turn influences the release of hormones from the 
pituitary gland. One study has demonstrated that H2S may be capable of modulating 
the hypothalamo-pituitary (HPA) axis. NaHS (1 mM) has been demonstrated to 
significantly inhibit the release of CRH from ex vivo hypothalamus explants induced by 
KCl (Dello Russo, et al. 2000). However, NaHS did not have effect on CRH release in the 
unstimulated hypothalamus (Dello Russo, et al. 2000). Indeed, whether physiological 
concentrations of H2S are capable of modulating the HPA axis is unclear and remains to 
be explored. 
Transient receptor potential (TRP) A1 ion channel (TRPA1) is an ion channel 
found on capsaicin-sensitive sensory neurons of the peripheral nervous system 
(Streng, et al. 2008). It was initially characterised as a noxious cold receptor but is now 
thought to be a channel involved in mechanosensation (Streng, et al. 2008). NaHS has 
been demonstrated to activate TRPA1 ion channels on unmyelinated C-fiber afferents 
of the rat urinary bladder (Streng, et al. 2008) and may be a mechanism by which H2S 
can initiate micturition. Furthermore, NaHS increases intracellular Ca2+ in TRPA1-
expressing Chinese hamster ovary (CHO) cells (Streng, et al. 2008). This evidence 
suggests that H2S may function as a nociceptive messenger by sensitising T-type Ca
2+ 





1.9.2. H2S and the pancreas  
There appears to be increasing interest in H2S and the regulation of endocrine 
function, particularly in the pancreas. H2S has previously been demonstrated to 
activate KATP channels and induce hyperpolarisation in smooth muscle cells (Zhao, et al. 
2001). Interestingly, the release of insulin is dependent on the inactivation of the KATP 
channels found on the β-islets of Langerhans. The presence of glucose results in the 
rise of intracellular ATP concentrations which leads to KATP channel inactivation, 
resulting in membrane depolarisation and opening of voltage gated Ca2+ channels and 
finally insulin release (Huopio, et al. 2002). In the presence of ADP (or less ATP), KATP 
channels open, resulting in membrane hyperpolarsation  leading to closure of Ca2+ 
channels and suppression of insulin secretion (Huopio, et al. 2002). Both endogenous 
and exogenous H2S has also been shown to increase the open probability of single-
channel KATP channels in INS-1E cells, an insulin-secreting cell line (Yang, et al. 2005). 
Interestingly, the INS-1E cell line appears to be susceptible to apoptosis induced by H2S 
(100 μM), possibly through activation of P38 MAPK pathway and endoplasmic 
reticulum stress (Yang, et al. 2007). Indeed the loss of β-islets is thought to be one of 
the causes of diabetes (Butler, et al. 2003). 
In a rat model of streptozotocin-induced diabetes, an increase in H2S enzyme 
activity in liver and pancreas was noted, and this was associated with an increase in 
CBS mRNA in both liver and pancreas (Yusuf, et al. 2005). The increased enzyme 
activity was normalised by insulin administration into the diabetic rats (Yusuf, et al. 
2005). In the zucker diabetic fatty rat model, the pancreas of these rats had increased 
CSE expression and increased H2S production compared to control (Wu, et al. 2009). 
Moreover, zucker diabetic fatty rats injected with PAG (33.9 mg/kg i.p.) over 4 weeks, 
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lead to a significantly increased serum insulin levels (Wu, et al. 2009). These authors 
suggested that insulin release was impaired in zucker diabetic fatty rats as a result of 
increased H2S production in the pancreas (Wu, et al. 2009). Interestingly, in a model of 
non-obese diabetic mice, the reduction in plasma H2S was suggested to be the cause of 
vascular dysfunction in these animals (Brancaleone, et al. 2008). Similarly, type-2 
diabetic and overweight humans have also been demonstrated to have reduced 
plasma H2S levels compared to lean controls (Whiteman, et al. 2010a).  
Indeed H2S appears to play a role in regulating insulin release and may possibly 
play a role in the pathological consequences of vascular dysfunction in diabetes. 
However, the roles of H2S in this field are still in its infancy and require further 
exploration.  
 
1.9.3. H2S and the gastrointestinal tract 
H2S is present in the gastrointestinal tract (GIT) with reported levels of up to 1 mM H2S 
present in the cecum (Deplancke, et al. 2003). This is thought to be a consequence of 
sulfate-reducing bacteria (Deplancke, et al. 2003). Interestingly, sulfate 
supplementation into the drinking water (16.7 mM) over 7 days to a year, did not alter 
H2S concentrations in the GIT but did alter the bacterial community profiles 
(Deplancke, et al. 2003). Although supplementary H2S does not increase H2S in the GIT, 
supplementing dietary sulfur amino acids has been shown to increase human fecal H2S 
concentrations  (Magee, et al. 2000). CSE and CBS enzymes are present throughout the 
GIT  (Martin, et al. 2009), and may also contribute to the H2S in the GIT.  
Using immunohistochemistry both CSE and CBS has been demonstrated to be 
present in the rat colon (Wallace, et al. 2009). CBS was found to be predominately in 
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the fibroblast and smooth muscle cells (Wallace, et al. 2009). Conversely, CSE 
expression was more diffuse and was shown to be located in blood vessels, epithelial, 
crypt and goblet cells of the rat colon (Wallace, et al. 2009). The presence of these 
enzymes in the GIT may suggest that H2S may play a role in GIT movement. Indeed, 
NaHS (EC50 62.6 ± 4.7 μM) has been shown to relax the guinea pig ileum (Teague, et al. 
2002). Furthermore, inhibiting CSE using PAG (1 mM) was shown to increase the 
contractile response of the guinea pig ilieum to field stimulation (Teague, et al. 2002). 
The predominant expression of CBS in the smooth muscle cell layer of the intestine 
(Wallace, et al. 2009) suggests that CBS has a greater role in gastric mobility than CSE. 
There appears to be increasing interest in the therapeutic benefit of H2S-
releasing NSAIDS (non-steroidal anti-inflammatory drugs) in the GIT. In the presence of 
biological samples the ester bond linking the NSAID to the H2S releasing moiety ADT-
OH (5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione) is thought to be hydrolysed 
liberating the NSAID and ADT-OH which releases H2S (Distrutti, et al. 2006b, 
Chattopadhyay, et al. 2011). Interestingly, these compounds have been demonstrated 
to be more potent at inhibiting colitis (Fiorucci, et al. 2007), ulcer healing (Wallace, et 
al. 2007b) and other  models of gastric injury (Fiorucci, et al. 2005a) than NSAIDS 
without the H2S releasing moiety. Moreover, in a mouse model of ethanol-induced 
gastric damage, NaHS (75 µmol/kg, p.o., 30 min pretreatment) prevented macroscopic 
gastric lesions and PAG (50 mg/kg, p.o., 30 min pretreatment) inhibited the protection 
induced by L-cysteine (Medeiros, et al. 2009). It has also been demonstrated that 
injecting PAG (50 mg/kg, i.p., twice daily) after the induction of colitis with 
trinitrobenzene sulfonic acid significantly (P<0.05) increased the mortality of these rats 
(Wallace, et al. 2009). Interestingly, injecting PAG in normal animals without colitis had 
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no effect on survival rate after 14 days (Wallace, et al. 2009). Moreover, 4 day post-
treatment with NaHS (30 µmol/kg, intracolonical, twice daily) significantly (P<0.05) 
reduced the severity of the colitis, as determined by a reduction in TNF-α expression, 
colon thickness and damage score (Wallace, et al. 2009).  H2S-releasing NSAIDS appear 
to be a promising field of H2S therapeutics. Indeed, ATB-429 (H2S releasing 
mesalamine) is currently entering first stage clinical trials for inflammatory bowel 
disease (Childers, et al. 2008). However, in July 2010, •NO-releasing NSAID naproxcinod 
was rejected by the Food and Drug Administration for its indication in osteoarthritis, 
due to limited data on the long term safety effects of this drug in the cardiovascular 
and GIT (Song 2010).  This suggests, although H2S-NSAIDs may be beneficial in 
preclinical models of inflammatory disease, it is likely that there may be some time 
before these drugs will be available for patients.  
 
1.9.4. H2S and the respiratory system 
H2S appears to have a role in the respiratory system. In humans, there are reduced 
serum levels of H2S in patients with asthma and this appears to correlate with disease 
severity (Wu, et al. 2008). H2S donors, GYY4137 and NaHS (both 100 μM) have been 
demonstrated to inhibit human airway smooth muscle cell proliferation induced by FCS 
and IL-1β in vitro, and this effect was inhibited by CBS inhibitor CHH (O-
(Carboxymethyl)-hydroxylamine hemihydrochloride), but not CSE inhibitor PAG (Perry, 
et al. 2011). Moreover, in the same study, both GYY4137 and NaHS reduced CBS, but 
not CSE, mRNA expression suggesting CBS is the predominant enzyme involved in 
producing H2S in human airway smooth muscle cells (Perry, et al. 2011). Interestingly, 
PAG appeared to aggravate airway responsiveness in a rat cigarette smoke model, 
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suggesting endogenous CSE is involved in the bronchodilation in this model (Chen, et 
al. 2010). It is possible there may be differences in the roles for CSE/CBS between 
humans and rodents and/or differing roles between CSE and CBS in the respiratory 
system. In a model of ovalbumin induced asthma in the rat, administration of NaHS (14 
μmol/kg i.p. pre-treatment) significantly reduced iNOS expression in lung tissue, 
inflammatory cell infiltration, airway mucus secretion, subepithelial fibrosis and goblet 
cell hyperplasia; suggesting exogenous H2S is anti-inflammatory (Chen, et al. 2009). In 
contrast, in another study, H2S was shown to irritate the airways. In this study, NaHS 
(50 mM, 200 μl, intratracheal) was shown to increase total lung resistance in 
anesthetised guinea pigs, and this effect was inhibited by tachykinin antagonists 
(Trevisani, et al. 2005). Moreover, NaHS (10 μM – 30 mM) concentration-dependently 
induced guinea-pig bronchial contraction ex vivo (Trevisani, et al. 2005). These authors 
concluded that exogenous H2S induces neurogenic inflammatory responses in guinea-
pig airways (Trevisani, et al. 2005). 
A reduction of H2S synthesising activity in the lung was described in an in vivo 
rat model of hypoxic vasoconstriction (Wei, et al. 2008). The administration of NaHS 
(14 μmol/kg i.p.) significantly reduced the increase of oxidised glutathione (GSSH) 
suggesting H2S may acts as an antioxidant during oxidative stress in the lung (Wei, et 
al. 2008). 
Acute lung injury is a potential cause of acute respiratory failure in the clinic (Li, 
et al. 2008c). In a model of acute lung injury induced by oleic acid, rats pre-treated 
with NaHS (3.1 mg/kg, i.p.) had increased partial pressure of oxygen in arterial blood, 
reduced pulmonary wet/dry weight and a reduction in polymorphonuclear cell 
infiltration (Li, et al. 2008c). Moreover, in the same model, H2S reduced pro-
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inflammatory cytokine IL-6 and chemokine IL-8 and increased anti-inflammatory 
cytokine IL-10 in the lung and plasma (Li, et al. 2008c).  
To date, the role of H2S in airway inflammation is unclear but appears to trend 
towards an anti-inflammatory role. Whether H2S therapy will translate to the clinic is 
yet uncertain. Indeed, H2S has a pungent smell and is unlikely to be patient compliant 
even if H2S did exert beneficial effects in the respiratory system. 
1.9.5. H2S and the cardiovascular system 
a)  H2S and blood pressure  
A biological role for H2S in the cardiovascular system was first described in 2001 (Zhao, 
et al. 2001). In this study, a bolus injection of NaHS (2.5 µmol/kg i.v.) caused a 
transient (30 sec) reduction in mean arterial blood pressure (MAP) of approximately 
12.5 mmHg in anaesthetised rats (Zhao, et al. 2001). This vasoactive property of NaHS 
in vivo was mimicked by the KATP channel opener pinacidil (2.8 µmol/kg) and inhibited 
by pre-treatment with a KATP channel blocker glibenclamide (2.8 µmol/kg) (Zhao, et al. 
2001). Moreover, NaHS induced a dose dependent relaxation (10 µM – 1 mM, IC50 = 
125 µM) in phenylephrine pre-contracted rat aortic rings (Zhao, et al. 2001). The effect 
in ex vivo blood vessels studies was inhibited by glibenclamide (IC50 = 140 µM), but not 
by 4-aminopyridine (2.5 mM, voltage-dependent K+ (Kv) channel blocker), 
indomethacin (10 µM, non-selective cyclooxygenase inhibitor), SQ22536 (100 µM, 
adenylate cyclase inhibitor), ODQ (10 µM, guanylate cyclase inhibitor), staurosporine 
(30 nM, protein kinase C (PKC) inhibitor), superoxide dismutase (SOD, 160 U/ml ) or 
catalase (1000 U/ml) (Zhao, et al. 2001). This suggests that the vasorelaxant effects of 
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H2S are due to activation of KATP channels, and not voltage-dependent K
+ channels, 
prostaglandins, cAMP, cGMP, PKC, O2
•- or H2O2. 
Currently the major mechanism underlying the vasoactive effect of H2S is 
thought to be a direct action of H2S to open KATP channels in vascular smooth muscle 
cells, causing the muscle cells to hyperpolarise and relax (Zhao, et al. 2001).  This effect 
is a direct action of H2S on KATP channels rather than an effect of H2S on ATP 
metabolism due to three observations: (i) intracellular ATP concentration was fixed, (ii) 
when H2S were washed out, the effect on KATP channels were promptly reversed and, 
(iii) varying intracellular ATP concentrations did not change the effect of H2S on KATP 
channels (Zhao, et al. 2001).  
It has also been demonstrated that Cl-/HCO3
- channel inhibitor DIDS (1 mM) can 
also abolish H2S induced relaxation in the rat aortic rings (Kiss, et al. 2008). In the same 
study, H2S was shown to reduce ATP levels in rat aortic rings (Kiss, et al. 2008). 
Consequently, these authors hypothesised that the incubation of rat aortic rings with 
H2S led to the inhibition of mitochondrial cytochorome c oxidase, reducing ATP 
generation, leading to cellular acidosis and the eventual activation of Cl-/HCO3
- 
channels to bring about vasodilatation (Kiss, et al. 2008).  
Interestingly, the effect of H2S on blood vessels were partially inhibited by the 
application of L-NAME (non-selective NOS inhibitor, 100 μM), charybdotoxin/apamin 
(inhibitors of endothelium-derived hyperpolarising factor (EDHF), both 50 μM) or 
removal of the endothelium; which may suggest H2S stimulates the release of 
•NO 
and/or EDHF from the endothelium, or H2S itself may act as an EDHF (Zhao, et al. 2001, 
Zhao and Wang 2002). In contrast to the results of previous studies (Zhao, et al. 2001, 
Zhao and Wang 2002), it was recently reported that NaHS can increase cGMP levels in 
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rat aortic smooth muscle cells through inhibiting phosphodiesterase (PDE) activity, and 
may be an alternative method of inducing vasodilatation (Bucci, et al. 2010). 
Interestingly, more recently, H2S has been demonstrated to enhance PDE activity in 
As4.1 juxtaglomerular cells (Lu, et al. 2011). Whether H2S exerts isoform differences on 
PDE activity, is currently unknown. 
Since 2001, H2S has been shown to cause vasodilation in various vessels such 
as: the rat aorta, H2S IC50, 125 ± 14 µM (Hosoki, et al. 1997, Zhao, et al. 2001), rat 
mesenteric arteries, H2S EC50 25.2 ± 3.6 µM and NaHS EC50 103.7 ± 10.0 µM (Cheng, et 
al. 2004), rabbit and human corpus cavernosum NaHS >100 µM (Srilatha, et al. 2007, 
d'Emmanuele di Villa Bianca, et al. 2009), human mammary artery NaHS >150 µM 
(Webb, et al. 2008), pig cerebral NaHS >10 µM (Leffler, et al. 2011),  rat hepatic NaHS 
100 µM (Fiorucci, et al. 2005b),  and renal NaHS >10 nmol/min/kg (Xia, et al. 2009) 
vascular beds. Interestingly, NaHS 1 mM does not affect coronary flow rate (Geng, et 
al. 2004, Johansen, et al. 2006).  
Although acute exposure to NaHS induces a transient (30 sec) reduction in 
blood pressure (Zhao, et al. 2001), H2S may have longer lasting effects on blood 
pressure unrelated to vasodilatation. Chronic administration of NaHS has also been 
demonstrated to reduce blood pressure in spontaneously hypertensive rats possibly by 
inhibiting collagen deposition and ROS production (Shi, et al. 2007, Zhao, et al. 2008). 
Moreover, chronic administration of NaHS has also been demonstrated to reduce the 
blood pressure of rats induced with renovascular hypertension but not in normal 
control rats  (Lu, et al. 2010). This effect was suggested to result from reducing renin 
release and synthesis in the kidney (Lu, et al. 2010), a mechanism suggested to be 
through inhibition of adenylate cyclase activity (Lu, et al. 2011). 
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Although exogenous H2S has been demonstrated to induce vasodilation, the 
endogenous role of H2S in blood pressure regulation is somewhat controversial. In one 
study, two daily injections of the irreversible CSE inhibitor PAG (with a total daily dose 
of 33.9 mg/kg i.p.) over 5 weeks caused a significant increase in systolic blood pressure 
within 2-3 weeks (Zhao, et al. 2003). However, in another study, a single injection of 
PAG (50 mg/kg, i.v.) had no effect on MAP or heart rate (HR) over 6 h in anaesthetised 
rats (Collin, et al. 2005). This is in contrast to L-NAME (1 – 10 mg/kg i.v.), which 
increases arterial blood pressure within 10 min (Gardiner, et al. 1990). CSE-/- KO mice 
have been described to develop an age dependent hypertension (Yang, et al. 2008). 
However, another group did not demonstrate blood pressure differences in their CSE-/- 
KO mice compared to WT (Ishii, et al. 2010).  
Although H2S is better known for its vasodilator effect, this gas can also cause 
vasoconstriction (e.g. alligator aorta, rat thoracic aorta) or a complex multiphasic 
vasoconstrictor and -dilator effect (e.g. duck and rat pulmonary artery), depending on 
the vascular bed and across different species (Dombkowski, et al. 2005). The 
mechanisms underlying its vasoconstrictive effects are unclear but several mechanisms 
have been proposed. It has been reported that H2S is able to contract rat aortic rings at 
low NaHS concentrations (<100 μM, below the threshold of KATP channel activation), 
possibly by quenching concurrently released •NO (Ali, et al. 2006), to form a novel 
nitrosothio (Whiteman, et al. 2006). NaHS (300 µM) has also been demonstrated to 
directly inhibit the conversion of [3H]-arginine into [3H]-citrulline by recombinant eNOS 
in vitro (Kubo, et al. 2007). However, whether H2S can directly inhibit eNOS activity in 
vivo is yet unclear. In addition, H2S can stimulate anion transporters to exchange HCO3
- 
for O2
•- which directly inactivates •NO (Liu and Bian 2011). NaHS (5 µM) has also been 
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demonstrated to inhibit forskolin-induced cAMP accumulation in rat aortic vascular 
smooth muscle cells and was suggested to be another mechanism by which H2S 
mediates its vasoconstrictive effects (Lim, et al. 2008) a mechanism possibly through 
stimulating phosphodiesterase activity and suppressing adenylate cyclase activity (Lu, 
et al. 2011). On the contrary, others have demonstrated H2S can inhibit 
phosphodiesterase activity in vitro (Bucci, et al. 2010). Indeed, this is an area which 
requires further clarification.  
Interestingly, hypoxia also induces vasodilation or vasoconstriction similar to 
that of H2S (Olson, et al. 2006). It has been hypothesised that H2S may serve as an O2 
sensor in vascular smooth muscle; where the balance of available H2S (produced 
endogenously) is dependent on its oxidation by available O2 (Olson, et al. 2006). 
Accordingly, when the O2 drops (e.g. in hypoxic conditions), the concentration of H2S 
increases which directly induces vasoconstriction/vasodilatation, or what is seen as 
hypoxic vasoconstriction/vasodilatation (Olson, et al. 2006). In accord with this 
hypothesis, a recent study demonstrated that in hypoxic conditions H2S synthesising 
activity is increased in the rat carotid body (Peng, et al. 2010). Moreover, injecting rats 
with PAG (200 mg/kg) significantly reduced response of the carotid body to hypoxia, 
suggesting a role for H2S in O2 sensing (Peng, et al. 2010). 
b)  H2S and cardiovascular remodeling 
H2S appears to play a role in vascular remodeling. Administration of NaHS (56 
μmol/kg/day) over 5 weeks inhibited collagen deposition in the aorta of spontaneously 
hypertensive rats (Zhao, et al. 2008). Moreover, NaHS (50 μM) was shown to inhibit 
angiotensin II induced vascular smooth muscle cell proliferation in vitro (Zhao, et al. 
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2008). Daily injection of NaHS (30 μmol/kg i.p.) over 4 weeks significantly reduced 
neointima hyperplasia after balloon injury in rats; and this effect was associated with a 
reduction in vascular smooth muscle cell proliferation (Meng, et al. 2007).  
ApoE-/- mice on a high fat diet injected with NaHS (56 μmol/kg) or PAG (37.5 
mg/kg) daily over 10 weeks led to a significant reduction or enlargement of aortic 
atherosclerotic plaque formation respectively (Wang, et al. 2009b). The effect of NaHS 
in ApoE-/- was associated with a reduction in plasma and aortic ICAM-1 expression 
(Wang, et al. 2009b). In the same study NaHS (50 – 500 μM) inhibited the 
transformation of THP-1-derived macrophages to foam cell phenotype in the presence 
of oxidised LDL (Wang, et al. 2009b). NaHS (750 μM) has previously been 
demonstrated to inhibit the modification of LDL (1 mg/ml) induced by HOCl (1 mM) 
(Laggner, et al. 2007). Moreover, NaHS (75 – 300 μM) was shown to concentration 
dependently induce the decomposition hydrogen peroxide (H2O2) and scavenge 
hypochlorous acid (HOCl), components that can oxidise LDL (Laggner, et al. 2007). 
Indeed, others have also shown that H2S can scavenge other reactive species including 
peroxynitrite (ONOO-) (Whiteman, et al. 2004) and superoxide (O2
•-) (Chang, et al. 
2008) all of which are capable of modifying LDL (Steinbrecher 1988, Dinis, et al. 2002). 
Vascular calcification is a process in which VSMCs are transformed into a 
phenotype similar to that of osteoblasts; characterised by over expression of proteins 
such as osteopontin and increased alkaline phosphatase activity (Wu, et al. 2006). In a 
rat model of vascular calcification induced by vitamin D3/nicotine, injection of NaHS 
(2.8 μmol/kg) over 4 weeks caused a significant reduction in vascular calcium content, 
reduced alkaline phosphatase activity and a reduction in osteopontin mRNA (Wu, et al. 
2006). Similarly, another study also demonstrated that NaHS (50 μM) could inhibit the 
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calcification of human aortic smooth muscle cells in vitro induced by inorganic 
phosphate (Zavaczki, et al. 2011). In the same study PAG (10 mM) significantly 
increased human aortic smooth muscle cell calcification (Zavaczki, et al. 2011). 
In a rat model of heart failure, daily treatment with NaHS (3.136 mg/kg) 
improved left ventricular systolic pressure (LVSP) with no change in heart rate (Wang, 
et al. 2011b). Moreover, the rats injected with H2S had significantly less fibrosis, 
reduction in apoptotic cardiomyocytes, and improved mitochondrial morphology 
compared to control hearts (Wang, et al. 2011b). Furthermore, mice with a targeted 
cardiac over-expression of CSE was protected against cardiac hypertrophy and left 
ventricular dysfunction (Calvert, et al. 2010). 
c)   H2S and angiogenesis 
Interestingly, although H2S can inhibit VSMC proliferation, H2S induces the 
proliferation of endothelial cells. NaHS (10 – 20 μM) was shown to increase migration, 
proliferation and induce tube-like structures in the RF/6A endothelial cell line and this 
effect was through activation of the phosphatidylinositol 3-kinase (PI3K)/protein 
kinase B (Akt) (Cai, et al. 2007). Moreover, the injection of NaHS (10 μmol/kg i.p.) over 
7 days significantly increased neovascularisation in vivo (Cai, et al. 2007). 
In another study, NaHS (300 μM) induced the expression of hypoxia inducible 
factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) mRNA in rat aortic 
VSMCs exposed to hypoxic conditions (Liu, et al. 2011). Moreover, the NaHS 
conditioned medium from the VSMC, induced the proliferation and migration of rat 
brain capillary endothelial cells; suggesting HIF-1α/VEGF is involved in H2S-mediated 
angiogenesis under hypoxic conditions  (Liu, et al. 2011). 
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 H2S ( 60 μM) was demonstrated to promote human umbilical vein endothelial 
cell (HUVEC) proliferation, migration and induced the formation of capillary tube-like 
structures; a mechanism that was dependent on KATP channel activation and p38 MAPK 
phosphorylation (Papapetropoulos, et al. 2009). Indeed, this promising effect of H2S on 
angiogenesis requires further exploration.   
d)  H2S and thrombosis/platelet function 
NaHS has been shown to inhibit the aggregation of human platelets in response to a 
wide range of platelet aggregating agonists in vitro (Zagli, et al. 2007). The anti- 
aggregatory effect of H2S was independent of potassium channel opening, cAMP, 
cGMP and •NO (Zagli, et al. 2007). However, only high concentrations (IC50 of 0.70-5.62 
mM, dependent on the platelet aggregating stimulus) of NaHS completely inhibited 
platelet aggregation (Zagli, et al. 2007), which may suggest endogenous H2S is unlikely 
to unlikely to inhibit platelet aggregation.  
Garlic may be a source of H2S in vivo (Benavides, et al. 2007).  In this study, 
human red blood cells (RBC) were capable of converting garlic polysulfides into H2S; 
and this was dependent on a non-enzymatic pathway involving thiols compounds such 
as GSH, cysteine, homocysteine, N-acetyl-cysteine and reduced thiols on the RBC 
membrane (Benavides, et al. 2007). Moreover, H2S derived from garlic is capable of 
relaxing PE-pre-contracted rat aortic rings in a dose dependent manner (Benavides, et 
al. 2007). In a double-blind, randomised, paired placebo-controlled trail, 14 healthy 
volunteers who took capsules of garlic oil (containing 9.9 g of garlic) had their blood 
taken 4 hours later (Wojcikowski, et al. 2007). The garlic oil did not reduce collagen- or 
ADP-induced platelet aggregation in vitro (Wojcikowski, et al. 2007). However, there 
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was a small but significant reduction (12%) in adrenaline-induced platelet aggregation 
from blood samples taken from volunteers taking garlic oil (Wojcikowski, et al. 2007). 
They concluded that an acute dose of garlic oil may not be beneficial in reducing 
platelet aggregation, however, it may be beneficial on chronic treatment (Wojcikowski, 
et al. 2007). 
e)  H2S and the myocardium 
H2S has negative inotropic effects in the heart both in vitro and in vivo (Geng, et al. 
2004). The perfusion of NaHS (3 mM) into the Langendorff heart perfusion model 
significantly inhibited left ventricular pressure development and reduced heart rate 
(Geng, et al. 2004). Moreover, injecting NaHS (2.8 μmol/kg i.v.) into rats induced a 
transient (60 sec) reduction in left ventricular pressure (Geng, et al. 2004). NaHS (100 
μM) was shown to inhibit L-type calcium channel (IcaL) opening and reduce the action 
potential duration in rat ventricular cardiomyocytes (Sun, et al. 2008), and may be a 
reason for the negative inotropic effects of H2S. 
H2S also protects the heart against myocardial ischemia and reperfusion, 
possibly through: stimulating the PI3/AKT/PKC pathway (Hu, et al. 2008b, Calvert, et al. 
2010, Hu, et al. 2011); inducing KATP channel activation and activating PKC/ERK1/2 
pathways (Hu, et al. 2008b); inhibiting Na+/H+ exchanger activity (Hu, et al. 2011); 
inducing nuclear localisation of nuclear factor-E2-related factor (Nrf2) (Calvert, et al. 
2010);  and preservation of mitochondrial structure and function (Elrod, et al. 2007). In 
general it appears that H2S is predominantly protective in models of ischemia-
reperfusion, which is also evident in ischemia-reperfusion models of the liver (Jha, et 
al. 2008, Kang, et al. 2009), kidney (Bos, et al. 2009, Xu, et al. 2009, Simon, et al. 2010),  
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lung (Fu, et al. 2008), retina (Biermann, et al. 2011) and intestines (Liu, et al. 2009, 
Henderson, et al. 2010). 
Moreover, H2S appears to be cardioprotective in a number of models including: 
cobalt chloride (CoCl2) induced hypoxia in vitro (Yang, et al. 2011a); adriamycin-
induced cardiomyopathy (Su, et al. 2009); metabolic inhibition (glucose-free buffer) in 
vitro (Pan, et al. 2006); and coxsakievirus B3 induced myocarditis (Hua, et al. 2009). 
1.9.6. H2S and inflammation 
a)  Local inflammation 
The four cardinal signs of inflammation were first described by Celsus (30–38 B.C, 
ancient Rome) as rubor (redness), calor (heat), dolor (pain) and tumour 
(swelling/oedema) (Punchard, et al. 2004). Galen (130–200 A.D.) subsequently added 
loss of function (functio laesa) as part of the list of staple signs of inflammation 
(Punchard, et al. 2004). Inflammation is now described as a complex process involving 
the influx of inflammatory cells (leukocytes) controlled by a balance of mediators such 
as cytokines, complement, eicosanoids (e.g. leukotrienes and prostaglandins) and 
others.  Acute inflammation is necessary for the healing and removal of harmful 
substances. Chronic or non-resolving inflammation, however, is a problem and may 
result in discomfort and the loss of function of normal tissue and lead to conditions 
such as osteoarthritis, multiple sclerosis, atherosclerosis and inflammatory bowel 
diseases. Leukocytes are a key component of the inflammatory cascade. To reach the 
site of inflammation, leukocytes must migrate from the blood into the tissues. In the 
process of leukocyte trafficking, selectins (e.g. E-selectin) are involved in the capture of 
leukocytes to the endothelial surface (Ehrhardt, et al. 2004). However, due to the low 
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affinity for their ligands results in a ‘capture and release’ motion resulting in the ‘slow 
rolling’ (<5 μm/second) of leukocytes along the endothelial cell surface (Ley, et al. 
2007). The process of leukocyte firm adhesion and leukocyte arrest is as a result of the 
up-regulation of: α4 and β2 integrins (e.g. very late antigen-4 and lymphocyte function-
associated antigen-1 respectively) on leukocytes and their respective ligands; adhesion 
molecules (ICAM-1 and VCAM-1) on endothelial cells (Ley, et al. 2007). Upon the firm 
adhesion to the endothelial cell wall, with the aid of other adhesion molecules such as 
platelet–endothelial-cell adhesion molecule (PECAM), vascular endothelial cadherin 
and junctional adhesion molecules (JAM), results in the migration of leukocytes 
through the endothelial barrier into the tissues (Muller 2003). 
b)  H2S in models of inflammation 
The role of H2S in inflammation is unclear and extensive reviews on this topic of H2S 
have been published (Li, et al. 2006, Wallace 2007, Olson 2011, Whiteman and 
Winyard 2011). A part of this thesis aims to examine the effects of H2S in inflammation. 
Therefore, this section of the thesis will cover aspects that have not been covered in 
the discussion or introduction of Chapter 5.  
Similar to •NO, a number of pro- and anti-inflammatory functions exist for H2S. 
In a model of acute pancreatitis induced by caerulein, pre- and post-treatment with 
PAG (100 mg/kg i.p.) significantly reduced lung and pancreatic substance P 
concentrations and neurokinin-1 receptor mRNA, suggesting a pro-inflammatory effect 
of endogenous H2S (Bhatia, et al. 2008a). Similarly, PAG (50 mg/kg i.p.) pre-treatment 
has been demonstrated to reduce rat hindpaw oedema and reduce myeloperoxidase 
(MPO, indicator of neutrophil infiltration) activity induced by carrageenan (Bhatia, et 
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al. 2005). Additionally, in a model of severe burn injury, both pre- or post- treatment 
with PAG (50 mg/kg i.p.) significantly reduced MPO activity in the lung and liver; 
whereas NaHS (10 mg/kg i.p.) injected at the time of burn injury, significantly 
increased MPO activity in the lung (Zhang, et al. 2010). NaHS (3 μmol/kg i.p.) pre-
treatment has also been demonstrated to enhance neutrophil migration to the 
peritoneal cavity induced by LPS, in a KATP channel dependent mechanism (Dal-Secco, 
et al. 2008). 
In contrast, pre-treatment with Na2S or NaHS (100 μmol/kg, intragastric) 
inhibited leukocyte adherence in mesenteric venules induced by aspirin or fMLP (N-
formyl-methionine-leucine-phenylalanine) through a KATP dependent mechanism 
(Zanardo, et al. 2006). Similarly, NaHS (100 μmol/kg i.p.) inhibited leukocyte infiltration 
in a rat model of carrageenan-induced inflammation of the air pouch (Zanardo, et al. 
2006). A H2S-releasing derivative of diclofenac (ACS15), but not diclofenac itself, 
significantly inhibited lung MPO activity on post- cerulein injection (Bhatia, et al. 
2008b). Moreover, in a model of smoke and burn injury, subcutaneous injection of 
Na2S (2 mg/kg) post-injury significantly reduced pro-inflammatory cytokine IL-1β and 
increased anti-inflammatory cytokine IL-10 in lung tissue (Esechie, et al. 2008).  
Although, H2S appears to have both pro- and anti-inflammatory effects in a 
number of models, H2S appears to be predominantly anti-inflammatory in models of 
gastric injury (Fiorucci, et al. 2005a, Distrutti, et al. 2006a, Fiorucci, et al. 2007, 
Wallace, et al. 2007b, Wallace, et al. 2009). Whether there are organ responsive 




c) Systemic inflammation 
Sepsis is a systemic inflammatory disorder due to infection (e.g. bacteria, 
viruses or fungi) of the bloodstream (Doi, et al. 2009). Sepsis is a common disease 
state, with an estimated mortality rate of 28% in sever septic cases in the United States 
(U.S.) (Angus, et al. 2001). Sepsis has an average cost of $22,000 per case costing the 
U.S. healthcare system an estimated $16 billion each year (Angus, et al. 2001). Sepsis 
can be defined into two distinct haemodynamic phases. The first phase being the 
hyperdynamic phase (also termed warm shock), characterised a low systemic vascular 
resistance compensated by an increased cardiac output (Buras, et al. 2005, Doi, et al. 
2009). During this phase, the innate immune system is activated through the binding of 
pathogen-associated molecular patterns to toll-like receptors (TLR) e.g. LPS to TLR-4 
(Lu, et al. 2008). TLR activation results in the activation of downstream signaling 
pathways that eventually lead to the activation of transcription factors such as NF-κB 
(nuclear factor-κB), AP-1 (activator protein-1) and IRF-5 (interferon regulatory factor 
5), and the subsequent production of pro-inflammatory cytokines and the activation of 
both immune and non-immune cell types  (Lu, et al. 2008). The second later 
hypodynamic phase (cold shock) is characterised by a low systemic vascular resistance 
but with a reduced cardiac output (Buras, et al. 2005, Doi, et al. 2009). Shock is defined 
as a disturbance between oxygen delivery and oxygen consumption to tissues (Spronk, 
et al. 2004). A reduced cardiac output in the second haemodynamic phase of sepsis, 
leads to a reduction in oxygen delivery to tissues leading to septic shock and multiple 
organ failure (Spronk, et al. 2004). Septic shock is clinically defined as a mean systemic 
blood pressure of <60 mmHg after attempted fluid resuscitation (Doi, et al. 2009). As a 
physiological reflex to reduce these consequences and maintain systemic blood 
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pressure and oxygen delivery to vital organs such as the brain and heart, low priority 
areas such as the microvascular beds in the skin are shunted (Spronk, et al. 2004). If 
the microcirculation is not perfused in a timely manner, this can result tissue damage 
and eventually multiple organ failure (Spronk, et al. 2004). Multiple organ dysfunction  
is defined when two or more organs systems are impaired and homeostasis cannot be 
maintained without therapeutic intervention (Robertson and Coopersmith 2006).  The 
consequences of reduced cardiac output and impaired microcirculatory perfusion are 
worsened by the activation of the clotting cascade, increased aggregability of 
leukocytes, endothelial adherence and increased blood viscosity (as a result of reduced 
deformability of red blood cells) leading to further oxygen deprivation to tissues (Astiz, 
et al. 1995, Spronk, et al. 2004).  
d) H2S in animal models of sepsis 
Plasma •NO is elevated in models of endotoxin shock and is thought to be one 
cause of the hypotension described in sepsis (Thiemermann and Vane 1990). Similarly, 
plasma H2S is elevated in a rat model of endotoxin shock (Li, et al. 2005). Like iNOS, 
CSE expression is induced by LPS (Li, et al. 2005, Zhu, et al. 2010) and consequently CSE 
may be seen as pro-inflammatory. H2S has been demonstrated to reduce blood 
pressure in vitro and in vivo (Zhao, et al. 2001), and it can be hypothesised that a rise in 
H2S contributes to the hypotension induced by endotoxin shock. However, unlike 
inhibiting •NO synthesis (Thiemermann and Vane 1990), inhibiting H2S synthesis using 
PAG (up to 50 mg/kg) did not affect the MAP of septic rats (Collin, et al. 2005). 
However, in the same study PAG was shown to reduce serum aspartate 
aminotransferase and alanine transaminase, lipase and creatine kinase levels, 
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indicating a reduction in liver, pancreatic and neuromuscular injury respectively (Collin, 
et al. 2005). This suggests that inhibiting endogenous H2S synthesis is beneficial in 
sepsis and these beneficial effects are independent of hemodynamic effects. Similarly 
in another study PAG (50 mg/kg i.p.) pre- and post- cecal ligation and puncture (CLP)-
induced sepsis, significantly reduced MPO activity in the lung and liver; This is in 
contrast to NaHS (10 mg/kg i.p. injected at the time of CLP) which increased MPO 
activity in the lung and liver (Zhang, et al. 2006).  Moreover, PAG treated mice had an 
increased survival rate compared to control (Zhang, et al. 2006). Another study utilising 
the same protocol as the latter demonstrated that PAG reduces and NaHS increases 
lung injury in CLP-induced sepsis through regulating the generation of the 
inflammatory neuropeptide substance P (SP) (Zhang, et al. 2007a). In a model of 
endotoxic shock, PAG (50 mg/kg i.p.) reduced lung and liver MPO activity, whereas 
NaHS (14 μmol/kg i.p) had the opposite effect and increased plasma tumor necrosis 
factor (TNF)-α (Li, et al. 2005). Evidence from the latter studies suggest both 
endogenous and exogenous H2S elicits pro-inflammatory effects in models of sepsis. 
 H2S has also been demonstrated to have anti-inflammatory effects in sepsis 
(Spiller, et al. 2010). PAG (50 mg/kg i.p.) pre-treatment increased TNF-α and 
macrophage inflammatory protein (MIP)-2 in the peritoneal exudates of CLP-septic 
mice (Spiller, et al. 2010). In addition, PAG was demonstrated to increase rolling and 
adhesion of leukocytes to the mesenteric venules of these septic mice; whereas NaHS 
(100 µmol/kg, subcutaneous) pre-treatment significantly reduced leukocyte rolling. 
(Spiller, et al. 2010) Moreover, NaHS pre-treatment significantly improved the 
mortality of CLP-septic mice (Spiller, et al. 2010). In another study, novel slow releasing 
H2S donor GYY4137 (50 mg/kg, i.p. post-treatment ) was shown to reduce the LPS-
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induced hypotension in anesthetised rats (Li, et al. 2008b). Moreover, GYY4137 
reduced plasma nitrite/nitrate, lung MPO, alanine aminotransferase, pro-inflammatory 
cytokines (TNF-α and interleukin (IL)-6) (Li, et al. 2008b). These data suggest that 
endogenous and exogenous H2S is anti-inflammatory in models of sepsis. 
The role of H2S in inflammation is complex and appears to be contradictory. As 
a result, a part of my thesis will attempt to examine the effects of H2S donors in 





















1.10. Aims of thesis 
 
1. To elucidate the mechanisms of endothelial cell derived H2S by i) examining the 
release of H2S from endothelial cells in response to agents that elevate 
intracellular Ca2+ ii) examining the Ca2+/CaM dependence of CSE and CBS 
enzymes from liver homogenates. 
 
2. To investigate the potential cross talk between •NO and H2S using eNOS
-/- and 
iNOS-/- knockout mice by i) assessing organ H2S synthesising activity and ii) 
examining CSE or CBS protein expression in different tissues. 
 
3. To determine the effects of a novel slow releasing H2S donor GYY4137 on i) 
endothelial cell adhesion molecule expression in vitro ii) to explore the 
mechanisms behind its effects on adhesion molecule expression and iii) 
investigate the effects of GYY4137 in carrageenan-induced mouse hindpaw 
oedema. 
  
4. To identify and characterise ZJ802, a novel organosulfur compound. With the 
use of biochemical techniques i) examine the ability of ZJ802 to release H2S and 
ii) determine its antioxidant capacity compared to NaHS and GYY4137. 
Determine whether ZJ802 has anti-inflammatory properties by investigating the 




CHAPTER 2 – General Materials and Methods 
 
2.1.  HUVEC cell culture 
Umbilical cords of healthy normaltensive mothers were collected at the birth centre in 
St. Thomas NHS Foundation Trust. Cords were stored at 4oC in cord pot solution (2.5 
mM HEPES buffer, 1x HBSS, 387.5 μM gentamicin sulphate (PBS), 18.75 mM 
bicarbonate) until collection. Umbilical cords greater than 3 days old were discarded. 
Informed written consent was provided with all umbilical cords employed in these 
experiments.  The umbilical vein was cannulated at both ends, and sterilised 
Dulbecco’s phosphate buffered saline (PBS, room temperature) was injected to 
remove blood and to ensure no leakage occurred along the length of the cord. The 
umbilical vein was injected once with air to remove excess PBS. 20 ml collagenase 
(crude Type IA from Clostridium histolyticum, 1 mg/ml in serum free M199) was 
flushed through the vein using two 10 ml syringes connected at both ends of the cord. 
Collagenase is used to cleave the bond between glycine and the neutral amino acid (X) 
in the sequence Pro-X-Gly-Pro, to induce endothelial cell dissociation from the 
connective tissue of the umbilical vein. The cord containing the collagenase was 
wrapped in foil and placed in a 37oC incubator for 10 min. After the incubation, the 
cord was subsequently massaged gently to aid removal of human umbilical vein 
endothelial cells (HUVEC).  The collagenase subsequently spun down at 1200 rpm for 
10 min and the pellet resuspended in full serum M199 (5 ml M199-20%: containing 
10% v/v fetal calf serum (FCS), 10% v/v newborn calf serum (NCS), endothelial cell 
growth supplement (ECGS 5 ng/ml, heparin 0.175 mg/ml), L-glutamate 2 mM and 
penicillin 100 U/ml, streptomycin 0.1 mg/ml). The cell suspension was placed in a 
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gelatin (10 mg/ml) coated T25 flask and left overnight in the cell culture incubator 
(37oC, 5% CO2 and 95% air, humidified with CuSO4).  This culture was denoted as 
passage zero (Po). The following day, the cells were rinsed twice with PBS to remove 
debris and fresh M199-20% was supplied.  
In optimal cell culture conditions, cells will proliferate until cells come in contact 
with one another until no room is left to grow, this is termed contact inhibition. If the 
cells are over confluent (that is too packed) their growth will cease and proliferation 
will cease. To ensure enough cells are obtained for experimentation, cells will need to 
be split before proliferation ceases. Therefore upon 90-95% confluence, cells should be 
split into cell culture flasks with a greater area to grow or into more than one cell 
culture flask of a similar size.    
Trypsin is a member of the serine protease family that is inactivated by Ca2+ or 
Mg2+, and is used to re-suspend cells that adhere to cell culture flasks.  To prevent cells 
from becoming over confluent, cultures were rinsed twice in Ca2+/Mg2+ free PBS to 
remove excess serum (a source of Ca2+) and 1 ml trypsin/EDTA (PAA, in Ca2+/Mg2+ free 
PBS) was added into each flask. Under the light microscope, once the cells become 
rounded in shape and begin to lift off the flask, the flask was tapped gently and M199-
20% was added to inactivate the trypsin. The cell suspension was subsequently divided 
into the appropriate number of flasks.    
For HUVEC, once the T25 (P0) was approximately 95% confluent, this culture was 
split directly into one T75 flask (termed passage 1, P1). On 95% confluence of P1, the 
T75 was split into three T75 flasks (P2). HUVECs in P2 were subsequently split into the 
final experimental conditions (P3). To reduce cell differentiation into other cell types, 
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HUVECs greater than P3 were not used. Endothelial cell cobblestone morphology was 
assessed under light microscopy before experiments were carried out. 
During experimental conditions, a reduced serum medium was utilised (M199, 1% 
v/v FCS, penicillin 100 U/ml, streptomycin 0.1 mg/ml, 2 mM L-glutamine) to arrest and 
synchronise the cells in cell cycle phase G0 or G1.  
2.2.  BAEC Cell Culture 
Primary bovine aortic endothelial cells (BAEC, Figure 2a) were kindly provided by Dr 
Richard Siow (King’s College London, Department of Physiology). Cells were grown in 
full serum M199 (40% v/v FCS and L-glutamate (2 mM) containing 100 U/ml penicillin 
with 0.1 mg/ml streptomycin (PAA) in serum free M199 (supplemented with 18.75 μM 
bicarbonate). To maintain the cell culture, the cells were split using trypsin/EDTA (PAA) 
in a split ratio of 1:3 on 1% w/v gelatin (Biorad) coated flasks and maintained in the cell 
culture incubator. BAEC up to passage 10 were used in all experiments.  
Cells were cryopreserved in M199-20% supplemented with 10% v/v DMSO 
(Method 2.4). Cells were defrosted in a water bath (37oC) for approximately 3 min until 
the contents were defrosted. The vial of cells were immediately placed in 20 ml fresh 
M199-20% and left in the incubator overnight. The next day the medium was replaced 
with 10 ml fresh M199-20%.  
2.3.  RAW 264.7 Cell Culture 
RAW 264.7 were purchased from the American Type Culture Collection (ATCC; TIB-71). 
RAW 264.7 is an immortalised murine macrophage cell line.  Cells were cultured in 
Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% v/v FCS, L-
glutamate 2 mM, penicillin 100 U/ml and  streptomycin 0.1 mg/ml (DMEM-10%) in the 
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cell culture incubator. During experimental conditions serum free medium was used 
(SF-DMEM: 10% v/v water, L-glutamate 2 mM, penicillin 100 U/ml and streptomycin 
0.1 mg/ml).   
Cells were cryopreserved in DMEM-10% supplemented with 10% v/v DMSO 
(Method 2.4). Cells were defrosted in a water bath (37oC) for approximately 3 min until 
the contents were defrosted. The vial of cells were immediately placed in 20 ml fresh 
DMEM-10% and left in the incubator overnight. The next day the medium was 
replaced with 10 ml fresh DMEM-10%.  
2.4.  Cryopreservation 
Adherent cell lines were washed twice in warm PBS and lifted from the plate using 
Trypsin/EDTA and resuspended with fresh medium. Cells were centrifuged at 1200 g 
for 7 min. Medium was aspirated and resuspended with 1 ml full serum medium 
supplemented with 10% v/v DMSO. Cells were transferred to a cryogenic vial and 
placed in a “Mr Frosty” container (Nalgene). The Mr Frosty container was stored at -
80oC for a minimum of 1 night. For longer term storage (> 2 months), frozen cells were 
transferred from -80oC to liquid nitrogen.  
2.5.  Bradford Protein Assay 
Protein concentration was determined using the Quick Start Bradford Protein Assay 
according to the manufactures instructions. The basis of the Bradford protein assay is 
the binding of Coomassie Brilliant Blue G-250 dye to aromatic and basic (particularly 
arginine) amino acid residues in proteins. The dye exists in three forms: cationic 
(acidic, red: 470 nm), neutral (green: 650 nm) and anionic form (blue: 595 nm). The 
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cationic form of the dye donates a free proton to proteins containing side chains that 
are ionisable. This causes the protein to expose its hydrophobic sites and positive 
amine groups which bind to the hydrophobic and anionic part of the dye. As a result, 
once the dye binds to proteins it stabilises in the anionic (blue) form. 
In brief, Bradford dye 250 μl and sample 5 µl were added to a 96-well plate and 
incubated at room temperature for at least 10 min. The standard curve was made up 
using bovine γ-globulin provided in the assay kit. The absorbance was then determined 
in a microplate reader (Spectra Max190) at 595 nm and analyzed using SOFTmax PRO 
(Version 3.0) software.  
2.6.  Bicinchoninic acid (BCA) Protein Assay 
The Bradford protein assay (method 2.4.) is not compatible with reducing reagents as a 
result the bicinchoninic acid (BCA) protein assay (Thermo Scientific Pierce) was carried 
out where reducing reagents e.g. cell lysis buffer was used. The theory behind the 
assay is based on the reduction of cupric ion (Cu2+) to cuprous ion (Cu+) following 
binding to protein in an alkali environment. Two molecules of BCA are thought to bind 
to one cuprous ion to form a purple coloured product. 
The BCA protein assay was carried out by mixing 50:1 of reagent A (containing 
bicinchoninic acid): reagent B (containing cupric sulfate). In a 96 well plate, working 
reagent 200 μl was mixed with of sample/standard 5 μl and allowed to incubate at 
room temperature for 30 min in the dark before absorbance was measured on a 
microplate reader at 562 nm. A standard curve was carried out using bovine γ-globulin 




2.7. Western Blotting and SDS-PAGE 
2.7.1. Theory behind SDS-PAGE 
Polyacrylamide gel electrophoresis (PAGE) is the process of separating proteins 
through a polyacrylamide matrix gel using an electric current. Proteins are sorted 
according to their size and/or charge, based on the principle that larger proteins 
migrate slower than smaller proteins. The pore size of the gel matrix that the proteins 
migrate through is determined by the percentage of acrylamide used. A higher 
percentage of acrylamide results in smaller pores that will impede the movement of 
larger proteins compared to smaller molecular weight proteins. Denatured proteins 
that are resolved in reducing conditions, that is in the presence of sodium dodecyl 
sulfate (SDS), is described as SDS-PAGE. Heating proteins in the presence of sample 
buffer containing SDS (a highly anionic detergent), results in the coating of negative 
charges in the unfolded proteins, as a result SDS-PAGE resolves proteins primarily 
according to their mass. This is in contrast to non-denaturing (native) PAGE that 
separates proteins with regard to their mass, shape of native structure as well as net 
charge. To ensure that the proteins running on SDS-PAGE have an overall net negative 
charge, the gels are immersed in electrophoretic running buffers that have an alkaline 
pH. Zwitterions are molecules that have both a negative and positive charge on the 
same molecule. Amino-acids in proteins are zwitterions as they have basic amine 
(NH3
+) and an acidic carboxylic acid (COO-) group. Immersing proteins in an alkaline pH 
neutralises the basic amine group (NH3
+  NH2) leaving the amino-acids with an 
overall negative charge from the carboxylic acid group, ensuring that the charge of a 
protein is not a variable in proteins running on SDS-PAGE. Reducing agents, such as β-
mercaptoethanol are also added to the sample buffer to cleave disulfide bonds in 
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proteins, to ensure that no tertiary or quaternary structure remain in proteins running 
in SDS-PAGE. Diffusion during electrophoresis can blur the protein bands and it is 
therefore common to apply a stacking gel on top of the resolving gel (termed a 
discontinuous buffer system). The stacking gel, concentrates (or stacks) the proteins 
together before it is resolved (or destacked) in the resolving gel and provides increased 
resolution of the protein bands (Davis 1964, Ornstein 1964). The theory behind the 
stacking the proteins is the Cl- in the gel buffer has the highest attraction to the anode 
and therefore migrates the fastest bringing it to the front of the moving boundary of 
proteins heading towards the anode (Davis 1964, Ornstein 1964). The glycine provided 
by the running buffer is only partially negative at the pH in the stacking gel and 
therefore has the slowest migration velocity towards the anode (Davis 1964, Ornstein 
1964). The mobility of sample proteins in the gel migrate intermediate between the 
leading ion Cl- and the trailing ion glycine (Davis 1964, Ornstein 1964). As the glycine 
front moves closer to the Cl- front it concentrates and stacks the proteins into narrow 
zone. The change in pH and pore size at the boundary between the resolving and 
stacking gel causes the trailing ion to speed up and migrate through and past the 
sample proteins to migrate with the Cl- ions. As the proteins escape the glycine/Cl- 
front in the resolving gel, the proteins unstack according to their mass (Davis 1964, 
Ornstein 1964).  
2.7.2. Theory behind Western blotting 
Blotting refers to the transfer of a substance, either protein, RNA or DNA, onto a 
membrane. Western blotting (also known as protein immunoblot) is a method where 
proteins are transferred to a membrane and antibodies are used to detect and 
quantify the specific protein of interest. The electrophoretic transfer of proteins from 
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polyacrylamide gels to a membrane was first described by (Towbin, et al. 1979) and is 
now used as a standard procedure used to quantify proteins since. This is normally 
carried out in running buffer used in SDS-PAGE supplemented with methanol, termed 
transfer buffer. The methanol improves the transfer of proteins from gel to membrane 
and causes SDS to dissociate from proteins. (Pettegrew, et al. 2009) The membrane is 
subsequently blocked by incubation with a blocking buffer such as albumin or non-fat 
milk, before incubation with primary antibody to reduce non-specific binding of the 
antibody and hence reducing background a improving the signal to noise ratio. Excess 
primary antibody is subsequently washed off the membrane in a wash buffer 
consisting of a physiological buffer (such as PBS) containing a light detergent such as 
Tween-20. The protein of interest is usually quantitated through incubating the 
membrane with a secondary antibody conjugated to horse radish peroxidase (HRP). 
Excess secondary antibody is washed off and the membrane is subsequently incubated 
with a substrate for HRP, most commonly a chemiluminescent substrate. The light 
emitted from the chemical reaction of substrate and HRP is subsequently quantitated 
using film or a gel documentation (gel doc) system. 
2.7.3. SDS-PAGE and Western blotting Protocol 
Cells and tissues were lysed in lysis buffer (EDTA 5 mM, NaCl 150 mM, Tris-HCl 50 mM, 
1% v/v Triton-X100, 1% w/v SDS, phenylmethylsulphonyl fluoride 1 mM (isopropanol), 
protease cocktail inhibitor (Sigma), Appendix B).  Stacking gel and the appropriate 
resolving gel and was prepared (Appendix A) for SDS-PAGE. Protein samples in lysis 
buffer was mixed 1:1 with laemmli sample buffer (Appendix A) and subsequently 
denatured at 95oC for 5 min. Denatured protein samples (10 µg / 25 µl) and molecular 
weight ladder (5 µl, GE healthcare RPN800E) were loaded into each well of the stacking 
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gel unless otherwise stated. The gel was subsequently run in running buffer (Tris-base 
25 mM, Glycine 192 mM, SDS 0.1% w/v, pH 8.3) using the Bio-Rad mini gel system, at 
110 V until the dye front reached the end of the plate. Proteins from the gel were then 
transferred to a polyvinylidene difluoride membrane (PDVF, 0.45 µm pore size, GE-
Healthcare) using the mini-trans blot Electrophoretic Transfer Cell in cold transfer 
buffer (20% v/v methanol, Tris-base 25 mM, Glycine 192 mM, SDS 0.1% w/v, pH 8.3) at 
130 V for 1 h. The PDVF membrane was subsequently blocked in 5% w/v non-fat milk 
in PBST (0.1% v/v Tween-20 in PBS) for 1 h. The membrane was subsequently 
incubated with primary antibody overnight at 4oC (Appendix C). The membrane was 
subsequently washed 3x 10 min in PBST on a shaker before incubation with secondary-
HRP linked antibody for 1 h at room temperature (Appendix C). After 1 h, the 
membrane was washed 3x 10 min in PBST and enhanced chemiluminescence (ECL) 
working reagent (Thermo Scientific, # 34080) was incubated with the membrane for 1 
min before being developed in the gel documentation system (Syngene). The blots 
were subsequently quantified using ImageJ software.  
 
2.8.  Endpoint PCR for HUVEC 
Genomic DNA is composed of nucleic acid sequences called introns and exons. Introns 
also known as ‘intervening sequences’, are not present in the final gene product. 
When RNA is transcribed from DNA, the RNA is processed, a term called splicing, 
where introns are removed and exons are joined to form messenger RNA (mRNA). The 
mRNA is used directly as a template by ribosomes to form proteins, and is an indicator 
of protein synthesis although not all mRNA is translated to protein. In summary, total 
RNA was extracted from HUVEC. Full length complementary DNA (cDNA) was reverse 
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transcribed from the total RNA extracted. The cDNA was subsequently amplified at the 
gene region of interest, CSE, as an indicator of CSE mRNA levels.  
 
2.8.1. Total RNA extraction from HUVEC: 
HUVEC were plated in 6 well plates (2.5 x105 cells/well) and treated with or without 
LPS (100 ng/ml, M199-1%) for 24 h. Medium was aspirated and Trizol (250 µl, 
Invitrogen) was immediately added to each well to lyse cells and stabilise RNA. Cells 
were homogenised on the plate using the back of a sterile, RNAse and DNAse free 
pipette tip and transferred to a sterile tube and frozen at -80oC until use. To extract 
total RNA, the frozen Trizol samples were defrosted on ice and the isolation of RNA 
was carried out according to manufacturer’s instructions (Invitrogen). In brief, 
chloroform (50 µl) was added to the Trizol sample, vortexed for 15 sec and incubated 
at room temperature for 5 min. The sample was centrifuged at 12,000 g for 15 min 
4oC. The upper aqueous phase containing the RNA was then aliquoted into DNA/RNAse 
free tubes. Isopropanol (125 µl) was added to the aqueous phase and incubated at 
room temperature for 10 min to precipitate the RNA. This was then centrifuged at 
12,000 g for 10 min 4oC. The RNA pellet was subsequently washed and resuspended in 
ethanol (250 µl, 75% v/v). This was subsequently centrifuged at 7500 g, 5 min, 4oC. The 
ethanol wash was removed and the RNA pellet allowed to dry at room temperature for 
10 min and subsequently resuspended in diethylpyrocarbonate (DEPC)-treated water 






2.8.2. First-strand cDNA Synthesis: 
Transcription is a physiological process in mammalian cells where RNA is synthesised 
from DNA, and is carried out by DNA polymerase. Reverse transcriptase is an enzyme, 
originally found in retroviruses, that is used to transcribe DNA from an RNA template 
and is termed reverse transcription or first-strand cDNA synthesis. DNA derived from 
RNA is termed complementary DNA (cDNA) and, in contrast to original full length 
genomic DNA, does not contain introns. To synthesise full length cDNA, RNA is reverse 
transcribed using oligo(dT) primers. Oligo(dT) primers work by annealing to the 
universal poly(A) sequences at the 3 prime (3’) end of mRNA. (Nam, et al. 2002) 
Reverse transcriptase binds to the primer-mRNA template and begins the first stand of 
cDNA synthesis. The resulting cDNA is used as a template for PCR amplification (see 
later).  
cDNA was synthesised by reverse transcription from the extracted total RNA 
using the First-Strand cDNA Synthesis kit (GE Healthcare). Commercial human liver 
RNA (AMS Biotechnology UK ltd: M1234149) was used as a positive control for CSE. 
Instructions were carried out as in manufacturer’s instructions (GE Healthcare). In 
brief, total RNA (1 μg in 25 μl DEPC water) was denatured at 65oC for 10 min to remove 
RNA secondary structure and chilled on ice for at least 2 min. Subsequently, the 
denatured RNA was added to commercial micro-centrifuge tubes with the first-strand 
reaction beads (containing Moloney Murine Leukaemia Virus (M-MuLV) reverse 
transcriptase and nucleotides). Oligo(Dt) primers (1.65 μl, Fermentas) was added to 
the reaction mix to synthesise non-specific cDNA and a final volume of 33 μl was made 
up using DEPC water. This reaction was allowed to incubate at 37oC for 1 h. After 
reaction, the cDNA was frozen -20oC for PCR later. RNA and DNA quality and 
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concentration was quantified using the nanodrop spectrophotometer (Thermo 
Scientific) where absorbance ratio 260/280 nm for DNA ranged between 1.8 ± 0.2 and 
RNA between 2.0 ± 0.2.  
 
2.8.3. Polymerase chain reaction (PCR): 
PCR is a process where genes are amplified or replicated, enough for detection or 
identification purposes. The first stand cDNA synthesised from reverse transcription, is 
used in PCR as a template to amplify our gene of interest. Oligonucleotide primers 
were designed for genes of interest using published nucleotide sequences (NCBI 
nucleotide database). These primers anneal to the 3’ or 5’end of the single strand of 
cDNA on the gene of interest, this occurs at an optimal temperature dependent on the 
primer nucleobases (cytosine, guanine, adenine and thymine). Optimal annealing 
temperature should be 3-5oC below the primer melting temperature (Tm) determined 
broadly by: 
Tm = 2(A + T) + 4(C + G) 
Where: C = cytosine, G = guanine, A = adenine and T = thymine 
 
Increasing the temperature from the annealing temperature to ~75oC, the optimal 
activity of Taq DNA polymerase, (Lawyer, et al. 1993) causes the enzyme to bind the 
primers and synthesise another stand of DNA by adding complimentary nucleotides to 
the ends of each primer and using the single strand of DNA as a template. This 
generates a double stranded DNA in the region of interest. The duration of the 
‘extension’ phase of the PCR reaction is dependent on the size of the gene of interest 
(typically 1 kilobase per minute). This cycle of heating and cooling, is repeated after 
heating the reaction mix to 95oC, denaturing the double strands of DNA to form single 
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stranded DNA to again allow primer binding when the temperature is cooled to its 
annealing temperature. The end product consists of amplified double stranded DNA of 
your gene of interest.  
Master mix (18 µl, Thermo scientific AB0575DCA, containing DNA Polymerase, 
nucleotides and MgCl2 1.5 mM), were added to DNAase free tubes containing cDNA (2 
µg/μl in DNase/RNase free water), dimethyl sulfoxide (DMSO, 0.5 µl) and primers (0.5 
µl in DNase/RNase free water, see Appendix D). DMSO was added to the reaction mix 
to reduce the formation of primer dimers. Settings that were used on the thermocycler 
(Techne, Cambridge, UK)  for CSE, CBS and α-tubulin included: initial denaturation 94oC 
for 5 min; followed by 40 cycles of denaturation at 94oC for 30 sec, annealing at 57oC 
for 40 sec and extension at 72oC for 60 sec; and a final extension at 72oC for 5 min and 
final hold at 10oC. Heated lid was set at 105oC. The predicted band for CSE, CBS and α-
tubulin were calculated to be 157 bp, 150 bp and 200 bp respectively.  
 
2.8.4. Agarose gel electrophoresis:  
 
In order to visualise PCR product, agarose gels (1 % w/v, in 1x Tris-Borate EDTA (TBE) 
buffer, BioRad) containing ethidium bromide (1 µg/ml) were prepared. Gels were 
immersed in TBE buffer in a gel tank. PCR reactions (20 µl) were loaded onto the 
agarose gel alongside a 1Kb ladder (10 µl, Bioline) and run for 45 min at 70 V. The gel 
was subsequently visualised under UV light and the image captured in a gel 
documentation system (Syngene). 
 
 
 2.9.  Methylene Blue method of H
In this assay H2S reacts with zinc acetate (Zn(O
then reacts with the azo dye 
presence of acid and ferric chloride (FeCl
blue which is subsequently quantitated spectrophotometrically
 
Figure 2.9.1. Methylene blue colourmetric method
2000). 
Culture medium (500 μl) was pipetted in
acetate (250 μl, 1% w/v in H
with H2S. Subsequently NNDPD dye (133 μl, 20 mM in 7.2 M HCl) followed by FeCl
(133 μl, 30 mM in 1.2 M HCl) was added to the zinc mix
temperature for 10 min. Thereafter, trichloroacetic acid (TCA, 250 μl 10% w/v in diH
was added to stop the reaction and the tubes were centrifuged at 13,000 g at 4
min. This mixture 300 μl was pipetted into a microplat
absorbance read at 670 nm. A standard 
3.125 to 250 μM in medium) was used to determine the concentration of H
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2.10.  Sulfide Ion Selective Electrode of H2S detection 
The sliver/sulfide (Ag2S) ion selective electrode is a solid state membrane electrode 
which can detect both the presence of free Ag+ and S2
- (Lazar research laboratories, 
CA). The electrode consists of an electrode body containing: a stable reference 
electrode, a filling solution (Ag2S) and a sensing membrane that is immersed into the 
sample. The solid state sensing membranes are made from insoluble metallic salts 
containing the ion of interest (Pfafflin and Ziegler 2006). These membranes are ionic 
conductors and derive its selectivity through restricting the migration of non-specific 
ions therefore only allowing the movement of the specific ion within the lattice (Wang 
2006). When the electrode is immersed in solution, sulfide molecules migrate through 
the membrane lattice until an equilibrium is reached between diffusion (high to low 
concentration) and electrostatic force (repulsion of molecules with similar charge) of 
the internal filling solution and the external sample solution (Wang 2006, Rundle 
2008). The voltmeter subsequently calculates the potential difference derived from the 
reference electrode and the amount of S2
- detected in the sample:  
 
E = Eo + S*log(A) 
 
Where E = potential difference across the membrane, Eo = reference potential, S = 
electrode slope (i.e. the change in mV with a 10 fold change in concentration), A = 
effective concentration of sulfide, which is the product of the free sulfide ion 
concentration and the activity coefficient. The activity coefficient is dependent on the 
total ionic strength of the solution (aka the concentration and charge of all ions in 
solution) and is therefore variable between solutions to solution.  
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The sulfide ion selective electrode (ISE) was obtained from Lazar Research 
Laboratories, Los Angeles, California. The probe was utilised according to the 
manufactures instructions. Antioxidant buffer (final concentration: sodium salicylate 
0.31 M, NaOH 2.13 M, ascorbic acid 0.37 M) was added to equal volume of sample to 
convert any form of free sulfide (HS- and H2S) into S2
- which is detected by the ISE. Cell 
culture medium 500 μl was aliquoted and placed in 2-times concentrate antioxidant 
buffer 500 μl and measured directly using the sulfide ion selective electrode. The 
probe was calibrated using a standard curve using NaHS (0.1 – 500 μM) in antioxidant 
buffer. 
 
2.11. Tissue H2S synthesising assay  
This assay is used to determine the P5’P and cysteine dependent enzymatic production 
of H2S in tissues as an estimate of the relative activity and/or up-regulation of H2S 
synthesising enzymes. To do this homogenised tissues were incubated with excess 
substrate cysteine and cofactor P5’P, at optimal enzyme conditions for 30 min at 37oC, 
pH 7.4. H2S concentration was used as the end point of the assay and detected through 
the methylene blue method of H2S detection (Method 2.9).    
Tissues from animals were snap frozen in liquid nitrogen and stored at -80oC 
until use. Tissues were subsequently allowed to thaw completely on ice before being 
homogenised in cold KHPO4 buffer (100 mM, pH 7.4) using a Polytron Homogeniser. 
The homogenate was then centrifuged at 13,000 g, 4oC for 10 min. Supernatant from 
the homogenate 430 μl was incubated with KHPO4 buffer control or treatment (30 μl), 
pyridoxal 5’ phosphate (P5’P, 20 µl, 2 mM) and L-cysteine (20 µl, 10 mM). The tubes 
were covered with parafilm and the mixture was then allowed to incubate at 37oC in 
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the waterbath for 30 min. All reactions were carried out in duplicate. As a background 
control, trichloroacetic acid (TCA, 250 μl of 10% w/v H2O, Alfa Aesar) was added to the 
tissue supernatant to denature protein prior to the 30 min incubation period at 37oC. 
After incubation, the samples were immersed in ice-cold water for 2-3 min to slow the 
rate of reaction and reduce the pressure built up in the tube. To trap H2S produced, 
zinc acetate (250 μl of 1% w/v in H2O) was injected and allowed to sit at room 
temperature for 5 min. To stop the reaction and precipitate protein TCA (250 μl of 10% 
w/v in H2O) was subsequently added to the samples without TCA. Samples were 
centrifuged at 13,000 g, 4oC for 4 min. N,N-dimethyl-p-phenylenediamine 
dihydrochloride dye (NNDPD, 133 μl of 20 mM in 7.2 M HCl), followed by iron chloride 
(FeCl3, 133 μl of 30 mM in 1.2 M HCl). The absorbance was then read at 670 nm in a 
96-well microplate reader. H2S concentration was calculated through the use of a 
NaHS standard curve (3.12-250 μM). Values were then standardised to protein content 
using the Bradford protein assay. 
 
2.12. Statistical analysis 
Data is expressed as mean ± SEM. A student’s unpaired t-test was used to determine 
significance between two sets of data. When comparing two or more groups, a one-
way analysis of variance (ANOVA) followed by a Dunnets post hoc test was carried out. 
A Dunnets test was carried out when comparing control to other variables. When 
comparing a time course, a two-way ANOVA was carried out followed by Bonferroni 
post hoc test. All statistics was carried out on GraphPad Prism (version 4). *P<0.05 was 




CHAPTER 3: Cystathionine Gamma Lyase and The Endothelium 
 
3. Introduction 
Exogenous H2S was first described to relax blood vessels in 2001 (Zhao, et al. 2001). In 
the same study, a bolus injection of H2S was shown to induce a transient reduction in 
mean arterial blood pressure of anaesthetised mice which was inhibited by pre-
treatment with glibenclamide, a KATP channel blocker (Zhao, et al. 2001). These authors 
also described the presence of CSE mRNA in the vascular smooth muscle cells, but not 
in the endothelium of rat aortic rings (Zhao, et al. 2001). Since then a vast amount of 
literature on the biological activity of H2S within the cardiovascular system has been 
described.   Blood pressure regulation by endogenous H2S was conceivable to scientists 
working in the H2S field, due to: the presence of H2S synthesising enzyme activity in a 
number of vascular beds (Zhao, et al. 2001); and the presence of plasma H2S in a 
number of vertebrates (Olson 2005, Yang, et al. 2008).   
However, inhibitors of both CSE (Burnett, et al. 1980) and CBS (Rej 1977, Ochs 
and Harris 1980) are not very selective. Moreover, reported concentrations of H2S in 
plasma were inconsistent between different laboratories, with reported levels from 2 
µM (Olson 2009) to 280 µM (Han, et al. 2006) and the well documented toxicology of 
H2S (Beauchamp, et al. 1984) caused speculation as to whether H2S was really an 
endogenous signalling mediator or an artefact of the methods used to detect H2S.   
However, in 2008 there was solid evidence to demonstrate that CSE was 
involved in the physiological regulation of blood pressure (Yang, et al. 2008). CSE-/- KO 
mice were described to develop age dependent hypertension that was ~18 mm Hg 
greater than control at 12 weeks of age (Yang, et al. 2008). In addition, there was a 
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significant (*P<0.05) reduction in serum H2S in the CSE
-/- KO (~20 µM) compared to WT 
mice (~40 µM) (Yang, et al. 2008). Moreover, methacholine (MCh) induced relaxation 
of mesenteric arteries was markedly impaired in CSE-/- KO mice (Yang, et al. 2008). 
They also demonstrated that the hypertensive phenotype seen in the CSE-/- KO mice 
was not due to changes in:  endothelial nitric oxide synthase (eNOS) protein levels; 
alterations in kidney architecture; accumulation of homocysteine; or increased levels 
of the superoxide anion in vascular tissue (Yang, et al. 2008). Interestingly, in contrast 
to their previous study (Zhao, et al. 2001), they showed the presence of CSE protein in 
the endothelial cell lining of wild type (WT) aortic rings which was absent in the CSE-/- 
KO mice (Yang, et al. 2008). Based on these results, the absence of CSE in the 
endothelium was hypothesised to be the cause of the endothelial cell dysfunction 
demonstrated with MCh in the mesenteric arteries of the CSE-/- KO mice (Yang, et al. 
2008).  To verify these results, they demonstrated the presence of CSE protein in 
cultured endothelial cells: bovine aortic endothelial cells (BAEC) and human umbilical 
vein endothelial cells (HUVEC) (Yang, et al. 2008). Furthermore, within 10 min of 
stimulating BAEC with calcium ionophore A23187 or MCh a measurable rise of H2S in 
the culture medium was noted (Yang, et al. 2008). Moreover, using RNA interference 
to deplete CSE in the BAEC significantly reduced the H2S produced de novo induced by 
MCh and A23187 by ~2-fold (Yang, et al. 2008). Exogenous H2S has previously been 
demonstrated to relax a number of blood vessels (Zhao, et al. 2001). Together this 
evidence demonstrated that H2S, like nitric oxide (
•NO), is an endothelial cell derived 
relaxing factor (EDRF) and is released upon a physiological stimulus such as calcium 





Hypothesis: H2S is an endothelial cell derived relaxing factor that is induced upon a 
Ca2+ stimulus. 
 
The primary aim of this project was to: 
 
1.  Examine the possibility of endothelium-derived H2S release in response to a 
range of agonists that increase intracellular calcium (Ca2+). 
2. Examine the activity of H2S synthesising enzymes using liver homogenates in 
the presence of calcium-calmodulin (CaM) antagonists.  
3.  Extend this study to assess the potential benefits of enhancing endothelium-



























3.1. Materials and Methods 
3.1.1. Stimulating HUVEC and BAEC with A23187 and methacholine (MCh) 
HUVEC (P2-P3) and BAEC (P3-P10) were plated in T25 flasks until 95% confluent. A23187 
(1 – 10 µM), MCh (1 – 10 µM) (Yang, et al. 2008), bradykinin (10 µM) (Brodsky, et al. 
2002), or vehicle (DMSO or acetic acid 0.1M, 1 µl per 1 ml) were added to the cells. H2S 
was measured in the cell culture medium (M199-20%, M199-1% or serum-free (SF) 
M199, ± L-cysteine 500 µM) using the methylene blue colourimetric assay (Method 
2.9) and the ISE (Method 2.10) after stimulation for 10 - 60 min. Using the methylene 
blue colourimetric method, zinc acetate (used to trap H2S) was either injected directly 
into the cell culture medium (1.5 ml 1% w/v zinc acetate into 3 ml culture medium) of 
stimulated cells or the cell culture medium (500 µl) aliquoted into tubes containing 
zinc acetate (250 µl, 1% w/v H2O). Several protocols were used to measure H2S using 
the ISE: the probe was either put directly into the cell culture medium with the cells to 
measure H2S production de novo; antioxidant buffer (Method 2.10) used to preserve 
sulfide, was directly injected into the cell culture medium (1:1, antioxidant buffer: cell 
culture medium) at the time point measured; at different time points cell culture 
medium from the stimulated cells were aliquoted into tubes containing antioxidant 
buffer.  
 
3.1.2. H2S enzyme activity assay in HUVEC and BAEC 
Adherent cells from two T75 flasks (each 2 x 106 cells) of HUVEC P3 or BAEC (P4-10) were 
lifted from the plate with trypsin (Method 2.1) and the cell suspensions from both 
flasks were pooled together and centrifuged at 1000 g for 10 min. The cell pellet was 
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resuspended in 1 ml PBS and transferred to a 1 ml tube and centrifuged at 1000 g for 5 
min. The PBS was removed and the cell pellet was frozen -20oC. 
The H2S enzyme activity was carried out as in Method 2.11 with slight 
modifications. HUVEC pellets were defrosted on ice and manually homogensied in cold 
KHPO4 buffer (260 µl, 100 mM pH 7.4). Mouse liver was used as a positive control and 
was homogensied again in the same way. The cell homogenates were centrifuged at 
13,000 g for 4 min. 10 µl of the homogenised cell supernatant was reserved for the 
Bradford protein assay (Method 2.5). To the remaining cell supernatant, pyridoxial 5’ 
phosphate (P5’P 10 µl 2mM in KHPO4 100 mM pH 7.4) and L-cysteine (10 µl 10 mM in 
KHPO4 100 mM pH 7.4) was added. The tubes were tightly covered with parafilm and 
the reaction was allowed to proceed at 37oC in the waterbath for 1 h. After incubation, 
the samples were immersed in ice-cold water and zinc acetate was injected into each 
tube (125 µl, 1% w/v H2O), followed by trichloroacetic acid (TCA, 125 µl, 10% w/v H2O). 
Samples were centrifuged at 13,000 g for 4 min. NNDPD (66.5 μl 20 mM in HCl 7.2 M) 
followed by FeCl3 (66.5 μl, 30 mM in HCl 1.2 M) was subsequently added to each of the 
tubes. After at least 15 min incubation at room temperature, the absorbance was read 
at 670 nm in a 96-well microplate reader. 
 
3.1.3. Measurement of intracellular Ca
2+
 using Fura-2AM 
Intracellular Ca2+ responses to A23187 (1 μM), MCh (10 μM) or bradykinin (BK, 10 µM) 
were measured in BAEC or HUVEC using Fura-2 acetoxymethyl ester (Fura-2AM). In 
brief, endothelial cells were plated on the centre of glass coverslips and grown in full 
serum M199 until confluence. On the day of the experiment, cells were loaded with 
pluronic acid (0.3 mg/ml in DMSO) and Fura-2AM (2.5 μM in DMEM containing 20% 
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FCS and buffered with HEPEs free acid) and incubated for 1 h in the dark at room 
temperature. Population experiments were performed in which the global intracellular 
Ca2+ response was measured from many individual cells. The coverslips were placed 
diagonally inside a cuvette containing warm (37oC) balanced salt solution (NaCl 145 
mM, KCl 5 mM, MgSO4 1 mM, HEPES 10 mM) to which A23187 (1 μM), MCh (10 μM) or 
BK (10 µM) was added once the background was stable. A spectrophotometer (Cairn 
Research Ltd, Faversham, UK) with a rotating wheel equipped with 340 nm and 380 nm 
filters were used to excite the Fura-2 and emission was subsequently detected at 510 
nm. ATP (100 µM) was used as a positive control for cell responsiveness. Before 
terminating the experiment, digitonin (40 μM) was used to permeabilise the cells to 
allow influx of extracellular Ca2+ to determine the maximal Ca2+ fluorescence. 
Subsequently, manganese chloride (MnCl2, 6 mM) was used to quench the Fura-2 
fluorescence to determine background autofluorescence. Fura-2 displays an 
absorption shift when the excitation wavelength changes between 300-400 nm while 
observing the emission at 510 nm. This useful property of Fura-2 allows the ratio of the 
absorbance when excited by two excitation wavelengths (e.g. 340 nm and 380 nm) to 
be calculated. Taking the ratio at two excitation wavelengths instead of an absolute 
value at one wavelength has its advantages: it can eliminate uneven distribution of the 
sensor, uneven dye loading, photobleaching, dye leakage and variations in cell 
thickness (Takahashi, et al. 1999). The ratio is normally taken at excitation wavelength 
of 340 nm (where the emission is at its peak) and at 380 nm (where the emission is 





3.1.4. H2S quenching studies 
NaHS (1 mM, 500 µl) was incubated with copper sulfide (CuSO4, 1 mM, 500 µl), 
magnesium chloride (MgCl2, 1 mM, 500 µl), calcium chloride (CaCl2, 1 mM, 500 µl), iron 
chloride (FeCl3, 1 mM, 500 µl), haemoglobin (Hb, 1 mM, 500 µl), unheparinised lysed 
rat whole blood, bovine albumin (2.5 mg/ml, 500 µl) and fetal calf serum (FCS, 500 µl). 
H2S was measured using either the methylene blue method of detection (Method 2.9) 
or the sulfide ISE (Method 2.10).  
 
3.1.5. Stimulating HUVEC and RAW264.7 with LPS to induce CSE protein expression  
Lipopolysaccharide (LPS) has been shown to stimulate CSE expression in RAW264.7 
and in the tissues of LPS treated mice (Li, et al. 2005, Zhu, et al. 2010). HUVEC or 
RAW264.7 cells were plated on 6-well plates and treated with 100 ng/ml or 1 µg/ml 
LPS (Escherichia coli 055:B5) in M199-1% or SF-DMEM respectively for 24 h (Biffl, et al. 
1996, Whiteman, et al. 2010c). Cells were subsequently rinsed twice in PBS and lysed 
with lysis buffer (50 µl) (Appendix B) and frozen at -20oC for CSE protein measurement 
by western blot later. Using the methylene blue H2S detection method (Method 2.9), 
H2S in the cell culture medium was measured in LPS stimulated RAW264.7 after 24 h.  
 
3.1.6. Western blot for CSE and CBS protein 
Western blot was carried out as in Method 2.7. In brief, 10 µg protein/well (HUVEC, 
RAW264.7 or mouse liver) was resolved on a 7.5% gel and transferred to a PDVF 
membrane (wet transfer). The membrane was incubated with 5%w/v non-fat milk for 
1 h prior to incubation with antibody for CSE, CBS or β-actin (Appendix C) overnight at 
4oC. The PDVF membranes were washed in PBS-tween for 30 min prior to incubation 
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with secondary-HRP linked antibody for 2 h (Appendix C). The membranes were 
further washed for 30 min and subsequently incubated with ECL working reagent for 1 
min prior to visualisation on a gel documentation system (Syngene). The molecular 
weight band described for CSE, CBS and β-actin were 43 kDa, 75 kDa, and 42 kDa 
respectively. 
 
3.1.7. Endpoint PCR for CSE and CBS messenger RNA 
 
HUVEC were plated on 6-well plates and treated with or without LPS (100 ng/ml, 
Escherichia coli 055:B5) in M199-1% for 24 h. At the end of the incubation period, 
Trizol (250 µl, Invitrogen) was added to each well, the cells homogenised and samples 
frozen at -80oC. Total RNA was extracted (Method 2.8.1) and first strand cDNA 
synthesis was carried out (Method 2.8.2).  Endpoint PCR was conducted as described in 
Method 2.8.3. In brief, a master mix (18 µl, Thermo scientific AB0575DCA), was added 
to DNAase free tubes containing human liver or HUVEC cDNA (2 µg/μl), DMSO (0.5 µl) 
and primers (0.5 µl, for human CSE, CBS and α-tubulin, see Appendix D). cDNA was 
amplified according to the following settings: initial denaturation 94oC for 5 min; 
followed by 40 cycles of denaturation at 94oC for 30 sec, annealing at 57oC for 40 sec 
and extension at 72oC for 60 sec; and a final extension at 72oC for 5 min and final hold 
at 10oC. Heated lid was set at 105oC.  
In order to visualise DNA, agarose gels (1 % w/v, in 1x TBE buffer) containing 
ethidium bromide (1 µg/ml) were prepared. PCR reactions (20 µl) were loaded onto 
the agarose gel alongside a 1Kb ladder (10 µl, Bioline) and run for 45 min at 70 V. The 
gel was subsequently visualised under UV light and the image captured in a gel 
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documentation system (Syngene). The predicted band for CSE, CBS and α-tubulin were 




/CaM dependence of H2S enzymes in liver homogenates 
H2S enzyme activity assay in liver was carried out as in Method 2.11 with the following 
modifications. Liver homogenates (5% w/v) were homogenised in cold KHPO4 buffer 
(100 mM, pH 7.4). The homogenate was then centrifuged (13,000 g, 4oC for 10 min) 
and the supernatant (430 μl) was incubated with pyridoxal 5’ phosphate (P5’P, 20 µl 2 
mM), L-cysteine (20 µl of 10 mM), treatment (30 µl KHPO4 buffer control, 
trifluoperizine 8.3 – 125 mM, CaCl2 8.3 mM or EGTA 100 mM). The tubes containing 
the reaction mix were covered with parafilm and allowed to incubate at 37oC in the 
waterbath for 1 h. Zinc acetate (250 μl of 1% w/v in H2O) was subsequently injected 
into the tubes and allowed to sit at room temperature for 5 min to convert sulfide 
produced by the liver homogenates into zinc sulfide. TCA (250 μl of 10% w/v in H2O) 
was subsequently added to stop the reaction and precipitate protein. Samples were 
centrifuged (13,000 rpm, 4oC for 4 min). Zinc sulfide was subsequently quantitated 
using the methylene blue colourimetric method where AZO dye NNDPD (133 μl of 20 
mM in 7.2 M HCl) and FeCl3 (133 μl of 30 mM in 1.2 M HCl) was added to each sample 
and incubated at room temperature for at least 10 min. The absorbance was read in a 
96-well plate at 670 nm. Values were then standardised to protein content using the 
Bradford protein assay (Method 2.5). H2S concentration was calculated through the 





3.2. Results  
3.2.1. Comparing the ISE and methylene blue method of H2S detection 
Initially, the limit of detection of H2S using the ISE and the methylene blue assays were 
characterised and compared. Varying concentrations of NaHS (0.1 – 500 µM) were 
made up in water and incubated with either zinc acetate (methlyene blue 
colourimetric method) or antioxidant buffer (ISE). The lower limit of H2S detection in 
antioxidant buffer using the ISE was approximately 10 µM NaHS and the linear working 
range was between 10 – 50 µM NaHS (Figure 3.2.1 a and b). In contrast, the methylene 
blue method of H2S detection was more sensitive and had a greater breadth of H2S 
detection with a linear working range from ~3 – 100 µM NaHS (Figure 3.2.1 c and d). 
 
3.2.2. Measuring H2S synthesis de novo from HUVEC and BAEC 
In contrast to previous reports (Yang, et al. 2008), stimulating BAEC or HUVEC with 
A23187 (1 µM), MCh (10 µM) or bradykinin (10 µM) for 10 min did not result in a 
measurable rise of H2S in the cell culture medium using both the methylene blue 
(Figure 3.2.2 b and d) and the ISE (Figure 3.2.2 a and c) methods of H2S detection. 
Moreover, increasing the time point at which H2S was measured (up to 60 min) did not 
lead to detectable amounts of H2S released from BAEC stimulated with A23187 (Figure 
3.2.3). Interestingly, homogenising HUVEC or BAEC and incubating them with substrate 
cysteine and co-factor pyridoxal 5’ phosphate demonstrated low levels of H2S 
synthesising activity in both cell lines (Table 3.2.1), suggesting the presence of H2S 






Figure 3.2.1. Standard curves for NaHS using the: sulfide ion selective electrode (ISE) 
a) 0.1 – 500 µM b) 5 – 50 µM; methylene blue colourimetric assay c) 0.1 – 500 µM d) 






Figure 3.2.2. HUVEC or BAEC were stimulated with A23187 (1 µM), MCh (10 µM) or 
bradykin (10 µM) for 10 mins and H2S in the medium (M199 containing 1% v/v fetal 
calf serum) was measured using the sulfide ISE a) and c) or via methylene blue 
colourimetric assay b) and d). Absolute H2S concentrations for control were 0 µM H2S 







Figure 3.2.3. BAEC were stimulated with A23187 (1 µM) for 10 – 60 mins. At each time 
point H2S was measured in the cell culture medium (M199 containing 1% v/v fetal calf 
serum) using the methylene blue colourimetric assay. Absolute H2S concentrations for 














Table 3.2.1. Typical values of H2S synthesising activity in different tissues done on 
separate occasions. Tissues were homogenised and incubated with cysteine and 
pridoxal 5’ phosphate for 1 h at 37oC. H2S produced was detected by the methylene 
blue colourimetric assay and used as an end point to estimate the H2S enzyme activity. 
Results show mean ± SEM of H2S nmol/mg protein. 
 
Tissue H2S nmol/mg protein 
 
 
HUVEC        
 
0.506 ± 0.070, n = 7 
 
BAEC 0.910 ± 0.236, n = 5 
 


















3.2.3. Calcium mobilisation in BAEC in response to A23187, MCh and BK 
To ensure that Ca2+ was elevated in BAEC treated with A23187 (1 µM), MCh (10 µM) or 
BK (10 µM), BAEC were loaded with Fura-2AM, a tool used to detect a rise in 
intracellular calcium (Ca2+). A23187 and BK induced an almost immediate measurable 
rise in florescence ratio, indicating a rise in intracellular Ca2+ (Figure 3.2.4 a and c).  
Interestingly, after 10 min MCh did not cause a rise in intracellular Ca2+ in BAEC 
(Figure 3.2.4 b). However, in the same cells, ATP (100 µM) positive control could 
induce a rise in intracellular Ca2+ indicating that the cells were viable and responsive to 
agonist stimulation (Figure 3.2.4 b). These results suggested that BAEC were 
responsive to A23187 and BK, but not MCh.  
3.2.4. H2S quenching in the medium 
To examine whether a component in the cell culture medium quenched the free 
unbound H2S, standard curves using NaHS were made up in different culture medium 
(M199 or phenol-red free DMEM) containing various amounts of fetal calf serum (1% 
v/v or 20% v/v) (Figure 3.2.5). Both types of medium containing high concentrations of 
serum (20% v/v) significantly reduced the amount of H2S detected using the methylene 
blue colourimetric method (Figure 3.2.5).  
To investigate this further, components found in cell culture medium and/or 
the body tissue (Cu2+, Mg2+, Ca2+, Fe3+, haemaglobin, rat whole blood, albumin and FCS) 
were incubated with equimolar NaHS (500 µM). 500 µM NaHS was chosen as a large 
measurable amount of H2S, to determine the extent of H2S quenching. Both the 
methylene blue method (Figure 3.2.6) the ISE (Figure 3.2.7) indicated that H2S was 
significantly quenched by copper (Cu2+), iron (Fe3+), haemogloblin (Hb), rat whole 
blood and fetal calf serum (FCS). Fe3+ is present in trace amounts in culture medium. 
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Therefore it is possible that low levels of H2S produced by endothelial cells are 
quenched by Fe3+. However, previous studies have successfully measured H2S in cell 
culture medium (Yang, et al. 2008). In the current studies, 1%v/v FCS was utilised in 
the studies to measure H2S release from endothelial cells in response to A23187, BK 
and MCh. It is possible the use of 1%v/v FCS quenched the H2S release from the 
endothelial cells. 
 
3.2.5. Measuring H2S synthesis de novo from HUVEC and BAEC in the presence of 
L-cysteine 
 
To guarantee the H2S was not quenched by serum, HUVEC and BAEC were stimulated 
with A23187 (1 µM) or BK (10 µM) in serum-free medium. Utilising lower passage 
HUVEC (P2) and BAEC (P3-5) together with the serum-free conditions did not lead to a 
measurable amount of H2S detected by the methylene blue assay (Figure 3.2.8 a and 
c). Furthermore, pre-treating these cells with L-cysteine (500 µM) (Furne, et al. 2008) 
for 1 h prior to stimulating HUVEC or BAEC with A23187 or BK for 10 min also did not 






Figure 3.2.4. BAEC were loaded with Fura-2AM for intracellular Ca2+ detection and 
stimulated with DMSO (1 µl), A23187 (1 μM), methacholine (MCh, 10 μM), bradykin 
(BK, 10 µM) or ATP positive control (100 μM). Digitonin (40 μM) was used to determine 








Figure 3.2.5. NaHS standard curves (3.125-250 μM) were carried out using water (H2O, 
green solid line), Medium-199 with 1% v/v serum (M199-1%, red dashed line), M199 
with 20% v/v serum (M199-20%, red solid line), Dulbecco's Modified Eagle Medium 
(DMEM without phenol red) with 1% v/v serum (DMEM-1%, blue dashed line) or 20% 
v/v serum (DMEM-20%, blue solid line). H2S was measured using the methylene blue 
colourimetric assay. Results show optical density at 670 nm, mean ± SEM, n = 3. 













Figure 3.2.6. NaHS 500 μM was incubated with 500 μM copper sulfide (CuSO4), 
magnesium chloride (MgCl2), calcium chloride (CaCl2), iron chloride (FeCl3), 
haemoglobin (Hb), unheparinised lysed rat whole blood, bovine albumin (2.5 
mg/ml) and fetal calf serum (FCS). H2S was measured using the methylene blue 











Figure 3.2.7. Sulfide ion selective electrode (ISE) measuring NaHS (500 µM, 500 µl), quenching substance (500 
µM or 500 µl) or quenching substance + NaHS, in millivolts (mV). Quenching substance being a) copper sulfate 
(CuSO4), b) magnesium chloride (MgCl2),  c) calcium chloride (CaCl2),  d) iron chloride (FeCl3) e) haemoglobin 
(Hb) f) rat whole blood (blood, 500 µl) g) albumin (2.5 mg/ml, 500 µl) h) fetal calf serum (FCS, 500 µl). Results 





Figure 3.2.8. HUVEC (P2) or BAEC (P3-5) were stimulated with A23187 (1 µM) or 
bradykinin (10 µM) and H2S was measured in cell culture medium after 10 min using 
the methylene blue colourimetric assay. a) HUVEC or c) BAEC were stimulated in serum 
free M199 b) HUVEC or d) BAEC were pre-treated with L-cysteine (500 µM, serum free 
M199) 1 h prior to stimulation. Absolute values for all data represent 0 µM H2S. Results 








3.2.6. CSE and CBS  mRNA and protein expression in HUVEC 
HUVEC were examined for CSE or CBS mRNA (end point PCR) and protein. HUVEC 
contained both CSE and CBS mRNA (Figure 3.2.9). However, neither CBS (Figure 3.2.10) 
nor CSE (Figure 3.2.11) protein was detectable in HUVEC. Furthermore, LPS stimulated 
HUVEC did not express CSE protein (Figure 3.2.11). 
 
3.2.7. CSE protein expression in LPS stimulated RAW264.7  
CSE protein expression was up regulated in RAW264.7 macrophages stimulated with 
LPS (1.0 µg/ml) (Figure 3.2.11). Although CSE was significantly up regulated in LPS 
stimulated RAW 264.7 cells, H2S was not detected in the culture medium of these 
macrophages at 24 h using the methylene blue H2S detection method (Figure 3.2.12). 
 
3.2.8. H2S-synthesising Activity in Liver Homogenates ± Calcium 
The Liver has been reported to be a large source of the H2S synthesising enzymes, CSE 
and CBS, with detectable amounts of H2S produced in the presence of substrate (L-
cysteine) and cofactors (pyrdoxial 5’ phosphate, P5’P) under optimal enzyme 
conditions (Li, et al. 2005, Kabil, et al. 2011). Indeed, in the current study, measurable 
amounts of H2S was detected from rat liver tissue on incubation with L-cysteine and 
P5’P (Figure 3.2.13). Smaller measureable amounts of H2S were detected in the 
absence of P5’P, but not in the absence of L-cysteine (Figure 3.2.13 a) suggesting L-
cysteine is the rate limiting factor in this reaction.  
Incubating liver homogenates with CSE inhibitor with DL-propargylglycine (PAG, 
60 µM, % inhibition 24.170 ± 1.100) or CBS inhibitor aminooxyacetic acid (AOAA, 60 
µm, % inhibition 88.729 ± 0.458) resulted in a significant (P<0.05) reduction in H2S 
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production (Figure 3.2.13 b) suggesting these enzymes are involved in the generation 
of H2S in these liver homogenates. 
To investigate whether these liver H2S synthesising enzymes were calcium-
calmodulin (Ca2+/CaM) dependent, H2S synthesising activity (as before) was carried out 
in the presence of either: Ca2+/CaM competitive antagonist trifluoperizine (TFP, 500 – 
7500 µM); added Ca2+ (CaCl2); or Ca
2+ chelator EGTA. Tissue H2S synthesising activity 
was significantly (*P<0.05) inhibited at exceptionally high concentrations of TFP 5 mM 
(Figure 3.2.14 a, % inhibition 18.382 ± 4.680), which may suggest either a Ca2+/CaM 
dependent component in H2S enzyme activity or a non-selective effect of the drug.  
The addition of Ca2+ (500 µM) alone to liver homogenates did not significantly 
increase H2S enzyme activity (Figure 3.2.14 b). This may suggest H2S enzymes are not 
Ca2+/CaM dependent or Ca2+ is already in excess and therefore not a rate limiting 
factor in H2S biosynthesis in the liver. However, adding Ca
2+ chelator EGTA (6 mM) did 
not significantly reduce H2S enzyme activity in these liver homogenates (Figure 3.2.14 
b).  
To ensure PAG, AOAA or TFP did not interfere with the colour change 
associated with the methylene blue colourimetric method, H2S donor NaHS was 
incubated with PAG, AOAA or TFP and the assay was carried out as usual. None of the 
inhibitors PAG, AOAA or TFP interfered with the colour change associated with the 
methylene blue assay (Figure 3.2.15). This suggests that these inhibitors do not 
interfere with the colour development in the assay and are instead directly inhibiting 







Figure 3.2.9. Image captured shows endpoint PCR expression for a) CSE (157 bp) b) α-
tubulin loading control (200 bp) and c) CBS (150 bp). Human liver cDNA (L) was used as 
a positive control. Blank wells without a cDNA template (B) were used as a negative 
control. Both unstimulated HUVEC (H) and HUVEC stimulated with LPS (100 ng/ml) for 
24 h (H+) express CSE, CBS and α-tubulin mRNA. Image is representative of 3 














Figure 3.2.10. Western blot of murine brain tissue and HUVEC lysates probed for CBS 
protein. β-actin was used as the loading control. Data show representative western 
blots and a graph of showing densitometry of CBS standardised to β-actin loading 









Figure 3.2.11. HUVEC and RAW264.7 cells were stimulated with LPS (100 ng/ml or 1 
µg/ml) for 24 h. CSE protein was blotted with mouse liver as a positive control. Results 


















Figure 3.2.12. RAW264.7 cells were stimulated with LPS (1 µg/ml) for 24 h in SF-
DMEM. At 24 h cell culture medium was assayed for H2S using the methylene blue 
assay. Absolute values indicate 0 µM H2S for all treatments. Results show mean optical 


















Figure 3.2.13. H2S synthesising enzyme activity assay was carried out in rat liver 
homogenates, at 37oC for 1 h. H2S produced from homogenates was detected by the 
methylene blue colourimetric assay. Liver homogenates were incubated a) with both 
pyridoxal-5’-phosphate (P5’P) and L-cysteine (control), without P5’P (-P5’P) or without 
L-cysteine b) P5’P and L-cysteine ± CSE inhibitor DL-propargylglycine (PAG, 60 – 600 
µM) or CBS inhibitor aminooxyacetic acid (AOAA, 60 – 600 µM). Results show mean ± 













Figure 3.2.14. H2S synthesising assay was carried out in rat liver homogenates 
incubated with a) Ca2+/CaM antagonist trifluoperizine (TFP, 500 – 7500 µM) or b) CaCl2 
(500 µM) or EGTA (6000 µM), for 1 h at 37oC. H2S produced from liver homogenates 
was detected by the methylene blue colourimetric assay.  Results show H2S nmol/mg 
















Figure 3.2.15. PAG (60 – 600 µM), AOAA (60 – 600 µM), TFP (5000 – 7500 µM) were 
incubated with NaHS (100 µM). Methylene blue colourimetric assay was carried out to 
ensure these inhibitors did not interrupt the colour formation.  Results show H2S µM, 
















3.3.  Discussion  
 
The main findings from this chapter are: 
1. H2S is not detectable in the culture medium of A23187, MCh or BK stimulated 
endothelial cells (HUVEC and BAEC) or LPS stimulated RAW264.7 using the 
methylene blue colourimentric assay or the ISE 
2. CSE/CBS mRNA, but not protein, is detectable in HUVEC 
3. MCh does not induce a rise in intracellular Ca2+ in cultured endothelial cells 
4. H2S synthesising enzymes in the liver are unlikely to be Ca
2+/CaM dependent  
 
It has previously been demonstrated that stimulating BAEC with A23187 (1 µM) or 
MCh (1 µM) results in a 1.5 and 3 fold increase in H2S levels of the culture medium 
(Yang, et al. 2008). The reason for the discrepancy between the latter study and the 
current study is unclear as the identical ISE was used in both studies. The reason 
behind this difference is discussed.  
 
3.3.1. Endothelial cell calcium response to A23187 and MCh 
In the current study MCh (10 µM, 10 fold that of the latter study) did not induce a Ca2+ 
influx BAEC (Figure 3.2.4). A direct measurement of intracellular Ca2+ was not carried 
out in the latter study (Yang, et al. 2008), instead the assumption that H2S release was 
mediated by a Ca2+ response was drawn from the response of A23187 and previous 
studies using MCh. Indeed, Ca2+ influx in endothelial cells on MCh/ACh stimulus have 
been noted in studies involving freshly isolated cells from coronary arteries of guinea 
pigs (Chen and Cheung 1992), rat thoracic aorta (Jen, et al. 2000), rabbit aorta (Wang 
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and van Breemen 1999), and arterioles from hamster cremaster muscles (Cohen and 
Jackson 2005). Interestingly, others have also failed to demonstrate a response from 
cultured cells treated with MCh (Loeb, et al. 1985, Tracey and Peach 1992).  One study 
demonstrated the presence of muscarinic receptors only in freshly isolated endothelial 
cells but not cultured endothelial cells (Peach, et al. 1985). The reason behind the 
muscarinic receptor liability in cell culture conditions is unknown. However, the 
absence of muscarinic receptors in cultured endothelial cells is independent of species, 
vessel type and passage number (Peach, et al. 1985).  
Interestingly, co-culturing smooth muscle cells with endothelial cells elicited a 
cGMP response from MCh (Loeb, et al. 1985) but the reason behind this is unknown. 
Whether the endothelial cells of previous studies (Yang, et al. 2008) were 
contaminated with smooth muscle cell remains unknown. Indeed, this may be one 
reason why the endothelial cells in their study contained CSE protein and elicited a 
response to MCh (Yang, et al. 2008). 
 In the current study, A23187 and BK were shown to increase intracellular Ca2+ 
in endothelial cells suggesting that the reason why H2S was not detected in the 
medium of cultured cells was not due to the lack of response to these compounds.  
 
3.3.2. H2S quenching in the cell culture medium 
Interestingly, H2S standard curves made in cell culture medium containing high serum 
(20% v/v) concentrations significantly reduced the gradient of standard curve (Figure 
3.2.5) suggesting a component in fetal calf serum (FCS) may be quenching or reacting 
with the H2S rendering it undetectable by the methylene blue assay. Indeed, 
incubating NaHS with FCS, but not albumin, significantly quenched the H2S as 
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demonstrated by both the methylene blue (Figure 3.2.6) and ISE (Figure 3.2.7). This 
result correlates with a finding from another group who demonstrated that FCS, but 
not bovine serum albumin, could absorb H2S (Ishigami, et al. 2009). The cause of the 
H2S quenching in serum is unknown and requires further investigation. 
Stimulating lower passage HUVEC or BAEC with A23187 (1 µM) or BK (10 µM) in 
serum free conditions with or without L-cysteine pretreatment still did not lead to a 
measurable rise in H2S determined by the methylene blue assay (Figure 3.2.8).  
 
3.3.3. CSE expression in HUVEC and RAW246.7 
The expression of CSE in endothelial cells has been slightly controversial: CSE protein 
has been described to be predominantly expressed in the endothelium lining of WT 
mice aorta (Yang, et al. 2008); whereas others have demonstrated that CSE protein is 
predominantly expressed in the media layer of the mouse aorta where the smooth 
muscle cells lye (Wang, et al. 2009b). Interestingly, CSE mRNA is not present in 
endothelial cells of rat aorta (Zhao, et al. 2001, Shibuya, et al. 2009a).  
It has recently been demonstrated that HUVEC and BAEC express CSE protein 
(Yang, et al. 2008). In the current study, CSE mRNA but not protein was expressed in 
HUVEC. The reason why CSE protein was not detected in the current study is unclear 
and may be either a sensitivity issue or a difference in the antibodies utilised. Indeed, it 
is plausible there may be a difference in their own made CSE antibody and the 
commercially bought CSE antibody utilised in this study. It is possible that the lack of 
CSE protein detected in HUVEC is due to poor commercial antibodies against human 
CSE. The presence of CSE and CBS message in HUVEC of the current study suggests that 
CSE protein is likely to be expressed in human endothelial cells. Indeed, H2S 
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synthesising enzyme activity appears to be present in BAEC and HUVEC (Table 3.2.1). 
However, the localisation of CAT and 3-MST has recently been described in rat thoracic 
aorta endothelial cells (Shibuya, et al. 2009a), and may be another source of H2S in 
endothelial cells. Indeed it will be interesting to take this study further to determine 
the presence of CAT and 3-MST in HUVEC. 
LPS has been shown to stimulate CSE expression in RAW 246.7 macrophages 
(Zhu, et al. 2010), as well as in the tissues of LPS treated mice (Li, et al. 2005). Although 
in the present study CSE protein was not detected in basal and LPS stimulated HUVEC, 
an increase in CSE protein levels were detected in LPS stimulated RAW246.7 cells 
(Figure 3.2.11). However, H2S was not detected in the culture medium of LPS 
stimulated RAW246.7 at 24 h even though CSE protein was strongly expressed at this 
time point (Figure 3.2.12) suggesting that the methods used in this study to detect H2S 
levels may not be sensitive enough to detect small changes in H2S production.  
 
3.3.4. Methods used to detect H2S 
There is much debate regarding the artificial elevation of sulfide in methods used to 
measure H2S (Olson 2009). Results presented in this report suggest the methods are 
insensitive to low levels of H2S produced by cells. Much of the debate regarding the 
artificial elevation of sulfide relates to the measurement of plasma H2S. However, this 
has provided clues as to why there may be differences in the H2S detected in the 
culture medium of the current work and in previous studies (Yang, et al. 2008). 
Speculations have arisen among the accuracy of the methods used to detect 
H2S, due the extreme pH conditions found in the conventional H2S detection assays 
which may induce the release of sulfur from protein leading to an artificial rise in the 
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sulfide detected (Olson 2009). Other than H2S, defined as free total free sulfide (H2S, 
HS- and S2-) in the context of this thesis, there are other forms of endogenous sulfur in 
the body such as sulfane sulfur. Sulfane sulfur atoms are reactive sulfur atoms with an 
unusual valency or oxidation state of 0 or -1 (in contrast to sulfide with a valency of -2) 
and are covalently bound to other sulfur atoms (Westley, et al. 1983, Toohey 1989, 
Iciek and Wlodek 2001). Some compounds that contain sulfane sulfur atoms include 
thiosulfate, disulfides, polysulfides and elemental sulfur (Westley, et al. 1983). 
Compounds containing sulfane sulfur have antioxidative properties and have biological 
function such as the regulation of enzyme activity (Iciek and Wlodek 2001). These 
compounds containing reactive sulfane sulfur atoms can be endogenously produced 
during anaerobic cysteine desulfuration (Westley, et al. 1983) by enzymes such as CSE, 
3-MST (3-mercaptopyruvate sulfurtransferase), CAT (cysteine transaminase) and 
rhodanese (Iciek and Wlodek 2001). Sulfane sulfur is also present on plasma albumins, 
which is hypothesised as a carrier for the transport of sulfane sulfur to the rest of the 
body (Westley, et al. 1983).  
Sulfane sulfur is highly reactive and can be released from the parent molecule 
in the form of sulfide (Iciek and Wlodek 2001). Furthermore, sulfane sulfur is liable for 
release by a number of different conditions e.g. excess glutathionine (GSH) or presence 
of dithiothreitol (DTT) (Warenycia, et al. 1990, Ishigami, et al. 2009). Indeed, some 
authors have suggested the physiological release of H2S from bound sulfane sulfur by 
physiological levels of GSH and cysteine in the neurons of rodents (Ishigami, et al. 
2009). These authors also suggested that free H2S may be stored as bound sulfur for 
later release (Ishigami, et al. 2009). More importantly, in the context of this chapter, 




has been suggested to induce protein desulfuration (Olson 2009). This effect has also 
been noted by others (Khan, et al. 1980, Whitfield, et al. 2008). One group 
demonstrated that when 5% bovine serum albumin was placed in antioxidant buffer, 
there was a measurable rise in sulfide detected by the ISE which continued to increase 
over 3 h (Whitfield, et al. 2008). Indeed, in the current study it was noted that making 
H2S standard curves in cell culture medium for the ISE lead to a continuous ‘drift’ or 
change in baseline voltage over time, or what Whitfield describes as the release of H2S 
from albumin, making it difficult to derive an accurate absolute value for varying 
concentrations of added sulfide. As a result, percentage change rather than absolute 
sulfide values were used when measuring sulfide values with the ISE in A23187 
stimulated HUVEC (Figure 3.2.2). Interestingly, incubating this sulfide probe in a range 
of different substances in the absence of sulfide, caused a measurable change in 
potential difference (Figure 3.2.7). Indeed, this probe detected ‘sulfide’ (a measurable 
reduction in voltage) on baseline incubation with MgCl2, CaCl2, FeCl2, blood, albumin, 
fetal calf serum (FCS) alone without added sulfide. Although, potentially sulfide may be 
released from bound sulfur from proteins in blood, albumin or FCS, no obvious protein 
was present in solutions of MgCl2, CaCl2 or FeCl2. It brings up some speculation of 
whether the apparently selective sulfide probe is measuring a change in sulfide, or 
whether background changes also induce changes in potential difference. Extreme pH 
< 5.4  has also shown to release sulfide from acid-liable sulfur sources predominately 
from the iron-sulfur centers in mitochondrial enzymes (Ubuka, et al. 2001, Ishigami, et 
al. 2009). Due to the acidic solution used in the methylene blue colourimetric method, 
this assay may be associated with an artificial rise in sulfide from potential acid-liable 
sulfur sources in plasma or tissues (Olson 2009). 
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It has previously been shown that baseline sulfide levels are increased within 
10 min of stimulating BAEC with A23187 and MCh using the ISE H2S detection method 
(Yang, et al. 2008).  Although these methods may lead to an artificial elevation of 
sulfide, sulfide levels were not detected in both basal as well as A23187 stimulated 
cells (HUVEC and BAEC) using both the methylene blue method and the ISE. In this 
study the ISE could only convincingly detect sulfide levels above 10 µM H2S, whereas 
the methylene blue method appeared to be the more sensitive method with detection 
levels of ~3 µM H2S. Although a 3 fold rise in H2S was detected in MCh stimulated BAEC 
(Yang, et al. 2008) absolute H2S concentrations and the sensitivity of the ISE were not 
stated. 
The difference between this study and the latter study (Yang, et al. 2008) brings 
up some important questions: 1. Whether the ISE in the latter study was indeed 
measuring sulfide; 2. Whether MCh in their study can induce a rise in intracellular Ca2+ 
in endothelial cells? If not, whether the rise in H2S detected by the ISE was due to a 
non-selective effect of MCh or the non-specific effect of the ISE? If MCh does indeed 
induce Ca2+ rise, could it be due to presence of smooth muscle cell contamination in 
the endothelial cell culture? (Loeb, et al. 1985). If there is smooth muscle cell 
contamination in the endothelial cell culture, could this be the reason for the presence 
of CSE protein expression in the latter study?  
 
3.3.5. H2S enzyme activity assay in liver homogenates ± Ca
2+
/CaM antagonists 
Liver is source of the H2S synthesising enzymes, CSE and CBS, and in the presence of 
substrate (L-cysteine) and cofactors (P5’P), detectable amounts of H2S are produced 
(Li, et al. 2005, Kabil, et al. 2011). In the current study, measurable amounts of H2S 
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were detected from rat liver tissue on incubation with L-cysteine and P5’P, and this 
effect was inhibited by irreversible CSE inhibitor PAG and CBS inhibitor AOAA (Figure 
3.2.13). PAG has a reported IC50 ~55 µM (Mok, et al. 2004) in rat liver homogenates. In 
the current study, PAG (60 µM) inhibited ~ 24.17% ± 1.10 H2S nmol/mg protein, at the 
same concentration AOAA (60 µM) CBS inhibitor inhibited ~88.73 ± 0.46 H2S nmol/mg 
protein of control. In neuronal cells, AOAA has an IC50 ~ 31 µM (Rzeski, et al. 2005). The 
greater reported potency of AOAA to PAG correlates with the current data that show 
AOAA has a greater inhibitory effect than PAG at the same drug concentration in the 
liver homogenates. 
To test whether H2S synthesising enzymes were Ca
2+/CaM dependent, an H2S 
synthesising enzyme assay was carried out using liver homogenates in the presence of 
a Ca2+/CaM antagonist trifluoperizine (TFP). TFP works by binding to Ca2+-bound 
calmodulin to induce a conformational change so Ca2+/CaM can no-longer interact 
with target molecules (Vandonselaar, et al. 1994). High concentrations of TFP 5 mM 
were required to significantly inhibit the production of H2S in the enzyme assay (Figure 
3.2.14). The effects of TFP, PAG and AOAA were not as a result of inhibiting the 
biochemical colour change associated with the methylene blue colourimetric assay 
(Figure 3.2.15). The concentrations of TFP used in this study to block H2S synthesis in 
liver were much higher than the concentrations of TFP used in the literature to block 
Ca2+/CaM action. For example, TFP inhibited the •NO-evoked cGMP response in rat 
cerebellar cells with an EC50 180 µM (James, et al. 2009). In the cytosolic fraction of rat 
liver homogenates TFP 25 µM inhibited the activity of phosphocholine 
cytidylyltransferase an enzyme involved in phosphatidylcholine biosynthesis by 5-fold 
(Pelech, et al. 1983). TFP is a competitive antagonist and higher concentrations of drug 
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may be necessary to block actions of these enzymes in the presence of excess Ca2+. 
However, due to the large concentrations of TFP used in this study it is plausible that 
inhibitory effect on H2S enzyme activity is a non-selective effect of TFP. Certainly in the 
current study another Ca2+/CaM antagonist is required to confirm the Ca2+/CaM 
dependence of H2S enzyme activity in liver homogenates and to confirm whether the 
inhibitory effects of TFP are as a result of a non-selective effect of this compound. 
In the current study, the addition of Ca2+ (500 µM) did not significantly increase 
H2S enzyme activity in liver homogenates (Figure 3.2.14). This suggests that the activity 
of H2S enzymes are either independent of Ca
2+ or, excess Ca2+ is already present in liver 
homogenates and adding more may not induce further effect. Interestingly in the 
current study addition of Ca2+ chelator EGTA (6 mM) did not significantly reduce H2S 
enzyme activity (Figure 3.2.14). However, one previous study showed that the addition 
of both Ca2+ (2 mM) and CaM (5 µM) increased the activity of purified CSE by two fold 
(Yang, et al. 2008). In the current study, only Ca2+ was added to the liver homogenates, 
further studies in the presence of both added Ca2+ and CaM may be necessary to 
determine the Ca2+/CaM dependence of H2S enzymes in liver homogenates. Earlier 
studies using purified CSE (Chiku, et al. 2009) and CBS (Kraus, et al. 1978, Kraus and 
Rosenberg 1983) have shown that these enzymes did not require added Ca2+ to induce 
its activity. However, these latter studies did not add Ca2+/CaM to determine whether 
a further increase in enzyme activity could be achieved. Further studies using purified 
CSE enzymes with added Ca2+/CaM are necessary to confirm previous findings (Yang, 





3.3.6. CSE, H2S and endogenous blood pressure regulation 
Earlier studies (Yang, et al. 2008) have demonstrated that CSE-/- KO mice develop an 
age dependent hypertension as a result of endothelial cell dysfunction which was 
suggested to be as a result of depleting CSE protein in the endothelium. On further 
examination, these authors demonstrated that both HUVEC and BAEC contain CSE 
protein, and stimulating BAEC with A23187 (1 µM) or MCh (10 µM) induced the release 
of measurable amounts of H2S in the cell culture medium within 10 min (Yang, et al. 
2008). This suggested that stimulating endothelial cells with agents that cause a rise in 
intracellular Ca2+ will lead to the activation of CSE and the production of H2S (Yang, et 
al. 2008). Exogenous H2S has been shown by various laboratories to induce vascular 
relaxation (Zhao, et al. 2001, Ali, et al. 2006), and as a result these authors (Yang, et al. 
2008) suggested that the endothelial cell dysfunction and age dependent hypertension 
observed in the CSE-/- KO mice was due to a lack of H2S release from the endothelium. 
Plasma concentrations of H2S have been reported to range from 2 µM (Olson 
2009) to 280 µM (Han, et al. 2006), with around average reported plasma 
concentrations ~ 40 µM H2S using the typical methods of H2S detection that is the 
methylene blue assay and the ISE  (Olson 2009). Interestingly, the use of a sensitive 
polorgraphic sensor which can measure H2S (up to 100 nM sulfide) in real time without 
the need for chemical modification, could not detect H2S in the plasma in a number of 
animal species including mouse, rat, trout, pig, lamprey and cow (Whitfield, et al. 
2008). Moreover, injection of H2S donors into animals only results in a transient (<30 
sec) reduction in blood pressure (Zhao, et al. 2001), which may suggest that the level 
of free H2S in blood plasma is transient. In a human phase I safety study, a significant 
rise in blood sulfide (42.5 ± 8.9 c.f. 106.2 ± 54.1 µM H2S, *P = 0.0004) was described on 
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an intravenous infusion of Na2S (i.v. 0.20 mg kg−1 over a period of 1 min) (Toombs, et 
al. 2010). However, this rise in blood sulfide did not lead to a change in blood pressure 
(Toombs, et al. 2010). This may suggest that >100 µM plasma H2S is required to a 
vasorelaxant effect. The current consensus, is that plasma concentration of 
endogenous free sulfide <100 nM (Whitfield, et al. 2008) is far less than the predicted 
concentration of H2S necessary to induce a vasorelaxant effect (>100 µM H2S ex vivo). 
Moreover, low concentrations of H2S (<100 µM) have been described to have a 
vasoconstrictive effect in ex vivo blood vessels (Ali, et al. 2006). Furthermore, a distinct 
smell of rotten eggs would be expected if concentrations of 40 µM free H2S in plasma 
were present. This raises questions whether micromolar H2S plasma are present 
physiologically and whether endogenous free H2S induces vasodilatation. It is also 
interestingly to note whilst the CSE-/- KO mice in the latter study demonstrated age 
dependent hypertension (Yang, et al. 2008), another laboratory who also developed 
CSE-/- KO did not observe the same phenomenon (Ishii, et al. 2010). The reason behind 
the differences in the CSE-/- KO mice is unclear and evidently requires further 
examining.  
However, on another note, although H2S may exist only transiently in the 
blood, it is possible that it can induce its effects as an endogenous signalling molecule 
by exerting its effects within cells or between adjacent cells. However, its role as a 







3.3.7. Conclusion  
Overall, due to the limitation in the sensitivity and selectivity of the methods used to 
measure H2S release de novo in culture, there is insufficient evidence to provide a 
definitive conclusion as to whether H2S is an endothelial cell derived relaxing factor. It 
is questionable whether H2S synthesising enzymes found in liver are Ca
2+/CaM 
dependent, further studies are needed to confirm this.  The role of endogenous H2S in 
cardiovascular physiology is still unclear and is limited by lack of reliable methods used 





































It has been suggested that a potential crosstalk exists between •NO and H2S.  H2S 
donors attenuate iNOS expression and •NO production in microglia (Hu, et al. 2007) 
and RAW264.7 cells (Oh, et al. 2006) exposed to LPS. Conversely, NaHS (25 – 100 µM) 
has also been shown to increase IL-1β induced iNOS protein expression in rat vascular 
smooth muscle cells (Jeong, et al. 2006). NaHS (50-100 µM) has been reported to 
reduce eNOS phosphorylation and eNOS maximal activity in HUVEC (Geng, et al. 2007). 
In contrast to the latter study, in a model of ischemia reperfusion, continuous infusion 
of NaHS (100 µM postconditioning, 2 min continuous infusion) was shown to stimulate 
PKC and Akt and induce the phosphorylation of eNOS in cardiomyocytes (Yong, et al. 
2008).  
In homogenates of aortic tissue, administration of the •NO donor SNP 
concentration-dependently increases H2S synthesis suggesting that 
•NO may increase 
CSE activity (Zhao, et al. 2001). Furthermore, in the same study the •NO donor SNAP (S-
nitroso-N-Acetyl-D,L-Penicillamine) increased CSE expression in cultured vascular 
smooth muscle cells (Zhao, et al. 2001). In a model of ischemia-reperfusion in the rat 
kidney, CBS activity was inhibited (Prathapasinghe, et al. 2008). However, this effect 
was reversed on injecting rats with a •NO scavenger 2-phenyl-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide (PTIO) suggesting •NO metabolites may 
contribute to the inhibition of CBS activity in this model (Prathapasinghe, et al. 2008).   
Other than “gas-enzyme” regulation, a “gas-gas” interaction has also been 
proposed. It has been suggested that •NO and H2S may chemically react to form a 
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novel nitrosothiol (RSNO) in vitro (Whiteman, et al. 2006). In support of this, incubating 
SNP (100 µM) with NaHS (100 µM) did not elevate cGMP levels in cultured RAW264.7 
cells, in contrast to SNP alone (Whiteman, et al. 2006). Moreover, in anaesthetised rats 
SNP induced a significant reduction in mean arterial blood pressure, whereas co-
administration of SNP (16.5 nmol kg−1, i.v) and NaHS (5 µmol/kg, i.v) abolished this 
reduction in blood pressure (Ali, et al. 2006). H2S can also react with peroxinitrite 
(ONOO-) to form a novel thionitrate (HSNO2) that is capable of releasing 
•NO (Filipovic, 
et al. 2011).  
•NO and H2S have very similar biological properties and exert similar effects 
within the vascular system. They are both small molecule gases capable of diffusing 
through cell membranes and are endogenously produced by endothelial cells and/or 
smooth muscle cells in blood vessels (Wang 2002a). •NO and H2S also exert anti-
hypertensive effects: either through the activation of soluble guanylate cyclase and 
subsequent elevation of 3’,5’-cyclic guanosine monophosphate (cGMP) (Lincoln, et al. 
2001); or through direct activation of KATP channels on VSMC to induce 
hyperpolarisation, respectively (Zhao, et al. 2001). H2S may also potentially enhance 
the effects of •NO through inhibition of phophodiesterase activity and subsequent 
elevation of cGMP levels (Bucci, et al. 2010).  
Under inflammatory conditions, both •NO donors (Kobayashi 2010) and H2S 
donors (Li and Moore 2008)  have been shown to exert both pro- and anti-
inflammatory effects. Moreover, both •NO (Napoli, et al. 2006) and H2S (Wang, et al. 
2009b) inhibit the development of atherosclerotic plaque formation. Indeed, both •NO 
and H2S have very similar actions and it is possible that loss of signalling from one 




Hypothesis: H2S synthesising enzymes will compensate for the loss of NOS activity. 
Thus, the aim of this study was to:  
1. Compare the H2S synthesising enzyme activity in multiple organs from wildtype 
(WT),  eNOS-/- and iNOS-/- KO mice 




















4.1. Materials and Methods 
4.1.1. Animal housing and breeding 
Male eNOS-/- and iNOS-/- (30 g) were a kind gift from Dr. Adrian Hobbs (University 
College London, UCL).  Both eNOS-/- and iNOS-/- mice were bred on a C57BL/6 
background. In all studies, age-gender matched wildtype (WT) littermates were used 
as controls. These mice were housed in the UCL Biological Services Unit (Euston) in a 
climatically controlled environment (20oC, 12 h light cycle). Laboratory chow and 
drinking water were available ad libitum. All experiments were carried out blinded 
and according to the 1986 UK Home Office Animals Scientific Procedures Act. 
4.1.2. Tissue processing 
Mice were anaethesised under isoflurane (4% v/v) before cardiac puncture was 
carried out using heparinised syringes. The mice were then killed via cervical 
dislocation and organs removed and flash frozen in liquid nitrogen prior to storage at 
-80oC. 
4.1.3. H2S synthesising activity 
Whole mouse tissue was homogenised in KHPO4 (100 mM, pH 7.4) as follows: liver 
(5% w/v), kidney (10% w/v) and brain, lung, spleen, stomach and small intestine (15% 





Western blot for CSE and CBS in mouse tissues 
Mouse tissues were lysed in 10% w/v (with the acceptation of aorta and brain which 
were lysed at 5% w/v and 20% w/v respectively) cell lysis buffer (Method 2.7) using a 
Polytron Homogeniser. Cell lysates were then left on ice for 2 h before centrifuging at 
13,000 rpm, 4oC for 10 min. The supernatant was collected and re-centrifuged at 
13,000 rpm, 4oC for 10 min, to remove excess debris. The clear supernatant was 
aliquoted and frozen at -20oC for Western blotting (Method 2.7). Immunoreactive 
bands at 42 kDa and 70 kDa corresponding to CSE and CBS respectively, were 
quantified with a Syngene gel quantification system. Due to problems with stripping 
CSE antibody from the membrane, the loading control (β-actin) was analysed on a 













4.2.1. H2S synthesising activity and CSE/CBS protein expression in WT mice 
H2S synthesising activity and CSE/CBS protein expression were initially assessed in 
multiple organs from WT mice. Clear differences in H2S production were observed in 
the different tissues under investigation. The organs with the greatest H2S synthesising 
enzyme activity (H2S nmol/mg protein) were liver (10.08 ± 0.76) > kidney (3.93 ± 0.28) 
> small intestine (2.40 ± 0.21) > stomach (0.95 ± 0.15) > brain (0.56 ± 0.02) (Figure 4.2.1 
a). H2S enzyme activity was at the limit of detection in lung (0.01 ± 0.01) and spleen 
(0.01 ± 0.03) tissues (Figure 4.2.1 a).  
CSE protein expression appeared to correlate with H2S enzyme activity assay 
(Figure 4.2.1 b). CSE protein was highest in liver > kidney > small intestine > stomach 
but undetectable in brain, lung, spleen and heart tissue (Figure 4.2.1 b).  
CBS protein expression was predominantly found in the brain with some CBS 
protein found in lung tissue (Figure 4.2.1 c) and did not correlate with the H2S enzyme 
activity assay (Figure 4.2.1 a and 4.2.1 c) suggesting that the H2S enzyme assay may be 
measuring CSE activity alone,  rather than both CSE and CBS activity.  
 
4.2.2. H2S synthesising enzyme activity in iNOS
-/-
 mice 
To determine whether H2S enzyme activity and expression were altered in a system 
which lacks NOS expression and activity, the above experiments were repeated using 
iNOS-/- mice. There was no difference in H2S synthesising enzyme activity in most of 
the organs (brain, lung, liver, spleen, stomach and small intestine) of the iNOS-/- mice 
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compared to WT (Figure 4.2.2 – 4.2.8). Interestingly, there was a significant reduction 
in H2S enzyme activity in kidney tissue of iNOS
-/- c.f. WT (Figure 4.2.3, P<0.05).  
 
4.2.3. CSE and CBS protein expression and H2S synthesising activity in eNOS
-/-
 mice  
H2S synthesising activity and CSE protein expression were also examined in tissues of 
eNOS-/- mice. In liver tissue, a significant (P<0.05) increase in H2S synthesising enzyme 
activity was measured in eNOS-/- compared to WT (Figure 4.2.2 a) and this correlated 
with an increased protein expression for CSE (Figure 4.2.2 b). A significant (P<0.05) 
increase in H2S enzyme activity in the stomach (Figure 4.2.4 a) and small intestine 
(Figure 4.2.5 a) was observed in eNOS-/- compared to WT. However, this did not 
correlate with a change in CSE protein expression in stomach and small intestine of 
eNOS-/- (Figure 4.2.4 b and 4.2.5 b).  
There was no significant difference in H2S enzyme activity and/or CSE protein 
expression of eNOS-/- and WT mice in: kidney tissue (Figure 4.2.3), brain (Figure 4.2.6), 
lung (Figure 4.2.7), spleen (Figure 4.2.8), heart and aorta (Figure 4.2.9). 
Lung and brain tissue contain basal amounts of CBS protein (Figure 4.2.1 c), 
therefore western blots for CBS protein in WT and eNOS-/- lung and brain tissue were 
carried out. No significant difference in CBS protein expression was found in brain or 




Figure 4.2.1. WT mouse organs a) H2S synthesising enzyme activity where data is expressed as 
H2S produced (nmol/mg protein), b) Representative western blots of CSE and β-actin loading 
control. Graph shows densitometry values of CSE standardised to β-actin c) Representative 
western blot of CBS and β-actin loading control. Graph shows densitometry values of CBS 





Figure 4.2.2. Graph shows liver tissue a) H2S synthesising enzyme activity as H2S 
nmol/mg protein from eNOS-/-, iNOS-/- and WT b) representative Western blot for CSE 
and β-actin (5 µg liver tissue, eNOS-/- c.f. WT) with graphs representing densitometry 
values of CSE standardised to β-actin. All data are shown as mean ± SEM, n = 6, 






Figure 4.2.3. Graph shows kidney tissue a) H2S synthesising enzyme activity (H2S 
nmol/mg protein) from eNOS-/-, iNOS-/- and WT b) representative Western blot for CSE 
and β-actin from eNOS-/- and WT kidney tissue (5 µg) with graphs representing 
densitometry values of CSE standardised to β-actin. All data are shown as mean ± SEM, 







Figure 4.2.4. Stomach tissue a) H2S synthesising enzyme activity in eNOS
-/-, iNOS-/- and 
WT (H2S nmol/mg protein) b) representative CSE and β-actin Western blot from eNOS
-
/- and WT stomach tissue (50 µg). Graph below Western blot shows densitometry 
values of CSE standardised to β-actin. All data are shown as mean ± SEM, n = 6, 





Figure 4.2.5. Data show a) H2S enzyme activity from small intestine of WT, eNOS
-/- KO 
and iNOS-/- KO mice represented as H2S ng/mg protein b) representative western blot 
of CSE and β-actin from eNOS-/- and WT small intestine tissue (50 µg). Graph below 
Western blot shows densitometry values of CSE standardised to β-actin. All data are 









Figure 4.2.6. Graph shows brain a) H2S enzyme activity (H2S nmol/mg protein) from 
WT, eNOS-/- and iNOS-/- mice b) representative western blot of CSE and β-actin loading 
control from eNOS-/- and WT brain tissue (40 µg) c) representative western blot of CBS 
and β-actin loading control with graphs representing densitometry values of CBS 
standardised to β-actin from eNOS-/- and WT brain tissue (40 µg). All data are shown as 




Figure 4.2.7. Graph shows lung a) H2S enzyme activity (H2S nmol/mg protein) from WT, 
eNOS-/- and iNOS-/- mice b) representative Western blot of CSE and β-actin loading 
control from eNOS-/- and WT lung tissue (40 µg) c) representative Western blot of CBS 
and β-actin loading control with graphs representing densitometry values of CBS 
standardised to β-actin from eNOS-/- and WT lung tissue (40 µg). All data are shown as 






Figure 4.2.8. a) Graph shows H2S enzyme activity in spleen, measured as H2S nmol/mg 
protein, in WT, eNOS-/- KO and iNOS-/- KO mice b) representative Western blot of CSE 
and β-actin loading control of spleen (50 µg) tissue from WT and eNOS-/- mice. All data 






Figure 4.2.9. Representative Western blots from a) heart  (50 µg) and b) aorta (20 















4.3. Discussion  
 
The main findings from this chapter are: 
1. H2S synthesising activity is different between different organs of WT mice 
2. There is increased H2S synthesising activity in eNOS
-/- but not iNOS-/- c.f. WT 
3. H2S synthesising activity assay correlates with CSE but not CBS protein 
expression 
 
The results presented in this chapter indicate that H2S synthesising activity correlates 
with CSE but not CBS expression and that this activity/expression is tissue dependent. 
Liver, kidney, small intestine and stomach were the predominant tissues tested that 
generated measurable levels of H2S above the limit of detection. Furthermore, H2S 
synthesising activity and CSE expression were up-regulated in eNOS-/- but not iNOS-/- 
mice. This is consistent with the hypothesis that H2S synthesis compensates for loss 
basal •NO signalling. The observation in iNOS KO mice may not be surprising as iNOS is 
not constitutively expressed and in general is only transcribed during inflammation 
(discussed later). 
 
4.3.1. H2S synthesising enzyme activity and CSE/CBS whole body expression profile 
in WT mice 
The organ with the highest H2S enzyme activity was liver followed by kidney, small 
intestine, stomach, and brain with negligible and largely variable amounts of H2S 
synthesising enzyme activity in the lung and spleen (Figure 4.2.1 a). Similarly, CSE 
protein expression followed a similar trend to H2S synthesising enzyme activity, and 
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was predominately expressed in the liver followed by kidney, and to a lesser extent 
small intestine and stomach, with undetectable amounts of CSE protein in other 
tissues. These findings correlate with a previous study which demonstrated a similar 
CSE protein and H2S synthesising activity expression profile in both mouse and rat 
tissues (Ishii, et al. 2004). Interestingly in the latter study, although brain, lung and 
heart tissue did not express CSE protein, CSE transcripts were detectable (Ishii, et al. 
2004). 
In contrast to CSE expression, in the current study CBS protein was 
predominately located in the brain tissue with smaller variable amounts in lung. Others 
have also described CBS protein and mRNA in mouse hippocampus and purkinje cells 
of the cerebellum (Robert, et al. 2003b). CBS message has also been described in 
mouse lung tissue (Kumaraswamy, et al. 2009). CBS mRNA (Bao, et al. 1998, Quere, et 
al. 1999) and protein (Robert, et al. 2003a, Vitvitsky, et al. 2007) have previously been 
described in the liver and kidney tissue. However, in the present study CBS protein was 
undetectable in liver and kidney lysates, although this may be attributable to 
differences in the epitope recognition sites of the antibodies utilised. Indeed, in most 
of the studies analysing CBS protein expression, custom made antibodies were 
developed whilst a commercially developed antibody (Abnova) was used in the 
present study. Another study utilising a similar strain of mouse (C57BL6J) to the 
current study (C57BL/6) also described a strong CBS band for brain tissue and a faint 
protein band for liver tissue, and the absence of a CBS band for kidney tissue (Al-
Magableh and Hart 2011). Interestingly, CBS is thought to be 60 and 20-fold lower than 
CSE in the liver and kidney respectively (Kabil, et al. 2011). These reported differences 
in relative expression of these two proteins may account for the lack of detectable CBS 
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protein in these tissues. Indeed, CBS mRNA was detected in human liver as described 
in Chapter 3. 
Irrespective of these slight differences in CBS protein expression presented 
within this chapter with that of other published findings, the H2S enzyme activity assay 
in the current study appeared to correlate with CSE expression but not CBS expression. 
This suggests that the current assay used to measure H2S enzyme activity is bias 
towards measuring the activity of CSE. Indeed it has been suggested that the preferred 
H2S generating reaction for CBS may be the condensation of cysteine and 
homocysteine and the predominant pathway for H2S generation by CSE is through the 
α, β-elimination reaction of cysteine (Chiku, et al. 2009, Singh, et al. 2009). In the 
current study, only L-cysteine was used as a substrate for tissue H2S generation. 
Moreover, the activity of CBS may also depend on S-adenosyl methionine (SAM) in 
addition to P5’P (Chen, et al. 2004). Therefore an alternative assay utilising both 
homocysteine and cysteine in the presence of SAM and P5’P may better reflect the 
activity of both CSE and CBS enzymes.  
 
4.3.2. H2S synthesising enzyme activity in iNOS
-/-
 mice 
In the current study, H2S synthesising enzyme activity was not altered in iNOS
-/- mice 
compared to WT in most tissues: brain, lung, liver, spleen, stomach and small intestine. 
iNOS is not constitutively expressed in most tissues and given that the hypothesis is 
that H2S generation will compensate for the loss of 
•NO production, it is not surprising 
that there was no change in H2S synthesising activity in these animals. Whether a 
difference in H2S enzyme activity in iNOS
-/- mice would transpire in response to a 
noxious stimulus, such as LPS, is another area that requires further investigation.  
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Interestingly, a significant reduction in H2S enzyme activity was noted in kidney 
tissue of iNOS-/- compared to WT.  The reason for this reduction in H2S enzyme activity 
is unknown. However, there have been reports that iNOS is constitutively expressed in 
kidney (Vaziri, et al. 1998, Poljakovic, et al. 2001, Chou, et al. 2002), which may suggest 
an alternative role for iNOS in the kidney other than in immunological defence. Indeed, 
further studies are required to examine the iNOS organ expression profile in WT mice. 
Interestingly, CSE and CBS expression, like iNOS, is found primarily in the renal tubules 
(Ishii, et al. 2004). iNOS-/- KO mice have been demonstrated to have a reduced fluid 
absorption, demonstrated by a reduction in Na+ absorption (Wang 2002b). Conversely, 
H2S has also been shown to inhibit Na
+ absorption (Xia, et al. 2009). It can be 
speculated that the reduction in H2S enzyme activity in the iNOS
-/- KO mice, may be a 
compensatory mechanism to reduce further loss of ions such as Na+ in the urine.  
 
4.3.3. H2S enzyme activity and CSE expression in eNOS
-/-
 mice CSE  
In contrast to iNOS-/- mice, significant differences in H2S synthesising activity and CSE 
expression was described in a number of tissues derived from eNOS-/- mice compared 
to WT control tissue. These differences will be discussed in an organ specific manner. 
 
a)  Liver 
The liver has many functions such as the biosynthesis of proteins and the removal of 
toxic substances. As a result this organ is a large source of enzymes involved in amino 
acid synthesis and metabolism. Indeed, both CSE and CBS enzymes are intimately 
involved in the transulfuration pathway of converting the toxic L- homocysteine to L-
cysteine (Persa, et al. 2004). The transulfuration pathway is also connected to the 
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transmethylation pathway between L-methionine and L-homocysteine (Riedijk, et al. 
2007). CSE and CBS are therefore vital for the conversion of L-methionine to L-cysteine 
and for the removal of L-homocysteine. Moreover, CSE may be essential for an 
adequate supply of cysteine necessary for the synthesis of GSH in the liver (Rao, et al. 
1990).  It is therefore not surprising why hepatocytes are a large source of these 
enzymes, and likely to be a reason why liver is one of the largest source of H2S in the 
body. 
Whether H2S has other functions in the liver other than being a by-product of 
cysteine metabolism is probable due to the vast number of biological actions described 
within the cardiovascular system. Indeed, the liver is a large source of blood vessels. 
CSE has been described to be present in the hepatocytes as well as the stellate cells of 
liver, but interestingly not in the sinusoidal endothelial cells of the liver vasculature 
(Fiorucci, et al. 2005b). Sinusoidal resistance is regulated by regulating the contraction 
and relaxation of hepatic stellate cells surrounding the sinusoidal endothelial cells 
(Fiorucci, et al. 2005b). CSE protein expression has been shown to be down regulated 
in hepatic stellate cells of rats with liver portal hypertension, suggesting that H2S 
derived from CSE plays a role in the maintenance of perfusion pressure in the liver 
vasculature (Fiorucci, et al. 2005b). 
In the current study, an up-regulation of CSE protein expression and H2S 
enzyme activity was described in the liver tissue of eNOS-/- KO mice compared to WT 
(Figure 4.2.2). eNOS is located in the endothelial cells of the vasculature of the liver as 
well as hepatocytes (McNaughton, et al. 2002), and the predominant role for eNOS in 
the liver is thought to be the regulation of hepatic perfusion (Li and Billiar 1999, Shah, 
et al. 2004). Indeed, •NO inhibitor N omega-nitro-L-arginine (NNA) has been 
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demonstrated to increase (P<0.05) baseline portal pressure compared to control 
(Mittal, et al. 1994). Moreover, other studies have suggested an up-regulation of eNOS 
activity in rats induced with portal vein ligation for two weeks (Cahill, et al. 1996). 
The liver is a large vascular organ and both •NO and H2S are vasodilators and 
both have been suggested to regulate hepatic perfusion.  The up-regulation of H2S 
enzyme activity and CSE protein expression in the current study may suggest a 
compensatory mechanism to normalise hepatic perfusion pressure for the loss of •NO 
production in the eNOS-/- KO mice. However, further study is required to confirm these 
conclusions. Whether an up-regulation of CSE occurs in the hepatocytes, hepatic 
stellate cells or both, requires further study. 
 
b) Kidney 
The core functions of the kidney are to remove filter, reabsorb and secrete fluids and 
free amino acids of the body. Another important function of the kidney is for the 
metabolism and removal of amino acids, such as homocysteine (Urquhart and House 
2007).  In the rat cortical tubules, homocysteine is metabolised predominately by the 
transulfuration pathway (House, et al. 1997). However, whether the kidney is a major 
organ for homocysteine metabolism in humans is debatable (Urquhart and House 
2007). 
Interestingly, in rats CBS is localised largely in the outer cortex and 
predominately in the proximal convoluted tubule segment of the kidney (House, et al. 
1997). In contrast, CSE is located largely in the outer medulla and primarily in the 
proximal straight tubules of the nephron (House, et al. 1997). This may suggest CSE 
and CBS are involved in regulating tubular function in the kidney. In the adult rodent 
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eNOS is located exclusively in the endothelial cell lining of all blood vessels, including 
glomerular capillaries and peritubular capillaries of the medulla (Han, et al. 2005a, 
Forbes, et al. 2007), suggesting a role for eNOS in the regulation of blood flow in the 
kidney.  
Interestingly it has been demonstrated that infusing AOAA (CBS inhibitor) and 
PAG (CSE inhibitor) together, both 0.5 µmol/min/kg, significantly reduced glomerular 
filtration rate, urinary sodium and potassium excretion (Xia, et al. 2009). Moreover, 
NaHS was shown to directly inhibit   Na+/K+/2Cl- cotransporter and Na+/K+ ATPase 
activity (Xia, et al. 2009), suggesting that H2S can inhibit the reabsorption of ions such 
as Na+. These authors suggested that H2S may have roles in both vascular and tubular 
actions in the kidney (Xia, et al. 2009). However, in the current study, no change in H2S 
enzyme activity or CSE protein expression was noted in eNOS-/- compared to WT mice. 
This may suggest that although, H2S produced by CSE in the kidney may contribute to 
the vascular regulation of the kidney, the role for H2S in vascular regulation may be 
minimal. However, other compensatory mechanisms may replace the role for eNOS in 
the kidney. Indeed, as described before (Discussion 4.3.2) iNOS is constitutively active 
in the kidney (Vaziri, et al. 1998, Poljakovic, et al. 2001, Chou, et al. 2002) and it can be 
hypothesised that iNOS may directly compensate for the loss of •NO in the eNOS-/-. 
However, further study is required to confirm this. 
Overall, in the current study, there was no significant difference in H2S enzyme 
activity or CSE expression in the kidney of eNOS-/- KO mice compared to WT. The 
reason behind this is unknown. However it is possible that the regulation of renal 




c) Gastrointestinal tract 
The predominant role of the GIT is for the digestion of food, absorption of nutrients, 
and the extrusion of waste. In the rat colon CBS is found predominately in the 
fibroblast and smooth muscle cells (Wallace, et al. 2009). Whereas CSE expression is 
more diffuse and was shown to be located in blood vessels, epithelial, crypt and goblet 
cells (Wallace, et al. 2009). 
In the current study, a notable amount of H2S synthesising enzyme activity was 
described in the stomach and small intestine of WT mice (Figure 4.2.1). Bacteria are a 
potential source of H2S enzyme activity in the gastrointestinal tract as they themselves 
are capable of synthesising H2S (Gibson, et al. 1990, Pitcher and Cummings 1996). The 
stomach and small intestine was thoroughly cleaned of their contents, leaving 
predominately the bulk tissue mass, therefore, bacteria is unlikely to be the main 
source of H2S synthesising enzyme activity in the current study. Moreover, although 
bacteria reside throughout the GIT, acid and bile is thought to hinder bacterial 
colonisation in the stomach and proximal small intestine (O'Hara and Shanahan 2006). 
Instead, bacteria predominately colonise in the distal end of the small intestine and 
large intestine  (O'Hara and Shanahan 2006), and is a reason why the large intestine 
and proximal end of the small intestine was not unitised in the current study. 
•NO derived from eNOS has been implicated in maintaining the mucosal barrier 
of the GIT (Shah, et al. 2004). NG-nitro-L-arginine methyl ester (L-NAME) has been 
shown to increase basal epithelial permeability in the small intestine of the cat (Kubes 
1992) and in the rat (Kanwar, et al. 1994). Moreover, the effects of L-NAME on 
epithelial permeability can be reversed on incubation with •NO donor, sodium 
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nitrossprusside (SNP) (Kubes 1992). Which may suggest that basal constitutive •NO 
production, is involved in protection of the mucosal barrier function. 
 Interestingly, eNOS-/- KO mice are less susceptible to dextran sodium sulfate-
induced colitis than iNOS-/- or nNOS-/- KO mice, which may suggest •NO derived from 
eNOS may promote colitis (Beck, et al. 2004). However, in the current study, an 
increase in H2S synthesising enzyme activity was noted in stomach and small intestine 
of the eNOS-/- compared to WT. Exogenous and endogenous H2S has previously been 
demonstrated to reduce the severity of colitis or gastric inflammation in a number of 
models (Fiorucci, et al. 2005a, Wallace, et al. 2007b, Medeiros, et al. 2009, Wallace, et 
al. 2009),  and may be the reason for the resistance against colitis in the eNOS-/- KO 
mice (Beck, et al. 2004).  
It is possible the compensatory increase in H2S synthesising enzyme activity in 
the GIT of eNOS-/- KO mice described in the current study, is a compensatory 
protective mechanism for maintenance of the GIT barrier. Furthermore, this 
compensatory up-regulation of H2S in the GIT of eNOS
-/- KO mice may be the reason 
for the protection against experimental colitis in eNOS-/- KO mice demonstrated in 
previous studies (Beck, et al. 2004). However, studies measuring H2S synthesising 
enzyme activity in eNOS-/- with gastric damage are required to confirm this hypothesis. 
 
d) Spleen, brain, lung, heart and aorta 
In the current study no significant difference in the H2S synthesising enzyme activity 
between eNOS-/- KO mice and WT was noted in the spleen, brain or lung tissue (Figure 
4.2.6 – 4.2.8). It should be noted that the H2S enzyme assay was not carried out in: 
heart due accidental loss of tissue; thoracic aorta as the tissue mass was too small to 
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carry out the H2S enzyme assay. H2S produced from these tissues were at the limit of 
detection, with ~5 µM H2S detected in brain tissue and ≤ 2 µM H2S detected from 
spleen and lung tissue (all tissues 15% w/v). Indeed, the small amounts of H2S 
produced in these tissues were small and variable making it difficult to determine a 
difference between WT and eNOS-/- KO mice if there was a difference. Similar to the 
current study, others have also described limited H2S enzyme activity in the spleen, 
brain and lung, and no H2S enzyme activity in heart tissue (Ishii, et al. 2004). 
CSE protein expression was not detected in heart, aorta, spleen, brain and lung 
tissue in the current study (Figure 4.2.6 – 4.2.9). This correlated with another study 
that demonstrated the absence of CSE protein in the brain, heart, spleen and lung 
tissue (Ishii, et al. 2004). Although CSE protein was not detected, in the same study, 
CSE mRNA was present in the brain, heart and lung tissue (Ishii, et al. 2004). While CSE 
protein was not detected in mouse aorta in the current study, CSE protein expression 
has previously been demonstrated in rat aorta by western blotting (Cheng, et al. 2004), 
and in mouse aorta by immunohistochemistry (Yang, et al. 2008).  
The reason for the differential location and density of CSE in peripheral tissue is 
unknown. It is possible the role for CSE in the brain, heart, spleen and lung may be of 
lesser importance than in the liver, kidney and GIT where CSE is expression is 
detectable. However, it is possible that the sensitivity of the detection methods for CSE 
protein and H2S generation is a reason why CSE/H2S was not detected in the brain, 
heart, spleen and lung tissue. 
CBS protein was only detectable in the brain and lung tissue. In both brain and 
lung tissue, there was no significant difference in CBS protein expression between WT 
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and eNOS-/- KO mice (Figure 4.2.6 and 4.2.7). This is consistent for a predominant role 
for CBS in the central nervous system rather than the cardiovascular system. 
 
4.3.4. Summary and conclusion  
In summary, an up-regulation of H2S synthesising enzyme activity was noted in tissues 
capable of generating robust and measureable concentrations of H2S (10 – 190 µM), 
that is the liver, stomach and small intestine; the exception being kidney, where no 
change in H2S synthesising enzyme activity or CSE expression was observed. The data 
from this descriptive study suggests that signalling mediated by •NO can be 
compensated by H2S. However, further functional studies are required to confirm 
these findings. The examination of the vascular reactivity of vessels derived from 
eNOS-/- on exogenous H2S administration would further provide further evidence for a 
functional compensatory effect of H2S for eNOS. Furthermore, the global examination 
of eNOS protein expression and total NOS activity would provide insight as to whether 
NOS has a similar expression profile to H2S synthesising activity. Finally, one should 
keep in mind that the H2S synthesising enzyme assay used in the current study is likely 
to reflect H2S generation by CSE (rather than both CSE and CBS) and therefore is not a 
true representation of the total H2S synthesising capacity of tissues and is a limitation 
















The role of H2S in inflammation is unclear. H2S donors have shown to exert both pro-
inflammatory (Bhatia, et al. 2006, Tamizhselvi, et al. 2007, Zhang, et al. 2007b, Zhi, et 
al. 2007, Zhang, et al. 2008) and anti-inflammatory action (Fiorucci, et al. 2005a, 
Zanardo, et al. 2006, Wallace, et al. 2007b, Andruski, et al. 2008, Chen, et al. 2009, 
Wallace, et al. 2009, Kloesch, et al. 2010). Similarly, H2S inhibitors have also 
demonstrated pro-inflammatory (Fiorucci, et al. 2005a, Zanardo, et al. 2006, Wallace, 
et al. 2009) and anti-inflammatory action (Bhatia, et al. 2005, Collin, et al. 2005, Li, et 
al. 2005, Bhatia, et al. 2006, Tamizhselvi, et al. 2007, Zhang, et al. 2007b, Mok and 
Moore 2008, Zhang, et al. 2008). 
Both inhibitors of H2S synthesising enzymes and H2S donors have their flaws. 
Most of the antagonists used to inhibit CSE or CBS, inhibit the pyridoxal 5’ phosphate 
binding site which may result in non-selective inhibition of other pyridoxal 5’ 
phosphate dependent enzymes (Tanase and Morino 1976, Rej 1977, Burnett, et al. 
1980, Loscher 1981, Hamel, et al. 1982). 
NaHS is the most commonly used H2S donor used in deciphering the actions of 
H2S in biological systems. One limitation with the use of NaHS is that cells may be 
subject to instantaneously high concentrations of H2S, which can be cytotoxic 
(Beauchamp, et al. 1984, Eghbal, et al. 2004, Cao, et al. 2006, Adhikari and Bhatia 
2008). Moreover, the volatile properties of H2S can make handling difficult, potentially 
leading to inconsistencies between individual investigators. Indeed, within several 
minutes of solubilising NaHS, the concentration of H2S released from NaHS would have 
been dissipated into the atmosphere leaving much less H2S present in solution (see 
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results later). Moreover, the instantaneous release of H2S from NaHS does not mimic 
the release of endogenous H2S. 
A novel organic slow releasing H2S donor GYY4137 has recently been 
characterised (Li, et al. 2008b). GYY4137 releases H2S at a rate of 4 nmol/25 min H2S at 
37oC pH 7.4 (Li, et al. 2008b). In addition, GYY4137 (100 µM) did not significantly affect 
rat vascular smooth muscle cell viability in culture (Li, et al. 2008b). Furthermore, 
treating spontaneously hypertensive rats with a daily dose of GYY4137 (133 µmol/kg, 
i.p.) over 14 days did not obviously induce abnormal behavioural changes (Li, et al. 
2008b). The slower progressive release of H2S from GYY4137 may provide further 
insight into the role of H2S in inflammation. Indeed, in a later study, GYY4137 was 
shown to have an anti-inflammatory effect in an in vivo model of endotoxin shock in 
the rat (Li, et al. 2009b). The current study will examine the effects of GYY4137 on in 
vitro and in vivo models of inflammation.  
 
Hypothesis: GYY4137 will exert anti-inflammatory effects in both in vitro and in vivo 
models of inflammation. Aim: 
1. Determine the effects of GYY4137 and NaHS on adhesion molecule expression 
from HUVEC and further characterise the mechanisms behind the actions of 
GYY4137 
2. Explore the effects of GYY4137 in the carrageenan hindpaw model of 
inflammation in the mouse, specifically: oedema, mechanical hyperalgesia and 








GYY4137 (morpholin-4-ium-4-methoxyphenyl(morpholino) phosphinodithioate was 
synthesised by Dr. Choon-Hong Tan (National University of Singapore, Singapore) on 
the basis of the structure of Lawesson’s compound as described by Li, et al. 2008b 
(Figure 5.1.1). GYY4137 was first used as an accelerant for the vulcanisation of rubber 
(Li, et al. 2008b). GYY4137 was identified from a screen of compounds in 2008, as a 
water soluble slow releasing H2S donor (Li, et al. 2008b).  Until 2008, GYY4137 had not 










Female CD1 mice (Charles river, 25g) were housed in King’s College London Biological 
Services Unit (Waterloo) and kept in a climatically controlled environment (45% 
humidity, 20oC, 12 h light cycle). Food and water was provided ad libitum. Aged 
matched female mice were used for all studies. All experiments were carried out 




5.1.3. Carrageenan hindpaw model  
 
The effects of GYY4137 were assessed using the mouse model of carrageenan induced 
paw inflammation (Campo, et al. 2009). Following induction of anaesthesia (isoflurane 
4% v/v), the hindpaw of mice were injected with 50 μl carrageenan (1% w/v in saline, 
29 G needle) and the contra-lateral paw with 50 μl saline control (0.9% w/v sodium 
chloride) (Dufton, et al. 2010). Mice were left undisturbed and allowed to recover for 1 
h. GYY4137 (50 mg/kg, 10 ml/kg, i.p.) (Li, et al. 2008b) was administered into conscious 
animal’s 1 h post- intraplantar (i.pl.) injection. All i.p. and i.pl injections were blinded 
and randomised.  
The extent of inflammation was quantified using Calipers (Mitutoyo, Japan) and 
paw and ankle thickness were determined at 0.5, 1.5, 3.5 and 5.5 h after carrageenan 
injection. To examine whether GYY4137 had an effect on mechanical hyperalgesia, in 
the same animals, a Von Frey-type filament was used to measure mechanical 
hyperalgesia at 1, 2, 4 and 6 h after saline or carrageenan i.pl injection (see Method 
5.1.4 for further detail). Mice were subsequently killed by cervical dislocation under 
anaesthesia (isoflurane 4% v/v). Paws were subsequently cut at the ankles, weighed, 
snap frozen in liquid nitrogen and stored at -80oC for biochemical analysis (Methods 
5.1.5 and 5.1.7). 
 
5.1.4. Mechanical hyperalgesia 
 
Conscious mice were allowed to acclimate for 30 min in individual chambers (L x W x 
H, 10 x 9 x 16 cm) containing metal mesh flooring. A dynamic plantar aesthesiometer 
(Ugo Basile, Milan, Italy) was used to determine the nociceptive threshold to a 
mechanical stimulus via a Von Frey-type filament (0.5 mm diameter) attached to an 
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actuator. The Von Frey-type filament was applied at the plantar surface until the 
mouse removed its hindpaw and the force at which the hindpaw was withdrawn (g) 
was subsequently recorded. An average of 4 withdrawal readings per hindlimb was 
recorded as the response to a mechanical stimulus. The device was calibrated to apply 
an increasing rate of 5 g/sec and a maximum force 50 g (cut off pressure to avoid 
tissue damage). 
 
5.1.5. MPO assay in mouse hindpaws  
 
Myeloperoxidase (MPO) was used as an indicator of leukocyte accumulation in the 
mouse hindpaw. 3,3’,5,5’-tetramethylbenzidine (TMB) is a substrate used to determine 
peroxidase activity (Andrews and Krinsky 1982). The activity of MPO was assayed using 
the H2O2-oxidation of TMB. In the presence of MPO, H2O2 is hydrolysed to form oxygen 
radicals that directly oxidises TMB. When TMB is oxidised it emits a blue colour which 
is most stable ≤ pH 6.2 (Andrews and Krinsky 1982).  
Hindpaws of the mice were homogenised (200 mg/ml) in a homogenising 
buffer (NaCl 600 mM, KH2PO4 600 mM, Na2HPO4 66 mM, hexadecyltrimethyl-
ammonium bromide (HTAB) 0.5% v/v) using a polytron homogeniser (Brinkman). The 
samples were then centrifuged at 13,000 g for 10 min at 4oC and the supernatant was 
diluted 1:50 in saline. Diluted supernatant or purified MPO standard (25 µl) was 
incubated with MPO buffer (25 μl, Na2HPO4 6.6 mM, KH2PO4 60.1 mM, HTAB 0.5% v/v, 
pH 6) and TMB/H2O2 100 μl in a 96-well plate. The plate was incubated at room 
temperature for 30 min and the absorbance was determined at 652 nm. Values were 
standardised to protein using the BCA protein assay (Method 2.6) to determine units 
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MPO/mg protein. A standard curve for MPO was constructed from purified MPO 
derived from human leukocytes (0.1 – 1 units MPO/ml, Sigma M6908). 
 
5.1.6. In vitro assay to determine the effects of GYY4137 on purified MPO activity 
 
Purified human MPO (0.75 units MPO/ml in KHPO4 100 mM, pH 7.4) was incubated 
with GYY4137 (5 – 500 µM) for 1 h at 37oC. 50 µl of MPO/GYY4137 was incubated with 
TMB/H2O2 substrate for 30 min. Absorbance was read at 652 nm using a 
spectrophotometer (Tecan).  
 
5.1.7. H2S synthesising enzyme activity in carrageenan hindpaws 
 
Mouse hindpaws were homogenised in cold potassium phosphate buffer (10% w/v, 
KHPO4 100 mM, pH 7.4) and the H2S synthesising assay was carried out as in the 
standard protocol (Method 2.11). A Bradford protein assay (Method 2.5) was carried 
out to determine the H2S synthesised nmol/mg protein. 
 
5.1.8. Soluble adhesion molecule expression 
 
HUVEC were seeded on gelatine coated 6-well plates (4 x 104 cells per well). When 
confluent, the cells were pre-treated with GYY4137 (31.125 – 500 µM) or NaHS (62.5 – 
500 µM) in M199-1% (1 ml) for 1 h prior to IL-1β (10 ng/ml) or LPS (Escherichia coli, 
serotype O127:B8, 100 ng/ml) stimulation for 24 h. The cell culture medium was 
subsequently stored and frozen at -80oC. Quantikine ELISA kit (R&D systems) were 
used to measure human soluble VCAM-1 (DVC00), ICAM-1 (DCD540) and E-selectin 
(DSLE00). The cell culture medium was assayed without dilution for soluble VCAM-1, 




5.1.9. Surface adhesion molecule expression on HUVEC 
 
HUVEC were seeded in gelatin coated 96-well plates (1 x 104 cells/well). Edge wells 
were not used. When confluent (2-3 days), HUVEC were pre-treated with GYY4137 
(31.25 – 5000 µM) or NaHS (62.5 – 5000 µM) for 1 h in M199-1% prior to stimulation 
with IL-1β (10 ng/ml) for 24 h. The cells were rinsed with PBS once and fixed in 2% v/v 
formalin (PBS, 100 µl/well) for 20 min at room temperature. The fixed cells were 
subsequently blocked with 5% w/v albumin (in PBST, PBS with 1% v/v Tween-20) for 1 
h. The cells were subsequently incubated with primary antibodies against VCAM-1 
(1:500, 5% w/v albumin PBST) or ICAM-1 (1:500, 5% w/v albumin PBST) for 1 h at room 
temperature. The antibody was aspirated and the plates washed with PBST (1x 1 min, 
2x 5 min, 1x 10 min) and 5% w/v albumin (1x 20 min). The wells were subsequently 
incubated with secondary-HRP linked anti-goat antibody (1:5000, 5% w/v albumin 
PBST) for 1 h at room temperature. The plate was then washed in PBST (1x 1 min, 2x 5 
min, 1x 10 min, 1x 20 min). Equal volumes of TMB (3,3′,5,5′-tetramethylbenzidine) and 
H2O2 were mixed (Thermo Scientific). 200 µl of TMB/H2O2 substrate was added to each 
well. At 30 min, the oxidation of TMB by peroxidase was subsequently quantitated 
spectrophotometrically at 652 nm as an indicator of surface adhesion molecule 
expression. The TMB was subsequently aspirated and the plate rinsed with water. On 
the same plate, the crystal violet viability assay was carried out to determine cell 
density (Method 5.1.11). Graphs of adhesion molecule expression were subsequently 






5.1.10. Crystal violet viability assay 
 
Crystal violet staining is used as an indicator of cell number. HUVEC (1 x 104 cells/well) 
were fixed in formalin (2% v/v in PBS, 100 µl/well) for 20 min and subsequently stained 
with 100 µl crystal violet (0.2% w/v crystal violet in 2% v/v aqueous ethanol) for 10 min 
at room temperature. The crystal violet solution was aspirated and the plate was 
rinsed in water to remove excess stain. Subsequently, 200 µl of 0.5% w/v SDS in 50% 
v/v ethanol was added to each well and incubated at 37oC for 1 h to dissolve the 
crystal violet stained cell membranes. The absorbance was quantified using a 
spectrophotometer at 610 nm.  
 
5.1.11. ATP viability assay 
  
To ensure HUVEC were still metabolically active in the presence of H2S donors, ATP 
production was used as an endpoint marker for cell viability. HUVEC were seeded in 
opaque-walled, clear bottom 96-well plates (1 x 104 cells/well). When confluent, the 
cells were treated with GYY4137 or NaHS (Method 5.1.8). The CellTiter-Glo 
Luminescent Cell Viability assay (Promega) was used to determine ATP production in 
cells. Lyophilized CellTiter-Glo Substrate, containing recombinant luciferase and 
luciferin substrate, was reconstituted in CellTiter-Glo buffer to form the working 
reagent. In the presence of ATP, luciferase catalyses the conversion of: 
 
Luciferin + ATP + O2  Oxyluciferin + AMP + PPi + CO2 + light 
 
The luminescent signal is then subsequently quantitated by a luminometer. The 
protocol was carried out according to manufacturer’s instructions. In brief, the plate 
containing treated HUVEC was left to equilibrate at room temperature for 30 min. 100 
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µl of working reagent (reconstituted luciferase/luciferin) was added directly to 100 µl 
of cell culture medium, and left on the shaker for 10 min before relative light 
units/second was measured using a microplate luminometer (Hidex).  
 
5.1.12. IKB-α degradation in HUVEC  
 
HUVEC were pre-treated with GYY4137 (125 or 500 µM) or vehicle (M199-1%) 1 h prior 
to stimulation with IL-1β (10 ng/ml) for 15, 30, 60 or 120 min. Cells were subsequently 
rinsed twice with PBS and lysed in lysis buffer. Western blots for IKB-α (43 kDa) were 
carried out. 
 
5.1.13. COX-2 expression in HUVEC 
 
HUVEC were pre-treated with GYY4137 (125 – 500 µM) or vehicle (M199-1%) 1 h prior 
to stimulation with IL-1β (10 ng/ml) for 24 h. Cells were rinsed twice with PBS and 
lysed in lysis buffer. Western blots for COX-2 protein expression (72 kDa) were 
subsequently carried out. 
 
5.1.14.  Griess assay for nitrate/nitrite from RAW264.7 cells 
 
RAW264.7 cells were plated on 6-well plates and treated with 1 µg/ml LPS (Escherichia 
coli 055:B5) in SF-DMEM respectively for 24 h (Whiteman, et al. 2010c). Cell culture 
medium was assessed for nitrite/nitrate. Cell culture medium 100 µl, was incubated 
with Griess reagent 100 µl (1:1 ratio of 2% w/v sulfanilamide in 5%v/v H3PO4: 0.2% w/v 
naphthylethylenediamine dihydrochloride in 5%v/v H3PO4) in a 96-well plate in the 
dark at room temperature for 15 min. A standard curve for nitrite was constructed 
using sodium nitrite (4 – 500 µM). Absorbance was quantified using a 
spectrophotometer at 540 nm. 
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5.2.  Results 
 
 
5.2.1. Comparing H2S release from GYY4137 and NaHS 
 
The rate of H2S release of from GYY4137 and NaHS was first compared. GYY4137 
(31.25 – 5000 µM) and NaHS (500 µM) were dissolved in cell culture medium (M199-
1%) and incubated at 37oC. The release of H2S from GYY4137 and NaHS was 
subsequently determined by the methylene blue assay. On exposing NaHS to solution, 
the concentration of H2S measured followed an exponential decay. Within 10 min 
approximately 50% of the H2S released from NaHS remained in solution (198.10 ± 5.89 
µM H2S, n = 3) and after 1 h the H2S was undetectable (Figure 5.2.1 b). In contrast to 
NaHS, H2S released from GYY4137 was sustained for 24 h (Figure 5.2.1 a).  
 
5.2.2. Effect of H2S on E-selectin, VCAM-1 and ICAM-1 
 
To determine the effects of H2S donors on adhesion molecule expression, HUVEC were 
pre-treated with GYY4137 or NaHS for 1 h prior to stimulation with IL-1β (10 ng/ml) for 
24 h. ELISAs for E-selectin, VCAM-1 and ICAM-1 were subsequently carried out. Soluble 
adhesion molecules were measured in the cell culture medium, whereas surface 
adhesion molecules were measured from the cell surface of HUVEC.  
 
a)  H2S donors on E-selectin expression 
 
IL-1β caused a significant (P<0.05) rise in soluble E-selectin (0.00 c.f. 2.49 ± 0.53 ng/ml, 
n = 4, Figure 5.2.2). Pre-treating HUVEC with GYY4137 or NaHS (up to 500 µM) did not 
significantly alter soluble E-selectin accumulation compared to control (Figure 5.2.2). 






Figure 5.2.1. GYY4137 and NaHS were dissolved in cell culture medium (M199-1%) and 
incubated at 37oC. The methylene blue assay was used to detect H2S at various time 
points a) H2S released from GYY4137 (31.25 – 5000 µM) is detectable after 24 h b) H2S 
released from NaHS (500 µM)  is no longer present after 60 min. Values show mean ± 
















Figure 5.2.2. HUVEC were pre-treated with GYY4137 (31.25 – 500 µM) or NaHS (31.25 
– 500 µM) for 1 h prior to stimulation with IL-1β (10 ng/ml) for 24 h. Cell culture 
medium was assayed for soluble E-Selectin using a commercial ELISA. Results show 















b) H2S donors on ICAM-1 expression 
 
IL-1β caused a significant (P<0.05) rise in soluble ICAM-1 (1.30 ± 0.50 c.f. 4.43 ± 0.86 
ng/ml, n = 4, Figure 5.2.3) compared to control. However, neither GYY4137 nor NaHS 
(32.25 – 500 µM) pre-treatment significantly reduced IL-1β induced soluble ICAM-1 
expression (Figure 5.2.3).  
GYY4137 appeared to trend towards a reduction in soluble ICAM-1 expression. 
Therefore further work was undertaken to characterise the effects of H2S donors on IL-
1β induced surface ICAM-1 expression on HUVEC. Surface ICAM-1 was maximally 
expressed at 24 h (Figure 5.2.5), as shown by a 1.15 ± 0.03 fold increase compared to 
control cells. Although GYY4137 and NaHS (500 µM) did not statistically inhibit soluble 
ICAM-1 expression (Figure 5.2.3), GYY4137 (5000 µM % inhibition 98.91 ± 20.88, 
P<0.05, n = 8, Figure 5.2.6 c) and NaHS (2000 µM, % inhibition 72.85 ± 14.32, P<0.05,  n 
= 8, Figure 5.2.6 d) significantly inhibited surface ICAM-1 expression.  
c) H2S donors on VCAM-1 expression 
 
IL-1β caused a significant rise in soluble VCAM-1 expression (14.79 ± 1.34 c.f. 34.69 ± 
5.69 ng/ml, P<0.05, n = 4, Figure 5.2.4). This rise in soluble VCAM-1 expression induced 
by IL-1β was significantly inhibited by GYY4137 pre-treatment (62.5 µM, % inhibition 
70.37 ± 13.22, P<0.05, n = 4, Figure 5.2.4 a). In contrast to GYY4137, NaHS (500 μM) 
did not significantly reduce soluble VCAM-1 (Figure 5.2.4 b). 
To determine whether GYY4137 or NaHS (32.25 – 500 µM) effects LPS induced 
soluble VCAM-1 expression, HUVEC were pre-treated with GYY4137 or NaHS (32.5 – 
500 µM) and stimulated with LPS (100 ng/ml) for 24 h. LPS significantly increased 
soluble VCAM-1 expression (10.25 ± 0.74 c.f. 16.61 ± 1.59 ng/ml, P<0.05, n = 4, Figure 
5.2.4 c). Pre-treatment with GYY4137 significantly reduced soluble VCAM-1 induced by 
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LPS in HUVEC (125 µM, % inhibition 101.75 ± 19.27, P<0.05, n = 4, Figure 5.2.4 c). In 
contrast, NaHS did not significantly reduce LPS-induced soluble VCAM-1 expression 
(Figure 5.2.4 d). 
Further work was undertaken to characterise the effects of H2S donors on 
surface VCAM-1 expression on HUVEC. Surface VCAM-1 was maximally expressed at 24 
h (Figure 5.2.5), as shown by a 1.22 ± 0.07 fold increase compared to unstimulated 
cells. Similar to the soluble VCAM-1 data, GYY4137 significantly reduced surface 
VCAM-1 expression (500 µM, % inhibition 52.05 ± 6.59, P<0.05, n = 8, Figure 5.2.6 a). 
Interestingly, higher concentrations of GYY4137 were necessary to significantly reduce 
surface VCAM-1 expression (500 µM, Figure 5.2.6 a) compared to soluble VCAM-1 
(62.5 µM, Figure 5.2.4 a). 
Although NaHS (500 µM) did not significantly affect soluble VCAM-1 expression 
(Figure 5.2.4 b), NaHS significantly inhibited surface VCAM-1 expression (1000 µM, % 
inhibition 42.95 ± 5.43, n = 8, Figure 5.2.6 b). Interestingly, NaHS had a bi-phasic effect 
on surface VCAM-1 expression, where low concentrations also inhibited surface 
VCAM-1 expression (62.5 µM, % inhibition 54.00 ± 4.97, P<0.05) and middle 
concentrations 125 – 500 µM had no effect (Figure 5.2.6 b).  
To ensure the adhesion molecule effects of GYY4137 or NaHS were due to the 
release of H2S. These H2S donors were solubilised in culture medium and utilised when 
H2S was no longer detected (typically > 4 weeks for GYY4137 5 mM). Preliminary 
experiments (n = 2) indicate that time-expired GYY4137 and NaHS did not have an 
effect on surface VCAM-1 expression (Figure 5.2.7), indicating the effects of adhesion 






Figure 5.2.3. HUVEC were pre-treated with GYY4137 (31.25 – 500 µM) or NaHS (31.25 
– 500 µM) for 1 h prior to stimulation with IL-1β (10 ng/ml) for 24 h. Cell culture 
medium was assayed for soluble ICAM-1 using a commercial ELISA. Results show 










Figure 5.2.4. HUVEC were pre-treated with GYY4137 (31.25 – 500 µM) or NaHS (31.25 
– 500 µM) 1 h prior to stimulation with IL-1β (10 ng/ml) or LPS (100 ng/ml). At 24 h cell 
culture medium was frozen and later used to measure soluble VCAM-1 using a 
commercial ELISA. GYY4137 pre-treatment significantly reduces soluble VCAM-1 
expression induced by a) IL-1β or c) LPS. NaHS does not significantly reduce soluble 
VCAM-1 expression induced by b) IL-1β or d) LPS. Results show soluble VCAM-1 ng/ml 






Figure 5.2.5. HUVEC were stimulated with IL-1β (10 ng/ml) for 4 h and 24 h. HUVEC 
were fixed and incubated with primary antibody against VCAM-1 or ICAM-1 and a 
secondary HRP-linked antibody. Surface adhesion molecule expression was 
quantitated through the HRP induced oxidation of TMB/H2O2 (OD 652 nm) and these 
values standardised to cell count (crystal violet assay, OD 610 nm). Data show fold 
change of control without IL-1β stimulation a) VCAM-1  b) ICAM-1. Results are 






Figure 5.2.6. HUVEC were pre-treated with GYY4137 (31.25 – 5000 µM) or NaHS (62.5 
– 5000 µM) 1 h prior to IL-1β (10 ng/ml) stimulation for 24 h. Cells were fixed and 
incubated with antibodies against VCAM-1 and ICAM-1, and a secondary HRP-linked 
antibody. Surface adhesion molecule expression was quantitated through the HRP 
induced oxidation of TMB/H2O2. Values were subsequently standardised to cell count, 
determined by the crystal violet assay.  Surface VCAM-1 a) GYY4137 b) NaHS and 
surface ICAM-1 c) GYY4137 b) NaHS. Results show absorbance 652nm/610nm as mean 






Figure 5.2.7. GYY4137 (500 – 5000 µM) and NaHS (500 – 5000 µM) were left to 
decompose and expire of H2S by incubation at 37
oC > 4 weeks. HUVEC were pre-
treated with time expired GYY4137 or NaHS for 1 h prior to stimulation with IL-1β (10 
ng/ml) for 24 h. Cells were fixed and incubated with primary antibody against VCAM-1 
and secondary HRP-linked antibody. VCAM-1 expression was quantitated through the 
HRP induced oxidation of TMB/H2O2. Values were subsequently standardised to cell 
count (crystal violet assay). Values show absorbance measured at 652nm/610nm mean 
± SEM, n = 2 independent experiments (each in triplicate) *P<0.05 c.f. control + IL-1β, 











5.2.3. Effect of H2S donors on HUVEC cell viability 
 
To ensure the effects of H2S on surface VCAM-1 was not due to cell death, two cell 
viability assays were performed. The crystal violet viability assay was carried out as an 
indicator of cell density and the ATP viability assay was undertaken to ensure the cells 
were still metabolically active.  
Apoptosis is induced on serum starving HUVEC (Karsan, et al. 1997). As a 
positive control for the cell viability assays, HUVEC were treated in low (1% v/v) or 
normal (20% v/v) serum medium for 24 h. Cells grown in 20% v/v serum had a greater 
cell density (1.35 ± 0.02 fold increase, n = 4, P<0.05) compared to those grown in 1% 
v/v serum (Figure 5.2.8 b). Moreover, HUVEC grown in 20% v/v serum exhibited 
greater ATP production than those grown in 1% v/v serum (1.79 ± 0.16 fold increase, 
P<0.05, n = 4, Figure 5.2.8 a).  
 Cell viability assays were performed using the same protocol for measuring 
adhesion molecule expression in HUVEC. Consequently, HUVEC were pre-treated with 
GYY4137 (32.25 – 5000 µM) or NaHS (62.5 – 5000 µM) prior to stimulation for with IL-
1β (10 ng/ml) for 24 h. GYY4137 did not significantly reduce cell metabolic activity 
(Figure 5.2.9 a) or cell density (Figure 5.2.10 a), suggesting the effects of GYY4137 on 
surface adhesion molecule expression was not as a result of cell death. Similarly, NaHS 
did not significantly reduce metabolic activity of HUVEC (Figure 5.2.9 b). However, 







Figure 5.2.8. HUVEC were incubated in M199 containing 1% v/v (M199-1%) or 20% v/v 
(M199-20%) serum for 24 h. Incubating HUVEC in M199-1% significantly reduces cell 
viability compared to incubation in M199-20% determined by a) ATP metabolic 
viability assay, measured as relative luminescence units/second expressed as mean ± 
SEM, n = 4, *P<0.05 c.f. M199-20% b) crystal violet cell count assay, measured by 












Figure 5.2.9. HUVEC were pre-treated with a) GYY4137 (31.25 – 5000 µM) or b) NaHS 
(62.5 – 5000 µM) for 1 h, prior to IL-1β (10 ng/ml) stimulation. At 24 h ATP was 
measured as an endpoint for cell viability using a commercially available kit. Results 














Figure 5.2.10. HUVEC were pre-treated with a) GYY4137 (31.25 – 5000 µM) or b) NaHS 
(62.5 – 5000 µM) for 1 h, prior to IL-1β (10 ng/ml) stimulation for 24 h. Cells were fixed 
and stained with crystal violet as an indicator of cell density. Results show absorbance 















5.2.4. Mechanism underlying the adhesion molecule effects of GYY4137 
 
It has previously been reported that H2S may be involved in regulating the NF-κB 
translocation pathway. To explore the mechanism behind the effect of GYY4137 on 
adhesion molecule expression, HUVEC were pre-treated with GYY4137 and stimulated 
with IL-1β. Subsequently, the cells were lysed and blotted for inhibitor of κB (IκB-α) 
and cyclooxygenase-2 (COX-2), two proteins up- and down-stream NF-κB respectively.  
Western blots for IκB-α protein expression were carried out in HUVEC pre-
treated with GYY4137 (125 µM) for 1 h prior to stimulation with IL-1β (10 ng/ml) for 
15, 30, 60 and 120 min. GYY4137 (125 µM) reduced soluble VCAM-1 induced by both 
IL-1β and LPS (Figure 5.2.4) and was therefore the concentration used in this 
experiment.   
Under normal conditions, IκB-α is found in the cytoplasm bound to NF-κB. 
Following a pro-inflammatory stimulus such as IL-1β stimulation, IκB-α is thought to be 
immediately ubiquitinated and degraded, therefore allowing NF-κB translocation to 
the nucleus (Karin 1999). In the absence of IL-1β stimulation (control cells), IκB-α 
protein was present in HUVEC (Figure 5.2.11 and 5.2.12). IL-1β treatment for 15 and 30 
min did not lead to detectable amounts of IκB-α protein (Figure 5.2.11), suggesting IκB-
α protein had been degraded following IL-1β stimulation. IκB-α was shown to be fully 
recovered by 120 min of IL-1β treatment (Figure 5.2.11). Preliminary studies suggested 
that pre-treating HUVEC with GYY4137 (125 µM) increased the rate of IκB-α recovery 
at 60 min (Figure 5.2.11, blot 2), suggesting that GYY4137 inhibited NF-κB translocation 
to the nucleus. However, on further work a lot of variation was noted in the recovery 
of IκB-α between HUVEC derived from different mothers (Figure 5.2.11). Blots 2 – 5 
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(Figure 5.2.11) suggest that GYY4137 (125 µM) increases the rate of recovery of IκB-α 
at 60 min compared to IL-1β alone without GYY4137 pre-treatment. However, blots 6 
and 7 (Figure 5.2.11) showed that IκB-α did not recover at 60 min on GYY4137 pre-
treatment, suggesting a later time point is necessary to determine whether GYY4137 
induces a faster rate of IκB-α recovery, in these particular cells. In contrast, blots 8 – 10 
(Figure 5.2.11) showed recovery of IκB-α by 60 min in both IL-1β control and GYY4137 
pre-treated HUVEC potentially suggesting an earlier time point between 30 and 60 min 
would be necessary to determine if IκB-α in GYY4137 treated HUVEC was faster 
recovering. Pooling the data together suggested that GYY4137 (125 µM) pre-treatment 
did not increase the recovery rate of IκB-α protein (Figure 5.2.12 a) necessary to inhibit 
NF-κB translocation to the nucleus. Furthermore, increasing the concentration of 
GYY4137 (500 µM) did not improve the variation between HUVEC and the rate of IκB-α 
recovery was not significantly greater in the GYY4137 pre-treated HUVEC compared to 
the IL-1β control (Figure 5.2.12 b). Overall, this data suggest that, statistically, GYY4137 
does not inhibit NF-κB translocation to the nucleus. 
COX-2 expression, a protein downstream of NF-κB, was also used to determine 
whether GYY4137 inhibited NF-κB translocation to the nucleus. HUVEC were pre-
treated with GYY4137 (125 – 500 µM) for 1 h prior to stimulation with IL-1β (10 ng/ml) 
for 24 h and western blots for COX-2 protein were carried out. IL-1β significantly 
enhanced the expression of COX-2 protein compared to control unstimulated HUVEC 
(Figure 5.2.13). Interestingly, GYY4137 (500 µM) pre-treatment significantly inhibited 
COX-2 expression in HUVEC (Figure 5.2.13). In contrast to the IκB-α data, this data 




iNOS is another protein downstream of NF-κB. Nitrate/nitrite production from 
LPS stimulated RAW264.7 cells is a robust technique utilised as an indicator of iNOS 
expression. As a result the therapeutic potential of both H2S donors were further 
characterised using this technique. RAW264.7 cells were pre-treated with NaHS, 
GYY4137 and subsequently stimulated with LPS for 24 h and nitrite/nitrate was 
subsequently quantified. All compounds reduced nitrate/nitrite production from 












Figure 5.2.11. Western blots of IκB-α protein, n = 4-9, (blots 2 – 9, 43 kDa band found 
between molecular weight marker 35 – 50 kDa) from HUVEC pre-treated with GYY4137 
(125 µM, denoted as 125 Y) and stimulated with IL-1β (10 ng/ml) for 15, 30, 60 or 120 
min. Blot 1 is the loading control for blot 2 and represents a typical western blot for α-







Figure 5.2.12. Column graphs showing IκB-α densitometry values standardised to α-
tubulin loading control. HUVEC were pre-treated with a) GYY4137 125 µM where n = 4 
– 9 (from blots 1 – 9 in Figure 5.2.11) or b) GYY4137 500 µM n = 4, prior to stimulation 










Figure 5.2.13. HUVEC were pre-treated with GYY4137 (125 – 500 µM) 1 h prior to 
stimulation with IL-1β (10 ng/ml) for 24 h.  Western blots for COX-2 and β-actin 
(loading control) were made, and analysed by densitometry.  Results show 
representative western blot and densitometry values of COX-2/β-actin shown as mean 












Figure 5.2.14. RAW 264.7 cells were pre-treated with NaHS (white bars) or GYY4137 
(black bars), 125 – 1000 µM, for 1 h prior to stimulation with LPS (1 µg/ml) for 24 h. 
Culture medium was assayed for nitrite/nitrate using the Griess assay.  Data show 











5.2.5. Carrageenan oedema hindpaw model characterisation 
 
Carrageenan is a seaweed derivative and can induce local inflammation on 
subcutaneous injection (Campo, et al. 2009). The carrageenan hindpaw model was 
utilsed to characterise the effects of GYY4137 in this model of inflammation. It was 
first necessary to characterise endpoint markers in this model to assess appropriate 
time points to measure oedema, mechanical hyperalgesia and myeloperoxidase 
(MPO), prior to examining the effects of GYY4137 in this model. Carrageenan was 
injected into one hindpaw of anaesthetised mice and saline was injected into the 
contralateral paw.  
At 0.5, 1.5, 3.5 and 5.5 h after carrageenan injection, hindpaw oedema was 
measured using a caliper. Carrageenan induced a significant increase in paw thickness 
at all time points (0.5 – 5.5 h) compared to saline control and this effect was greatest 
at 5.5 h (Figure 5.2.15). It should be noted that the small increase in paw thickness 
noted at 0.5 hs post-saline i.pl (and probably post-carrageenan) (Figure 5.2.15), is likely 
to result from an injection of a relatively large volume of fluid and is probably not 
indicative of a true inflammatory effect.  
Mechanical hyperalgesia was carried out 30 min after measuring paw thickness 
(1, 2, 4 and 6 h post i.pl.). A Von Frey-type filament was used to measure mechanical 
hyperalgesia induced by carrageenan. The mechanical threshold effect of saline paws 
was significantly (P<0.05) lower than baseline at 1 h but recovered after 6 h (Figure 
5.2.16 a). In contrast, the mechanical pain threshold in the carrageenan paws did not 
recover by 6 h (Figure 5.2.16 b). 
On terminating the experiment, the hindpaws were cut and assayed for 
myeloperoxidase (MPO) activity (an indicator of leukocyte infiltration) or H2S 
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synthesising enzyme activity.  Saline i.pl injection did not induce a significant increase 
in MPO activity compared to naïve uninjected paws (Figure 5.2.17). In contrast, there 
was a significant increase in myeloperoxidase (MPO) activity in carrageenan paws 
compared to saline (Figure 5.2.16). No significant difference in MPO activity between 
carrageenan paws was noted at 4 and 6 h (Figure 5.2.16).  
The injection of carrageenan into mouse hindpaws significantly (P<0.05) 
increased the endogenous H2S synthesising activity compared to saline control at 6 h 
post- i.pl (Figure 5.2.18).  
  
5.2.6. Effect of GYY4137 on pain and inflammation in the mouse hindpaw 
 
To examine whether GYY4137 had an effect on paw oedema, mechanical hyperalgesia 
or MPO in carrageenan hindpaws GYY4137 (50 mg/kg i.p.) was injected 1 h post- i.pl. 
injection.  
GYY4137 had no effect on paw oedema as determined by paw weight and paw 
thickness at 6 h (Figure 5.2.19). Moreover, GYY4137 did not significantly increase the 
pain threshold in the carrageenan paws at both 4 and 6 h after i.pl (Figure 5.2.20). 
 Carrageenan i.pl significantly (P<0.05) increased MPO activity compared to the 
saline i.pl injected contralateral paw, in both control and GYY4137 treated groups 
(Figure 5.2.21). However, comparing MPO activity between carrageenan injected paws 
of the two groups, the GYY4137 treated mice had significantly less MPO activity 
compared to control (% inhibition 55.46 ± 3.89, P<0.05, Figure 5.2.21).   
Interestingly, incubating purified MPO with GYY4137 (5 µM) in vitro 
significantly reduced MPO enzyme activity (Figure 5.2.22) suggesting a direct 







Figure 5.2.15. Mice were anaesthetised (isofluorane) and each hindpaw was injected 
intraplanter (i.pl) with either saline (50 µl) in one paw or carrageenan (50 µl, 1% w/v) 
in the contralateral paw. Paw thickness was measured using a calliper at 0.5 h, 1.5 h, 
3.5 h and 5.5 h. Results show paw thickness (mm) shown as mean ± SEM over time, n = 










Figure 5.2.16. Mice were anaesthetised (isoflurane) and each hindpaw was injected 
intraplanter (i.pl) with either a) saline (50 µl) in one paw or b) carrageenan (50 µl, 1% 
w/v) in the contralateral paw. A plantar aesthesiometer attached to a Von Frey-type 
filament was used to measure paw withdrawal reflex at 0 h, 1 h, 2 h, 4 h and 6 h post 
i.pl. Data show force (g) at which paw was withdrawn, shown as mean ± SEM, n = 6, 









Figure 5.2.17. The hindpaws of mice was injected intraplanter (i.pl) with either saline 
(50 µl) in one paw or carrageenan (50 µl, 1% w/v) in the contralateral paw. Mice were 
culled at 4 h or 6 h after i.pl and hindpaws frozen. Myeloperoxidase (MPO) activity was 
assayed in mouse hindpaws with no injection (naïve), saline or carrageenan injection. 








Figure 5.2.18. The hindpaws of mice was injected intraplanter (i.pl) with either saline 
(50 µl) in one paw or carrageenan (50 µl, 1% w/v) in the contralateral paw. Mice were 
culled at 4 h or 6 h after i.pl and hindpaws frozen. H2S synthesising enzyme activity 
assay was carried out in the hindpaw homogenates. H2S (µM) produced was measured 
using the methylene blue assay and standardised to protein, as an indicator of H2S 
synthesising enzyme activity. Results show H2S nmol/mg protein shown as mean ± 







Figure 5.2.19. The hindpaws of mice was injected intraplanter (i.pl) with either saline 
(50 µl) in one paw or carrageenan (50 µl, 1% w/v) in the contralateral paw. An 
intraperitoneal (i.p.) injection of GYY4137 (50 mg/kg) or saline (10 ml/kg) was given 1 h 
post i.pl injection. Paramaters for oedema formation was measured a) paw weight at 6 
h b) paw thickness at 5.5 h. Results show paw weight (mg) or paw thickness (mm) 























Figure 5.2.20. The hindpaws of mice was injected intraplanter (i.pl) with either saline 
(50 µl) in one paw or carrageenan (50 µl, 1% w/v) in the contralateral paw. An 
intraperitoneal (i.p.) injection of a) and c) saline (10 ml/kg) or b) and d) GYY4137 (50 
mg/kg) was given 1 h post i.pl injection. A plantar aesthesiometer attached to a Von 
Frey-type filament was used to measure paw withdrawal reflex at 4 h and 6 h post i.pl. 
Data show filament pressure (g) at which paw was withdrawn, shown as mean ± SEM, 










Figure 5.2.21. The hindpaws of mice was injected intraplanter (i.pl) with either saline 
(50 µl) in one paw or carrageenan (50 µl, 1% w/v) in the contralateral paw. An 
intraperitoneal (i.p.) injection of GYY4137 (50 mg/kg) or saline (10 ml/kg) was given 1 h 
post i.pl injection and mice were culled at 6 h. Myeloperoxidase (MPO) activity was 
assayed in hindpaws. GYY4137 significantly reduced carrageenan induced MPO 




Figure 5.2.22. Purified human myeloperoxidase (MPO, 0.75 units/ml) was incubated 
with GYY4137 (5 – 500 µM) for 1 h at 37oC. MPO enzyme activity was measured 
through the oxidation of TMB. Results are units of MPO activity shown as mean ± SEM, 











5.3. Discussion  
 
 
The main findings from this chapter are: 
1. GYY4137 and NaHS are capable of reducing VCAM-1 and ICAM-1 expression in 
HUVEC 
2. Unlike NaHS, GYY4137 is unlikely to have cytotoxic effects at the 
concentrations utilised in HUVEC 
3. The adhesion molecule effects of GYY4137 is perhaps, through inhibiting NF-κB 
translocation to the nucleus 
4. GYY4137 appears to have anti-inflammatory effects in vivo, as demonstrated by 
a reduction in MPO activity in carrageenan hindpaws  
 
Overall, GYY4137 and NaHS are capable of reducing VCAM-1 and ICAM-1 expression 
from HUVEC but not E-selectin; in contrast to NaHS, the effects of GYY4137 on 
adhesion molecule expression are unlikely to result from cell death. In correlation with 
the adhesion molecule data, GYY4137 appears to reduce MPO activity in carrageenan 
hindpaws. However, GYY4137 does not have an effect on oedema or mechanical 
hyperalgesia.  
 
5.3.1. H2S and adhesion molecule expression 
 
To reach the site of inflammation, leukocytes must migrate from the blood into the 
tissues. To accomplish this, leukocytes need to attach and adhere to the endothelial 
lining along the vessel wall and subsequently migrate through this endothelial barrier 
and its underlying basement membrane to the affected tissues. The process of 
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leukocyte attachment and tethering/rolling along the endothelial layer is aided by 
selectins e.g. P-selectin or E-selectin, and the process of leukocyte arrest is assist by 
adhesion molecules such as ICAM-1/VCAM-1 (Ley, et al. 2007).  
This chapter demonstrates that both H2S donors, NaHS and GYY4137 are 
capable of reducing VCAM-1, ICAM-1 but not soluble E-selectin expression in IL-1β 
treated HUVEC suggesting H2S donors may be capable of inhibiting leukocyte firm 
adhesion but not rolling along the endothelium. The effects on adhesion molecule 
expression are likely to result from H2S released from GYY4137 or NaHS rather than 
the parent molecule itself as decomposed GYY4137 or NaHS had no effect on adhesion 
molecule expression (Figure 5.2.7). Moreover the effects of GYY4137 (32.5 – 5000 µM) 
on adhesion molecule expression were not as a consequence of a cell death, 
determined by cell density (crystal violet) and cell metabolism (ATP endpoint). In 
correlation with the current study, previous studies have also demonstrated that 
GYY4137 (100 µM) does not induce cell death in rat aortic vascular smooth muscle 
cells as measured by the trypan blue exclusion assay and p53 expression (Li, et al. 
2008b). However, NaHS (1 mM) in the current study significantly (P<0.05) reduced 
HUVEC cell density (Figure 5.2.10) and may be one reason why NaHS reduced surface 
VCAM-1 (1 mM, P<0.05) and ICAM-1 (2 mM, P<0.05) expression at this concentration 
(Figure 5.2.6). However, it should be noted that adhesion molecule expression in the 
current study has been standardised to cell density, which may suggest that 
irrespective of the cell density, NaHS is capable of reducing adhesion molecule 
expression on HUVEC. Interestingly, both H2S donors appeared to increase ATP 
production from HUVEC (Figure 5.2.9, not significant). H2S has been shown to inhibit 
cytochrome c oxidase activity in mitochondria in vitro (Beauchamp, et al. 1984) and 
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therefore a reduction in cell ATP generation may be expected. The increase in ATP 
production observed in this study may be due to: a compensatory increase in ATP 
production by glycolysis, as a result from the reduction of ATP by inhibition of the 
oxidative phosphorylation (Leschelle, et al. 2005); H2S has also been suggested to 
contribute to the donation of electrons to the electron transport chain and may be an 
alternative reason why an increase in ATP was noted (Goubern, et al. 2007). Whether 
the increase in ATP described in the current study is as a result of an increased activity 
by oxidative phosphorylation or gylcolysis requires further examination. 
Although the effects of NaHS on adhesion molecule expression may be due to 
cell death at higher millimolar concentrations, interestingly, NaHS had a biphasic effect 
on surface VCAM-1 expression. Relatively low concentrations of NaHS ~60 µM and 
high millimolar concentrations of NaHS (1 – 5 mM) significantly (P<0.05) reduced 
surface VCAM-1 expression. However concentrations between NaHS 100 – 1000 µM 
had no significant effect (Figure 5.2.6 b). Interestingly, another study using NaHS (50 – 
1000 µM) demonstrated a biphasic effect on PGE2 and nitrite production from LPS 
stimulated RAW 264.7 cells (Whiteman, et al. 2010c). In the latter study, NaHS (50 – 
100 µM) decreased PGE2 and nitrite production whilst NaHS (200- 1000 µM) increased 
the production of these inflammatory mediators (Whiteman, et al. 2010c). These 
biphasic effects on inflammatory mediators also occur with •NO donors. •NO donor 
DEA-NO (30 nM – 300 µM, 24 h) was previously demonstrated to induce a biphasic 
effect on iNOS and COX-2 protein expression (Connelly, et al. 2001). In the latter study 
DEA-NO (300 nM to 3 µM) significantly increased iNOS and COX-2 protein expression in 
LPS stimulated RAW 264.7 cells (Connelly, et al. 2001). However, DEA-NO (30 nM, 30 - 
300 µM) had no effect or significantly reduced iNOS and COX-2 expression (Connelly, 
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et al. 2001).  This effect of DEA-NO was suggested to be as a consequence of a biphasic 
regulation of NF-κB activity (Connelly, et al. 2001), and may also be a mechanism by 
which NaHS induces its effects. 
In correlation with the current study, another study demonstrated that pre-
treating HUVEC with NaHS (1 µM, 6 h) significantly inhibited ICAM-1 protein 
expression induced by TNF-α (10 ng/ml, 6 h) (Wang, et al. 2009b). More recently, NaHS 
(100 µM, 30 min pre-treatment, P<0.05) has been shown to significantly inhibit E-
selectin, P-selectin, VCAM-1 and ICAM-1 mRNA expression induced by TNF-α (10 
ng/ml, 6 h) (Pan, et al. 2011). However, in the current study neither NaHS nor GYY4137 
(31.25 – 500 µM) pre-treatment significantly reduced soluble E-selectin protein 
expression from HUVEC (Figure 5.2.2). The reason behind the difference in E-selectin 
expression in the current study and the latter study may be due to the difference in 
stimulating agent (IL-1β c.f. TNF-α), time course (24 h c.f. 6 h), the methods used to 
quantitate E-selectin expression (ELISA c.f. RT-PCR) or the type of E-selectin itself 
(soluble E-selectin c.f. E-selectin message). Although, E-selectin mRNA is an indicator of 
protein expression, message is not always translated to protein and the latter study 
did not directly examine E-selectin protein expression (Pan, et al. 2011).  
5.3.2. Mechanism behind the adhesion molecule effects of GYY4137 in vitro 
 
NF-κB is an important transcription factor in the immune system involved in the 
regulation of cytokine, effector enzyme and growth factor expression (Hayden and 
Ghosh 2004). In the inactivated form, NF-κB exists in the cytosol as a hetero- or 
homodimer bound to IκB which prevents NF-κB from translocating to the nucleus 
(Hayden and Ghosh 2004). In the classical pathway of NF-κB activation, pro-
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inflammatory mediators such as TNF-α, IL-1, LPS, result in downstream signalling 
pathways that lead to the phosphorylation of the β subunit of IκB kinase (IKK) causing 
its activation and the subsequent phosphorylation of two conserved amino acids 
(Ser32 and Ser36) on the N-terminal domain of IκB (Karin 1999, Hayden and Ghosh 
2004). Phosphorylated IκBs subsequently undergo post-translational modification 
termed polyubiquitination (Karin 1999). When the target protein is conjugated to a 
polyubiquitin chain a multisubuinit protease complex, the 26S proteasome, catalyses 
the protein into small peptides (Hochstrasser 2009).  The uninhibited NF-κB is then 
capable of translocating to the nucleus and bind to promoter and enhancer regions of 
DNA containing κB sites with consensus sequence GGGRNNYYCC (R = purine, Y = 
pyrimidine, N = any base) (Hayden and Ghosh 2004).  
H2S has been suggested to inhibit NF-κB translocation to the nucleus. H2S donor 
NaHS has been demonstrated to increase the rate of IκB-α recovery (NaHS 10 µM, IL-
1β 2.5 ng/ml, fibroblast-like synoviocytes (FLS) (Stuhlmeier, et al. 2009); NaHS 200 µM, 
LPS 1 µg/ml, RAW264.7 (Oh, et al. 2006)). NaHS has also been demonstrated to inhibit 
IκB-α phosphorylation (NaHS 2 mM, IL-1β 2.5 ng/ml, FLS (Stuhlmeier, et al. 2009); 
NaHS 0.2 mg/kg 10 min prior to retransfusion in a model of hemorrhagic shock in rats 
(Ganster, et al. 2010)). NaHS can also directly inhibit NF-κB translocation into the 
nucleus (NaHS 200 µM, LPS 1 µg/ml, RAW264.7 (Oh, et al. 2006); NaHS 1000 µM, LPS 1 
µg/ml, RAW264.7 (Whiteman, et al. 2010c)).  
Conversely, NaHS has also been demonstrated to enhance NF-κB nuclear 
translocation, by mechanisms such as: inducing IκB-α degradation (NaHS 100 µM, 
U937 human monocyte cell line (Zhi, et al. 2007)); or directly enhance the 
translocation of NF-κB into the nucleus (NaHS 100 µM, U937 (Zhi, et al. 2007); NaHS 10 
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mg/kg i.p. at the time of cecal ligation operation (Zhang, et al. 2007b); NaHS 100-200 
µM, LPS 1 µg/ml, RAW264.7 (Whiteman, et al. 2010c)). This evidence suggests that H2S 
has variable roles in regulating the NF-κB translocation pathway. 
Adhesion molecules VCAM-1, ICAM-1, and E-selectin have been shown to be 
regulated by the NF-κB pathway (Collins, et al. 1995), and was hypothesised as a 
mechanism by which  GYY4137 may inhibit adhesion molecule expression. In the 
current study GYY4137 (125 µM or 500 µM 1 h pre-treatment) did not affect the rate 
of IκB-α recovery in HUVEC at 30 or 60 min induced by IL-1β 10 ng/ml (Figure 5.2.11  
and 5.2.12), suggesting that GYY4137 may not be acting through inhibition of NF-κB 
translocation to the nucleus in these circumstances. Although it should be noted that 
the rate of IκB-α recovery appeared vary between HUVEC from different mothers 
(Figure 5.2.11). Indeed, the evidence for variation between HUVEC has previously been 
documented (Hofman, et al. 1993, Zoellner, et al. 1998, Overhoff and Sczakiel 2005, 
Paez, et al. 2008). Indeed further study to examine more time points for IKB-α 
degradation, or alternative means of measuring NF-κB translocation are necessary.  
COX-2 is downstream NF-κB (Nie, et al. 2003), and has previously been used as 
an indicator of NF-κB translocation to the nucleus (Liang, et al. 1999). In contrast to 
the IκB-α data, GYY4137 (500 µM) significantly (P<0.05) reduced IL-1β induced COX-2 
expression at 24 h in HUVEC (Figure 5.2.13), suggesting that GYY4137 inhibits NF-κB 
translocation. The variability between the rate of IκB-α recovery between HUVEC (30 
– 120 min) in the current study made it difficult to interpret the data, particularly as 
only one time point (60 min) was used to determine IκB-α recovery. Endpoint markers 
such as the maximal expression of COX-2 in the presence or absence of H2S may 
therefore provide clearer depiction of NF-κB regulation by H2S. However, COX-2 may 
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be regulated by other pathways independent of NF-κB. Indeed, MAPK pathways have 
been shown to regulate COX-2 stability at the transcriptional and post-transcriptional 
level (Tsatsanis, et al. 2006). Furthermore, transcription factor CCAAT/enhancer-
binding protein (C/EBP) has also been implicated in COX-2 regulation in endothelial 
cells (Kang, et al. 2007). 
INOS is also another downstream affector of the NF-κB pathway (Xie, et al. 
1994). Due to technical difficulties in measuring iNOS protein expression in HUVEC, an 
alternative approach to examinine the effects of H2S on iNOS expression was needed. 
The measurement of nitrate/nitrite production from LPS stimulated RAW264.7 cells is 
a robust and relatively quick method to examine whether GYY4137 effects iNOS 
activity and/or expression. Both GYY4137 and NaHS could concentration dependently 
reduce nitrate/nitrite production from LPS stimulated RAW264.7. This correlates with 
another study that deomonstrated that GYY4137 and NaHS could inhibit 
nitrate/nitrite production from LPS stimulated RAW264.7 cells (Whiteman, et al. 
2010c). Interestingly, NaHS has been shown to inhibit LPS induced iNOS expression in 
RAW264.7 (Oh, et al. 2006) and microglia (Hu, et al. 2007) which may suggest H2S is 
capable of inhibiting NF-κB translocation to the nucleus. However, like COX-2, iNOS is 
also regulated by other transcription factors such as STAT (Bolli, et al. 2001) and AP-1 
(Cho, et al. 2002). 
E-selectin has also been reported to be regulated by NF-κB (Ehrhardt, et al. 
2004). However, in the current study, H2S did not inhibit soluble E-selectin expression 
(Figure 5.2.2). If H2S was to inhibit NF-κB translocation to the nucleus H2S should also 
inhibit E-selectin expression which was not the case in the current study. E-selectin is 
maximally expressed at 4 h and rapidly declines at 24 h (Ghersa, et al. 1997). In 
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contrast, VCAM-1 expression has been reported to be maximal at 6-8 h and unlike E-
selectin its expression is relatively stable at 24 h (Ghersa, et al. 1997). The different 
kinetics in the regulating adhesion molecules suggests alternative mechanisms of 
adhesion molecule regulation which may be independent of NF-κB. In a previous study, 
shear stress was shown to increase both protein and mRNA levels of TNF-α induced 
ICAM-1, but reduced TNF-α induced VCAM-1 and E-selectin in HUVEC (Chiu, et al. 
2004), demonstrating different regulatory mechanisms between each of the adhesion 
molecules that may not be solely related to the NF-κB translocation pathway.  
H2S itself has also been demonstrated to act on a number of different signalling 
pathways. For example, H2S regulates the MAPK pathway. In HUVEC treated with TNF-
α, p38 MAPK activation was inhibited by NaHS (100 µM, pre-treatment) but had no 
effect on ERK1/2 or JNK1/2 (Pan, et al. 2011). In another study, HUVEC exposed to H2S 
(60 µM) induced a sustained phosphorylation of ERK1/2 and a transient 
phosphorylation of p38 MAPK (Papapetropoulos, et al. 2009). Indeed, a number of 
MAPK pathways are also capable of integrating with NF-κB pathway as demonstrated 
in a number of tissues: human kidney specimens (Sakai, et al. 2002), human bronchial 
epithelial and eosinophils (Wong, et al. 2005), bovine chondrocytes  (Chowdhury, et al. 
2008) and murine embryonic fibroblasts (Tang, et al. 2001, Papa, et al. 2006).  
The activation of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B 
(AKT) pathway is involved in cell cycle progression (Liang and Slingerland 2003), the 
regulation of protein trafficking (Wurmser, et al. 1999), and the regulation of 
angiogensis (Cai, et al. 2007).  H2S has been shown to activate this pathway in HUVEC 
(Papapetropoulos, et al. 2009) and RF/6A endothelial cells (Cai, et al. 2007). 
Interestingly, the activation of PI3K/AKT pathway has been shown to negatively 
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regulate the NF-κB pathway in a model of acute pancretitis induced by caerulein 
(Tamizhselvi, et al. 2009).  
Other pathways of H2S activation may include antioxidant pathways. TNF-α 
stimulated HUVEC exposed to NaHS (10-100 µM) has been shown to increase the 
protein expression of HO-1 (Pan, et al. 2011). This may suggest that H2S is capable of 
regulating the nuclear factor erythroid 2-related factor (Nrf2) antioxdant pathway in 
endothelial cells. Interestingly, this antioxidant pathway has also been shown to 
negatively regulate the NF-κB pathway in a mouse model of traumatic brain injury (Jin, 
et al. 2008). 
Overall, H2S affects a number of different signalling pathways and it is unlikely 
there is a single straight forward pathway for the regulation of adhesion molecule 
expression.  Indeed, it is possible that H2S may indirectly inhibit NF-κB translocation 
through affecting other signalling pathways such as MAPK, PI3K/AKT or Nrf2. The 
integration of several signalling pathways at one time is probable and likely to be 
dependent on the stimuli, cell type, timing, concentration of H2S and cell environment.  
In the current study, GYY4137 and NaHS significantly reduced ICAM-1 and 
VCAM-1 expression but not E-selectin expression. This effect may be partially 
mediated by regulating the NF-κB pathway, however further study is necessary to 
confirm this. Indeed, alternative methods to measure NF-κB activation include the 
measurement of IκB-α phosphorylation, NF-κB nuclear translocation and NF-κB DNA 
binding. The reason for the selectivity of H2S on ICAM-1 and VCAM-1 expression is 





5.3.3. GYY4137 and oedema induced by carrageenan in the mouse hindpaw 
 
To determine whether GYY4137 has an effect on MPO activity, pain and oedema 
formation in vivo, the carrageenan hindpaw model was used. In the current study, 
GYY4137 (50 mg/kg i.p. 1 h post carrageenan) had no significant effect on paw oedema 
(Figure 5.2.19). In contrast to the current work, another study demonstrated that 
injection of NaHS (150 µmol/kg i.p., 30 min pre-treatment) significantly reduced 
carrageenan induced paw oedema in rats (Zanardo, et al. 2006). Similarly, others have 
demonstrated that S-diclofenac (H2S releasing NSAID) was more potent than diclofenac 
at reducing carrageenan induced paw oedema in rats (Sidhapuriwala, et al. 2007). The 
reason behind the difference in the current study and the two latter studies, may be 
due to the use of different H2S donors (GYY4137 c.f. NaHS/s-diclofenac), species 
(mouse c.f. rat), timing (post-treatment c.f. pre-treatment) and/or different methods 
to measure oedema (paw weight/size c.f. paw volume using a plethysmometer).  
In contrast to administrating H2S donors (Zanardo, et al. 2006, Sidhapuriwala, 
et al. 2007), one study demonstrated that PAG (25 – 75 mg/kg i.p., 60 min pre-
treatment) dose dependently reduced carrageenan-induced hindpaw oedema in rat 
(Bhatia, et al. 2005),  suggesting that endogenous and exogenous H2S exert different 
effects. Indeed, the controversies on oedema formation with vasodilators have also 
been demonstrated with •NO. •NO donors have been shown to reduce oedema 
formation in the mouse carrageenan hindpaw model (Fernandes, et al. 2002). In 
contrast, administration of L-NAME (NOS inhibitor, 50 mg/kg) has also been shown to 




Indeed, it is difficult to predict whether a vasodilator like H2S may reduce or 
enhance oedema peripherally. Increasing blood flow should in theory increase 
perfusion pressure and enhance oedema formation. However, both •NO (Fernandes, et 
al. 2002) and H2S donors (Zanardo, et al. 2006) have been demonstrated to reduce 
oedema formation. However, the anti-oedema effects induced by these agents may 
not be a direct effect as a result of their vasoactive properties. There are several 
mediators involved in increasing vascular permeability, namely serotonine (5-
hydroxytryptamine 5-HT, released from mast cells, platelets and noradrenergic nerve 
terminals), histamine (predominately released from mast cells) and prostaglandins 
(synthesised by COX-1 and COX-2, both ubiquitously expressed) (Posadas, et al. 2004). 
H2S donors have been demonstrated to inhibit COX-2 expression (Hu, et al. 2008a, 
Yang, et al. 2011a) and prostaglandin production (Whiteman, et al. 2010c). In rats, 
COX-2 message and PGE2 is up-regulated in carrageenan hindpaws within 1 h of 
injection (Nantel, et al. 1999). Three hours after carrageenan injection, 
immunohistochemical analysis suggests that COX-2 is predominately expressed in the 
stratum corneum of the epidermis, inflammatory cells and depending on the severity 
of the inflammation, skeletal muscle cells (Nantel, et al. 1999). The inhibition of COX-2 
expression may be a reason for the H2S induced reduction in carrageenan-induced paw 
oedema described in previous studies (Zanardo, et al. 2006). Whether GYY4137 
inhibits COX-2 expression and prostaglandin synthesis, or alternative mediators 
involved in vascular permeability (e.g. histamine or 5-HT), in the carrageenan model of 
inflammation requires further study.  
In mice, the carrageenan induced paw-oedema model is biphasic, with the first 
phase of swelling occurring between 1-6 h and the second phase of further swelling 
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occurring between 24 – 96 h (Posadas, et al. 2004). In CD-1 mice, the expression of 
COX-2 protein induced by carrageenan occurs at later time points (>6 h), typically in 
the second phase of carrageenan induced paw oedema (Posadas, et al. 2004). In the 
current study, the carrageenan paw-oedema model was terminated at 6 h due to 
home office licence requirements. Indeed, it would be interesting to determine 
whether GYY4137 would have more prominent effects on paw oedema in the second 
phase of this carrageenan model as GYY4137 has been demonstrated to inhibit COX-2 
expression at 24 h in HUVEC (Figure 5.2.13).  
 
5.3.4. GYY4137 and hyperalgesia in the carrageenan paw-oedema mouse model  
 
In the current study, GYY4137 did not have an effect on mechanical hyperalgesia 
(Figure 5.2.20). In an inflammatory model of arthritis (2% w/v kaolin- 2% w/v 
carrageenan), an intra-articular injection of Na2S (60 µM in 100 µl, 24 h post-insult) 
significantly (P<0.001) reduced leukocyte adhesion (Andruski, et al. 2008). However in 
the same model of inflammation, Na2S (100 µM in 100 µl) had no effect on joint pain 
measured using von Frey hair algesiometry (Andruski, et al. 2008), which accords with 
the current study. However, in contrast another study utilising the carrageenan-
induced knee joint synovitis model, pre-treatment with the H2S donor Lawesson's 
reagent (3.6 µmol per joint, 60 min) ameliorated the severity of knee joint pain, as 
measured by a behavioural observation gait score (Ekundi-Valentim, et al. 2010). 
The role of H2S in pain is still unclear. Both pro-nociceptive (co-injection of 
NaHS 1 nmol/0.1 mL and formalin 1.25% in rat hindpaw (Lee, et al. 2008), NaHS 0.5 – 5 
nmol/mouse intracolonic (Matsunami, et al. 2009), L-cysteine 100 nmol/paw i.pl. in rat 
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(Kawabata, et al. 2007), CBS inhibitor hydroxylamine 25 μmol/kg in rat colorectal 
distension) and anti-nociceptive (NaHS 30 µmol/kg i.p. in a rat model of colorectal 
distension (Distrutti, et al. 2006a), Lawesson’s reagent 3.6 µmol per joint in a 
carrageenan knee joint model (Ekundi-Valentim, et al. 2010)) effects of H2S have been 
described. These nociceptive effects have been suggested to involve T-type calcium 
channels (Kawabata, et al. 2007, Matsunami, et al. 2009), KATP channels (Distrutti, et al. 
2006a) and transient receptor potential A1 (TRPA1) ion channels (Streng, et al. 2008). 
In the current study, GYY4137 post-treatment had no effect on reducing 
mechanical nociceptive threshold. It would be interesting to determine whether 
GYY4137 pre-treatment would have an effect on mechanical hyperalgesia and whether 
other pain thresholds such as thermal nociceptive threshold would be affected.  
 
5.3.5. GYY4137 and MPO activity in carrageenan hindpaws 
 
 
Although GYY4137 did not significantly reduce paw oedema or hyperlagesia in the 
current study, GYY4137 significantly (P<0.05) reduced MPO activity, an indicator of 
neutrophil infiltration, in carrageenan hindpaw homogenates compared to control 
(Figure 5.2.21) implying perhaps an effect on leukocyte trafficking which may be 
secondary to inhibition of adhesion molecule expression reported in this chapter. 
Indeed, it has previously been demonstrated that H2S can inhibit leukocyte infiltration 
in carrageenan models of inflammation: pre-treatment with NaHS (100 µmol/kg i.p.), 
30 min prior to carrageenan injection into the air pouch of rats, significantly (P<0.05) 
reduced the leukocyte exudates cell count compared to control (Zanardo, et al. 2006); 
3 h pre-treatment with S-diclofenac (EC50 12.0 ± 2.1 μmol/kg, i.p.) was more potent 
than diclofenac (EC50 21.9 ± 2.0 μmol/kg i.p.) at inhibiting MPO activity in the 
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carrageenan hindpaws of rats (Sidhapuriwala, et al. 2007); Lawesson’s reagent (H2S 
donor, 3.6 µmol per joint, 60 min pre-treatment) was shown to reduce total, 
neutrophil and lymphocyte cell count in the synovial lavage fluid from rats with 
carrageenan-induced synovitis (Ekundi-Valentim, et al. 2010).   
Interestingly, the incubation of GYY4137 (5 µM) with purified MPO in vitro 
significantly reduced MPO enzyme activity (Figure 5.2.22) suggesting the reduction of 
MPO activity in carrageenan hindpaws induced by GYY4137 may not be as a 
consequence of leukocyte infiltration but due to the inhibition of MPO enzyme activity 
itself. Interestingly, another study using purified MPO, demonstrated that NaHS (35 – 
500 µM) could concentration dependently reduce MPO activity (Laggner, et al. 2007). 
Indeed, further work is necessary to determine whether GYY4137 directly reduces 
leukocyte infiltration, possibly by cell count or histochemical analysis. Moreover, an in 
vitro assay to measure leukocyte adherence to stimulated HUVEC in the presence or 
absence of H2S will provide further evidence for a functional effect of reducing VCAM-
1/ICAM-1 in vitro.  Interestingly, in a rat model of endotoxin shock, GYY4137 did not 
reduce MPO activity in liver or lung when injected 1 h prior to LPS insult (Li, et al. 
2009b). This implies that, although GYY4137 can directly inhibit MPO activity in vitro 
(Figure 5.2.22), GYY4137 does not directly affect MPO enzyme activity in vivo.  
In correlation with the overall anti-inflammatory effect of GYY4137 in this 
study, others have shown that GYY4137 (50 mg/kg i.p.) injected 1 h post-treatment 
(but not 1 h pre-treatment) significantly reduced MPO activity in the lung of septic rats 
(LPS 4 mg/kg i.p), suggesting GYY4137 inhibits leukocyte infiltration (Li, et al. 2009b). 
Moreover, GYY4137 reduced the severity of tissue damage in the lung and liver 
induced by LPS, confirmed by histology (Li, et al. 2009b). Furthermore, these authors 
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demonstrated a reduction in plasma nitrate, L-selectin, TNF-α, IL-1β and IL-6 on 
injection of GYY4137 1 h post insult (Li, et al. 2009b). In addition, the administration of 
decomposed GYY4137 did not significantly alter plasma TNF-α or tissue MPO activity 
suggesting that the H2S released from GYY4137 is the reason for the anti-inflammatory 
effects demonstrated in this model of inflammation (Li, et al. 2009b). In another study 
GYY4137 was shown to inhibit IL-1β, TNF-α, PGE2 and nitrite in LPS stimulated 
RAW264.7 macrophages (Whiteman, et al. 2010c). Moreover, these effects were 
shown to be through inhibiting NF-κB activation (NF-κB DNA binding), HSP-27 (heat-
shock-protein-27) phosphorylation and ATF2 (activating transcription factor 2) 
phosphorylation (Whiteman, et al. 2010c). Moreover, GYY4137 also been 
demonstrated to exhibit antioxidant properties, as demonstrated by its ability to 
inhibit apoptosis induced by H2O2 in human chondrocytes (Fox, et al. 2011).  
5.1.1. Conclusion 
 
The current study has demonstrated that H2S donors GYY4137 and NaHS are capable 
of reducing VCAM-1 and ICAM-1, but not E-selectin expression on HUVEC. In contrast 
to NaHS the effects of GYY4137 on HUVEC are unlikely to be a direct effect on cell 
toxicity. The inhibitory effects of GYY4137 on adhesion molecule expression on HUVEC 
correlate with a reduction in MPO activity in carrageenan hindpaws. In the current 
study, GYY4137 presents an overall anti-inflammatory effect. However, the effects of 
GYY4137 on MPO activity may not be a direct effect on leukocyte infiltration and 
further study is required to confirm this. The slow release of H2S from GYY4137 is the 
foremost beneficial advantage of this H2S donor compared to the conventional H2S-
salts and is likely to be the cause of the anti-inflammatory effects described in this 
study and is a useful tool to further our understanding in the H2S field.  
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NaHS has been demonstrated to have both pro- and anti- inflammatory effects in 
different models of inflammation. Many of the anti-inflammatory properties of H2S 
donors may be in part due to their ability to act as antioxidants. Indeed, H2S donors 
have also been demonstrated to scavenge reactive oxygen species such as H2O2, HOCl 
(Laggner, et al. 2007), ONOO- (Whiteman, et al. 2004), O2
•- (Chang, et al. 2008) and 
•NO (Whiteman, et al. 2006, Fox, et al. 2011). However, the pro- inflammatory and 
pro- apoptotic effect of H2S donors may arise as a result of the nature of the H2S 
donor. Indeed, some of the problems with the traditional H2S donors, NaHS or Na2S, is 
that H2S is released almost immediately in solution. Potential problems include the 
release of high instantaneous concentrations of H2S which may be toxic to cells 
(Beauchamp, et al. 1984). GYY4137 a novel organic slow releasing H2S donor has 
recently been shown to exert anti-inflammatory affects in vivo (Li, et al. 2009b) and in 
vitro (Whiteman, et al. 2010c), and data shown in Chapter 5 of this thesis supports  an 
anti-inflammatory effect of GYY4137. In addition, GYY4137 has been shown to induce 
cell death selectively in tumour cell lines, but not non-cancer cell lines, suggesting that 
GYY4137 may have therapeutic potential in the treatment of cancer (Lee, et al. 2011). 
As mentioned in Chapter 5, there is a need for more organic H2S donors in order to 







The aim of this chapter was: 
1.  Using biochemical techniques, characterise a library of potential H2S releasing 
donors:  
a) For their ability to release H2S, using the methylene blue, ISE and DTNB 
methods. 
b) For their antioxidant ability by assessing a) the ability to scavenge free 
radicals (ABTS and DPPH) and b) reducing capacity (ferricyanide reducing 
power) of these compounds. 
2. On identifying a potent antioxidant, ZJ802, this compound was further 
characterised for potential anti-inflammatory actions in vivo: by characterising 













6.1 Materials and Methods 
6.1.1 ZJ802 
ZJ802 was synthesised by Professor Tan Choon Hong (National University of 
Singapore, Singapore) m.w. 246.44. 
 
Figure 6.1.1. Structure of ZJ802 
 
6.1.2 Animal housing 
CD-1 male mice (Charles River, 25 g) were housed in King’s College London Biological 
Services Unit (Waterloo) in a climatically controlled environment (45% humidity, 20oC, 
12 h light cycle). Laboratory chow and drinking water were provided ad libitum. All 
experiments were carried out according to the 1986 UK Home Office Animals Scientific 
Procedures Act. 
 
6.1.3 Blood pressure measurement in anaesthetised mice 
C57Bl6 (male, 25 g) were anesthetised under isoflurane (2.5% isofluorane induction, 
then 1.5% for maintenance using an air pump) placed on a homeothermic heating 
blanket (Harvard) in a supine position. Pressure catheter implantation was performed 
with the aid of a Leica M60 Stereo Zoom Microscope and Schott KL1500 LCD (220-240 
V / 50/60 Hz) lighting system. 
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The skin of the throat was cut from the chin to the sternum and the right and 
left sternohyoid muscles were separated via blunt dissection exposing the trachea. The 
right carotid artery was subsequently located, cleaned of nerves and connective tissue, 
and three pieces of silk sulture (5.0) were placed under the vessel. A ligature was made 
to the distal part of the carotid artery to stop blood flow to the brain. A loose ligature 
was made using a single loose knot to temporarily occlude blood flow from the heart 
to prevent blood loss during cannulation of the vessel. A pair of hemostats were used 
to put tension on the artery to allow catheterisation using the suture ties. A modified 
23G needle (tip bent 90o) was used to carefully puncture a hole in the carotid artery 
between the two ligatures and guide the catheter (1.2F Pressure Catheter, Scisense) 
into the vessel. Once in the correct position to record arterial pressure the catheter 
was secured in the vessel with a final suture. Pressure calibration, signal transduction 
and amplification were made by a FP891B pressure control unit (Scisense). Data was 
acquired using a Powerlab (35 series) and LabChart software (ADInstruments). The 
jugular vein was exposed for intravenous delivery of drugs. Following 10 min of stable 
arterial blood pressure recording an insulin needle (30G) was used to deliver LD802 
(203 µmol/kg), GYY4137 (133 µmol/kg),  NaHS (18 µmol/kg) (Li, et al. 2008b) or vehicle 
(saline, 2.5 ml/kg). Blood pressure was subsequently monitored for up to 1 h. 
 
6.1.4 LPS and ZJ802 administration 
ZJ802 (50 mg/kg, 10 ml/kg i.p., 27 G needle) or saline (10 ml/kg i.p. , 0.9% w/v sodium 
chloride) was injected into conscious male CD-1 mice 15 min prior to or 30 min post-
LPS injection (Escherichia coli, serotype O127:B8; 10 mg/kg, 10 ml/kg i.p.). Mice were 
immediately killed via cervical dislocation after whole blood was obtained in 
216 
 
heparinized syringes (50,000 units/ml) via cardiac puncher in anaesthetised mice 
(isoflourane 4% v/v), 4 h after LPS administration. Whole blood was centrifuged (2000 
g, 20 min) and the plasma collected. Organs (heart, lung, liver, kidney and spleen) were 
subsequently collected, rinsed with saline, snap-frozen in liquid nitrogen and stored at   
-80oC for assay later. 
 
6.1.5 H2S release from ZJ802 using the ISE and methylene blue assay 
ZJ802 was dissolved in phosphate buffer (100 mM, KHPO4 pH 7.5) and the release of 
H2S from ZJ802 was measured by the methylene blue colourimetric assay (Method 2.9) 
or the ISE (Method 2.10).  
 
6.1.6 H2S release from ZJ802 using DTNB 
Due to inconsistent results obtained between the methylene blue colourimetric assay 
and ISE, the DTNB (5,5'-dithiobis-(2-nitrobenzoic acid)) assay was used as an additional 
method used to measure H2S release from ZJ802. 
DTNB, also known as Ellmans reagent, is used to measure thiol (-SH) groups 
(Ellman 1959) and has been previously used to measure glutathione production and 
sulfhydryl groups bound to proteins (Sedlak and Lindsay 1968). DTNB is reduced by 
thiol groups to form 1 mole of 2-nitro-5-mercaptobenzoic acid per mole of SH (Sedlak 
and Lindsay 1968). The nitromercaptobenzoic acid anion, has an intense yellow colour 
that is most stable at pH 8.0, which is detected spectrophotometrically (Sedlak and 
Lindsay 1968). Due to its non-specific properties to measure thiols, this assay was only 
used to measure H2S in protein free in vitro conditions.  
To determine whether ZJ802 was an H2S releasing agent ZJ802 (5 mM) was 
incubated in water, KHPO4 (100 mM, pH 4.5) or KHPO4 (100 mM, pH 7.5) at room 
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temperature or 37oC for the indicated periods of time.  A standard curve using NaHS (4 
–  500 µM) was used as an indicator of H2S release. H2S (20 µl) was added to 96 well 
plates containing DTNB (50 µl, 1 mM in water) and HEPEs buffer (50 µl, 1 M pH 8.0). 
After 10 min incubation at room temperature and the absorbance measured at 421 
nm.  
6.1.7 MPO activity in mouse tissues 
Tissues from animals were snap frozen in liquid nitrogen within 5 min of death and 
stored at -80oC until use. Liver, lung and kidney tissues (5% w/v) were homogenised in 
ice-cold buffer 1 (20 mM KHPO4, pH 7.4) using a Polytron Homogeniser. Homogenates 
were subsequent centrifuged at 13,000 g for 10 min at 4oC. The supernatant was 
discarded and the pellet resuspended in 1 ml buffer 2 (50 mM KHPO4, 0.5% w/v 
hexadecyltrimethylammonium bromide (HTAB), pH 6). The suspension was 
subsequently snap frozen and thawed at 37oC, 4 times. The suspension was then 
sonicated for 10 sec at 20 amps followed by 20 sec rest in ice cold water, 4 times. 
Samples were then centrifuged at 13,000 g for 5 min. Supernatant (50 µl) was added 
into each well of a 96-well plate followed by TMB/H2O2 substrate (100 µl) and 
incubated at room temperature for 30 min. The absorbance was subsequently read at 
652 nm. A standard curve for MPO was constructed from purified MPO derived from 
human leukocytes (0.1 – 1 units MPO/ml, Sigma M6908). Values were standardised to 
protein, using Bradford protein assay (Method 2.6). Data was subsequently expressed 






6.1.8 Plasma TNFa and IL-1 
TNF-α and IL-6 levels in mouse plasma were determined via an Enzyme-Linked 
Immunosorbent Assay (ELISA), ab46105 and ab46100 (Abcam) respectively. Plasma 
was diluted 1:400 in the standard diluent and the assay conducted according to the 
manufacturers instructions. 
 
6.1.9 ABTS antioxidant assay 
ABTS (2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid, 7 mM) was converted to 
its free radical form (ABTS`+) through incubation with the oxidising agent potassium 
persulfate (K2S2O8, 2.5 mM) for a minimum of 12 h in the dark (Re, et al. 1999). In the 
presence of H+ donating antioxidants ABTS`+ is reduced and decolourises. The ABTS`+ 
was diluted using PBS to an absorbance of 0.6 at 734 nm. ABTS`+ solution (1 ml) was 
added to varying concentrations of ZJ802 (10 µl, 30-1000 µM, PBS) and incubated at 
room temperature for 5 min before the absorbance read at 734 nm.  Results were 
subsequently plotted as the absorbance reading at 734 nm. 
 
6.1.10 DPPH antioxidant assay 
DPPH (2,2-diphenyl-1-picrylhydrazyl) is a free radical (Ates, et al. 2008).  This assay is 
based in the ability of antioxidants to reduce DPPH to DPPHH. A reduction in DPPH 
colour intensity indicates increased radical scavenging power.  Varying concentrations 
of ZJ802 (50 µl, 30-1000 µM, H2O) was added to DPPH (1.45 ml, 10 mM, methanol) and 
left in the dark for 30 min at room temperature before being measured at 520 nm. 





6.1.11 Ferricyanide  reducing power  
This assay measures the reducing power of a compound, an indicator of antioxidant 
capacity (Ates, et al. 2008). In brief, potassium ferricyanide (K3[Fe(CN)6], 250 µl, 1% 
w/v in H2O) and KHPO4 (250 µl, 0.2 M, pH 6.6) was added to ZJ802 (100 µl, 30 – 1000 
µM, H2O) and incubated at 50
oC for 20 min. During this reaction, the ferricyanide ion is 
reduced to ferrocyanide ([Fe(CN)6]
4-) in the presence of reducing agents (Lillie and 
Donaldson 1974). The reaction was terminated by addition of TCA (250 µl, 10% w/v in 
H2O) and centrifuged at 13,000 g for 5 min. 250 µl of this solution was added to a tube 
containing 250 µl H2O and 50 µl ferric chloride (FeCl3.6H2O, 0.1% w/v H2O). Here, ferric 
ions react with ferrocyanide to form a blue colour, Prussian Blue (Lillie and Donaldson 
1974). After incubation for 5 min at room temperature, the absorbance was read at 
















6.2.1 H2S release from ZJ802 
H2S release from ZJ802 (1 mM, pH 7.4, n = 4, time = 0) was 11.07 ± 1.31 µM H2S 
according to the ISE (Figure 6.2.1). However, H2S was undetectable using the 
methylene blue assay. As a result the DTNB assay, which measures the presence of 
thiol (-SH) groups, was utilised as an alternative indicator of H2S release. The DTNB 
assay had a sensitivity from 15 µM H2S and was linear up to 10 mM H2S (Figure 6.2.2). 
Based on the results obtained from the DTNB assay, ZJ802 resulted in a dose 
dependent rise in -SH concentrations (Figure 6.2.3) an effect that was pH and 
temperature dependent (Figure 6.2.4).  
The release of -SH groups from GYY4137 is also pH and temperature dependent 
(Figure 6.2.4) as previously described in the literature (Li, et al. 2009b). The -SH release 
profile of ZJ802 was similar to that of NaHS (previously described in Chapter 5), that is 
the release of -SH groups was immediate and gradually declined over time (Figure 
6.2.4). This is in contrast to the slow releasing donor GYY4137 which released –SH 
groups gradually over time, leading to the steady accumulation of H2S/-SH groups in 
solution (Figure 6.2.4).   
6.2.2 ZJ802 and blood pressure in anesthetised mice 
As H2S donors have been shown to reduce blood pressure (BP) (Zhao, et al. 2001). As 
a result, studies were performed to investigate the blood pressure effects of ZJ802. A 
bolus injection of ZJ802 (50 mg/kg i.v.) was administered into anesthetised mice. 
ZJ802 caused an almost immediate drop in blood pressure (mean BP from 93.40 ± 
1.50 to 50.57 ± 8.11 mmHg, n = 3) which increased over 30 min but did not reach 
original baseline values over the time course studied (Figure 6.2.5 and 6.2.6).  
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NaHS was injected into the mice after injection of ZJ802, as a positive control 
and to compare the antihypertensive kinetics of both donors. The blood pressure 
induced by NaHS (1 mg/kg i.v.), caused an immediate transient drop in blood 
pressure (mean BP from 79.10 ± 22.31 c.f. 55.24 ± 33.57, n = 2) which lasted 
approximately 30 sec before reaching baseline (Figure 6.2.7) as previously reported 
(Zhao, et al. 2001). 
To ensure the blood pressure effect of ZJ802 was not a result from altering 
endogenous pH levels, the pH of this compound was examined. ZJ802 had a pH of 
7.15 in saline and hence it is unlikely that the observed blood pressure effects 
occurred as a result of rapid changes in pH following drug administration. 
 
6.2.3 Antioxidant capacity of ZJ802 
H2S donors have antioxidant properties and have previously been shown to scavenge 
radicals such as peroxynitrite (ONOO-) (Whiteman, et al. 2004) and superoxide (O2
•-) 
(Chang, et al. 2008). The antioxidant and reducing capacity of H2S donors (NaHS and 
GYY4137) were compared to ZJ802. All compounds dose dependently reduced 
ferricyanide to ferrocyanide (Figure 6.2.8 a). ZJ802 was a more potent reducing agent 
than both NaHS and GYY4137 (Figure 6.2.8 a).  
Two free radical scavenging assays were used to determine the antioxidant 
capacity of NaHS, GYY4137 and ZJ802. All compounds dose dependently scavenged 
free radicals generated by DPHH (Figure 6.2.8 b) and ABTS (Figure 6.2.8 c). ZJ802 was 
comparable to NaHS at scavenging DPHH (Figure 6.2.8 b) and more potent than both 





Figure 6.2.1. H2S release from ZJ802 (1 mM) in KHPO4 (100 mM, pH 7.4) measured 
using the methylene blue assay, and ISE. H2S was immediately measured once 









Figure 6.2.2. DTNB standard curve using NaHS (4 – 10000 µM). Data are shown as 
















Figure 6.2.3 Increasing concentration of thiol (-SH) groups with increasing 
concentrations of ZJ802 (7.5 – 1000 µM) in KHPO4 (100 mM, pH 7.4) as measured by 









Figure 6.2.4. GYY4137 (5 mM) was dissolved in a) H2O c) KHPO4 (100 mM pH 7.4) e) 
KHPO4 (100 mM pH 4.5). ZJ802 (5 mM) was dissolved in b) H2O d) KHPO4 (100 mM pH 
7.4) f) KHPO4 (100 mM pH 4.5) and incubated at room temperature or 37
oC over the 
indicated time. Data are shown as mean ± SEM, thiol (-SH) groups (µM) determined by 







Figure 6.2.5. Blood pressure traces using anaesthetised mice. Mice were injected with 
a) saline (2.5 ml/kg i.v.) or b) c) and d) ZJ802 (50 mg/kg, i.v.). Data are shown as 





Figure 6.2.6. Mean blood pressure (BP) traces in anaesthetised mice. Mice were 









Figure 6.2.7.  Blood pressure traces of anaesthetised mice injected with NaHS (1 
mg/kg, i.v.) preconditioned with an injection of ZJ802 (50 mg/kg, i.v.). Data show 













































































































































Figure 6.2.8. NaHS, GYY4137 or ZJ802 (30 – 1000 µM) were assayed for their 
antioxidant capacity as measured by  a) ferricyanide reducing assay b) DPPH free 
radial scavenging assay c) ABTS free radial scavenging assay. Data show mean ± SEM, 




6.2.4 ZJ802 in a mouse model of endotoxin shock  
The effect of ZJ802 was examined further in an in vivo model of endotoxic shock. 
Mice were pre-treated (15 min) with ZJ802 (50 mg/kg, i.p.) prior to stimulation with 
LPS (10 mg/kg, i.p.). A significant (P<0.05) reduction in MPO activity, an indicator of 
leukocyte infiltration, was observed in lung (% inhibition 39.31 ± 9.04) and liver (% 
inhibition 49.16 ± 15.43) but not kidney (Figure 6.2.10 a, c and e). This anti-
inflammatory effect of ZJ802 correlated with a significant reduction (P<0.05) in 
plasma IL-6 (% inhibition 50.57 ± 12.81) but not TNF-α (Figure 6.2.11).  
However, ZJ802 (50 mg/kg, i.p.) injected 30 min post LPS did not show  anti-
inflammatory activity as demonstrated by an inability to affect MPO activity in lung, 


















































































































































































































Figure 6.2.10. MPO activity in lung, liver and kidney of LPS (10 mg/kg i.p.) treated mice.  
Mice were pre-treated (15 min) with ZJ802 (50 mg/kg) and MPO was measured in a) 
lung c) liver e) kidney, 6 h post LPS injection. ZJ802 (50 mg/kg) was injected 30 min 
after LPS and MPO activity was measured in b) lung d) liver f) kidney, 6 h post LPS.  






Figure 6.2.11. Mice were pre-treated with ZJ802 (50 mg/kg, i.p.) 15 min prior to LPS 
injection (10 mg/kg, i.p.). Plasma from mice was collected via cardiac puncher at 45 
min or 4 h after LPS injection. Plasma levels of a) IL-6 (4 h LPS) or b) TNF-α (45 min 
LPS), were measured via ELISA. Data shown mean ± SEM, n = 4-5, #P<0.05 c.f. saline 
















The main findings from this chapter are: 
1. ZJ802 is not a conventional H2S donor 
2. ZJ802 is capable of reducing blood pressure in anaesthetised mice 
3. ZJ802 is an antioxidant  
4. ZJ802 is anti-inflammatory as demonstrated by its ability to reduce lung and 
liver MPO activity and plasma IL-6 in an in vivo mouse model of endotoxic 
shock. 
 
ZJ802 an organosulfur compound was synthesised as a putative H2S releasing agent. In 
this Chapter, ZJ802 was shown to reduce blood pressure in the mouse in vivo. ZJ802 
also displayed antioxidant properties and produced a concentration dependent 
reduction in nitrate/nitrite levels in RAW264.7 cells challenged with LPS. In addition, 
ZJ802 pretreatment was shown to significantly (P<0.05) reduce MPO activity in lung 
and liver of LPS injected mice. This anti-inflammatory effect was further evidenced by a 
reduction in plasma IL-6 in this in vivo model of endotoxic shock. However, ZJ802 
injected into mice after the injection of LPS did not significantly reduce MPO activity in 
lung, liver or kidney.  
 
6.3.1 Is ZJ802 a H2S donor? 
The release of H2S from ZJ802 was detected by the DTNB assay and the ISE. However, 
H2S was not detected from ZJ802 using the methylene blue colourimetric assay (Figure 
6.2.1) and therefore this compound cannot be considered as a conventional H2S donor.  
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The reason for the differences between the H2S detection assays is unclear. It can be 
postulated that ZJ802 interrupts the formation of methylene blue and may be one 
reason why H2S was not detected.  The DTNB assay is a method used to quantitate 
thiol (-SH) groups on compounds (Sedlak and Lindsay 1968). As ZJ802 does not have an 
obvious thiol group on the parent molecule itself, it is likely that ZJ802 breaks down to 
a smaller thiol containing moiety which the DTNB assay subsequently detects. 
Although both the ISE and the DTNB assay could both detect “H2S” (if it is indeed H2S), 
the absolute concentration of H2S detected between these two methods were 
strikingly different. ZJ802 (1 mM) was shown to release approximately ~330 µM H2S 
measured by the DTNB assay, whereas the ISE suggested ~10 µM H2S at the same 
concentration of ZJ802. There are several problems with using the ISE such as drift, 
harsh antioxidant buffer conditions (pH 13) and changes in voltage with background 
(see Chapter 3, discussion 3.3.4) and therefore whether the ISE is measuring a change 
in sulfide levels is questionable. On the contrary, if a concentration of 300 µM H2S was 
achieved it would generate a detectable odour, however, this was not the case. 
Therefore whether the DTNB assay is measuring H2S or an –SH group on an alternative 
breakdown product of ZJ802 is yet unclear.  
On injecting ZJ802 into anaesthetised mice, ZJ802 (50 mg/kg, i.v.) induced an 
almost instantaneous fall in blood pressure that was longer lasting than the transient 
drop in blood pressure induced by NaHS (Figure 6.2.7). Whether ZJ802 decomposes 
into a vasodilator product, possibly H2S or perhaps another biologically active sulfur-
containing species, or directly induces vasodilation is unknown. Interestingly, 
organosulfur compounds such as allicin, the active ingredient in garlic, has been shown 
to reduce blood pressure in humans (Ried, et al. 2008). Garlic is a source of H2S 
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(Benavides, et al. 2007) and/or sulfane sulfur (Iciek, et al. 2009), both of which may 
carry out some of its biological actions. Interestingly, although allicin has been 
implicated to be a source of H2S (Benavides, et al. 2007), solubilising allicin does not 
result in the characteristic H2S odour, but it has been suggested that in presence of 
endogenous thiols such as GSH, allicin decomposes to H2S (Benavides, et al. 2007). 
Indeed, further experiments would be necessary to examine whether ZJ802 releases 
H2S in vivo, by determining plasma H2S over a number of time points, and/or whether 
ZJ802 releases H2S in vitro on incubation with reducing agents e.g. GSH, or biological 
material such as liver or blood plasma.  
It is possible the blood pressure effects of ZJ802 are due to a number of 
mediators. It is therefore necessary to carry out ex vivo blood vessel caliber studies 
with the aid of antagonists that inhibit the action of vasoactive mediators: H2S 
(glibencamide, KATP channel blocker), prostaglandins (NSAIDS), 
•NO (L-NAME NOS 
inhibitor or haemoglobin •NO scavenger), cyclic GMP (ODQ, soluble guanylate cyclase 
inhibitor), cyclic AMP (SQ23356, adenylate cyclase inhibitor), endothelium-derived 
hyperpolarising factor (apamin/charybdotoxin, inhibitors of small/large KCa channels) 
or K+ channels (tetraethylammonium, non-selective K+ channel blocker). 
Overall, ZJ802 does not appear to be a conventional H2S donor like NaHS or 
GYY4137. However, it is possible ZJ802 may release H2S. Indeed, further studies are 








6.3.2 ZJ802 in inflammation 
Although the H2S releasing potential of ZJ802 is unclear, this compound exhibited 
comparable, if not more potent, antioxidant properties to GYY4137 and NaHS (Figure 
6.2.8). Antioxidants are important in limiting damage induced by free radicals and may 
therefore play an important role in limiting damage to healthy cells during the 
inflammatory process.  
Antioxidants have been demonstrated to have a number of anti-inflammatory 
effects (Fang, et al. 2002). Vitamin E has previously been shown to inhibit NF-κB 
activation (Suzuki and Packer 1993, Faruqi, et al. 1994). Furthermore, plant flavonoids 
also exhibit anti-inflammatory properties (Kim, et al. 2004) and have been shown to 
inhibit COX-2 and iNOS expression from inflammatory cells stimulated with LPS (Liang, 
et al. 1999, Chi, et al. 2001, Raso, et al. 2001). The antioxidant properties of ZJ802 
prompted further studies to determine whether this would be a pharmacologically 
viable compound in inflammation.  
ZJ802 pre-treatment significantly reduced MPO activity in lung and liver tissue 
of LPS-treated mice. In addition, ZJ802 significantly reduced pro-inflammatory cytokine 
IL-6 but not TNF-α in the plasma. The reason why ZJ802 significantly reduced IL-6 but 
not TNF-α is unknown. Plasma TNF-α is transiently up-regulated for <120 min following 
a pro-inflammatory stimulus in vivo (Barsig, et al. 1995, Amiot, et al. 1997). It is 
possible that time point utilised in this study had either past or preceded the optimal 
peak TNF-α plasma levels and may be one reason why large differences occurred in 
measuring plasma TNF-α between mice.  
Interestingly, ZJ802 post-treatment in vivo had no effect on tissue MPO activity 
compared to control. In contrast, GYY4137 has previously been demonstrated to 
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significantly reduce the LPS-induced hypotension in rats as well as plasma TNF-α, IL-1β, 
IL-6 and lung MPO activity when administered post-LPS insult (Li, et al. 2009b). 
Whether ZJ802 will be therapeutically viable in other models of inflammation requires 
further investigation.   
 
6.3.3 Summary and conclusion  
There are several potential problems with fast releasing H2S drugs, such as NaHS, most 
notably the effect on cell viability (see Chapter 5). The need for more slow releasing 
H2S donors, like GYY4137, may offer an alternative means of increasing our 
understanding of H2S in biological systems. Through analysing a cohort of potential 
viable H2S releasing compounds (not reported in this thesis), a potent antioxidant was 
discovered, ZJ802. This compound also exhibited anti-inflammatory properties in vivo. 
However, the anti-inflammatory effect of ZJ802 is not apparent when injected after 
LPS (i.e. post-treatment). Whether any apparent beneficial effects of this compound as 
an anti-inflammatory agent will be therapeutically viable is unknown as is the 











CHAPTER 7: Overview and Conclusion  
 
7. Introduction and summary of thesis 
 
The first half of this thesis attempts to elucidate the roles of endogenous H2S in the 
vasculature that is, whether H2S release from HUVEC is Ca
2+ dependent and if signalling 
crosstalk exists between •NO and H2S. The second half of this thesis utilises 
pharmacological and biochemical techniques to examine the potential therapeutic 
benefits of GYY4137 in models of inflammation and to characterise a novel compound, 
ZJ802. 
 
i)  Is H2S as an EDRF? 
Evidence suggests that H2S, like 
•NO, may be an EDRF (Yang, et al. 2008). Indeed it has 
previously been demonstrated that both HUVEC and BAEC contain CSE protein and 
that stimulation of these endothelial cells with a Ca2+ mobilising stimulus (A23187 and 
MCh) results in the release of detectable amounts of H2S into the cell culture medium 
(Yang, et al. 2008). If H2S is an EDRF, a number of exciting new questions could be 
answered, for example: Would H2S released into the medium from stimulated HUVEC 
relax vascular smooth muscle cells in vitro? ; Is H2S released from ex vivo blood vessels 
in the presence of a Ca2+ stimulus? ; Would an increase in plasma H2S be observed 
upon a Ca2+ mobilising stimulus/drug in vivo? ; Would other physiological means, such 
as flow, induce the release of H2S from cultured endothelial cells? Finally, does 
‘chronic’ incubation with L-NAME/L-argnine free medium or PAG/L-cysteine free 
medium, result in compensatory mechanisms leading to the release of H2S or NO 
respectively from endothelial cells? In order to answer these questions it is necessary 
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to measure detectable amounts of H2S release from endothelial cells. However, in 
Chapter 3 and in contrast to a previous study (Yang, et al. 2008), H2S was not 
detectable in the media of cultured endothelial cells or RAW264.7 macrophages, in 
response to a Ca2+ stimulus or from LPS respectviely (Chapter 3). Moreover, incubating 
liver homogenates with Ca2+, Ca2+ chelating agents or Ca2+/CaM antagonists did not 
alter H2S synthesising activity, suggesting CSE/CBS are Ca
2+ independent. One of the 
limitations of the studies presented within this thesis may have been that the H2S 
measuring methods may have not been sensitive enough to measure H2S elaboration 
from cultured cells. Evidence suggests that the release of endogenous H2S is likely to 
be below or within the nM range (Olson 2009), whilst in the current study the limit of 
detection of ISE and  methylene blue was 10 µM and 3 µM H2S respectively. Whilst the 
same techniques were identical to that used in Yang et al., 2008, they did not provide 
details relating to the limit of H2S detection, or the absolute concentrations of H2S 
released within their study. Interestingly a time-dependent drift was observed ultilising 
the ISE in cell culture medium. Moreover, changes in background unrelated to H2S 
release could also alter voltage differences utilising this method of H2S detection. Thus, 
it may be possible that the apparently detectable H2S in the study by Yang et al., 2008, 
may have been non-selective effect of the ISE.  
It was also interesting to note that MCh did not cause a measurable rise in 
intracellular Ca2+ in endothelial cells in the current study. The previous study did not 
directly demonstrate MCh could increase in intracellular Ca2+ in their endothelial cell 
lines (Yang, et al. 2008), questioning whether the release of ‘H2S’ from endothelial cells 
result from increasing intracellular Ca2+ concentrations. In contrast to the previous 
study (Yang, et al. 2008), neither CSE nor CBS protein was detected in HUVEC, possibly 
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due to method sensitivity or differences in antibody utilised. However, CSE and CBS 
mRNA was detected in HUVEC suggesting that H2S may potentially act as an EDRF. If 
H2S were to act as an EDRF, it is likely the methods utilised may not be sensitive or 
reliable enough to detect de novo H2S release in cell culture.  
 
ii) •NO and H2S crosstalk 
Although unable to measure H2S production from endothelial or RAW264.7 cells in 
culture, it was possible to elucidate crosstalk between endogenous •NO and H2S by 
measuring H2S synthesising enzyme activity from organs of genetically modified mice 
lacking iNOS and eNOS. The examination of ‘gas-enzyme’ and ‘gas-gas’ crosstalk 
between •NO and H2S has previously been examined. For the first time, this thesis 
demonstrates a direct (‘enzyme-enzyme’) crosstalk between CSE and eNOS (Chapter 
4). This thesis has demonstrated that knocking out eNOS, but not iNOS, results in an 
increase in H2S synthesising activity in the liver, stomach and small intestine. This 
suggests that the actions of H2S may be able to compensate for the loss of 
•NO. 
Indeed, further functional studies are required to confirm these new exciting findings. 
During the process of examining H2S synthesising activity from a number of 
tissues, it was noted that the H2S synthesising assay was bias towards the activity of 
CSE. This was demonstrated by large detectable amounts of CBS protein with a lack of 
H2S synthesising activity in mouse brain homogenates. This assay, therefore does not 
examine the total H2S synthesising enzyme activity, as was initially predicted, and is a 
limitation to this study. Indeed, caution should be taken to interpret experimental data 
utilising H2S synthesising activity, particularly from literature where several ‘H2S 
synthesising enzyme’ assays have been utilised (Stipanuk and Beck 1982, Abe and 
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Kimura 1996, Li, et al. 2005, Singh, et al. 2009). Recently, lanthionine was suggested to 
be a biomarker of CBS (Singh, et al. 2009). Although CSE is also capable of synthesising 
lanthionine this reaction is negligible compared to CBS (Chiku, et al. 2009, Singh, et al. 
2009). Therefore measuring lanthionine as an endpoint marker, rather than H2S, may 
be an alternative means to measure the activity of CBS in vitro. 
 
iii) GYY4137 vs NaHS in inflammation 
The use of pharmacological tools such as H2S donors is one approach to elucidating the 
biological roles of H2S. Both H2S donors and H2S inhibitors have been demonstrated to 
exert both pro- and anti-inflammatory actions in various models of inflammation 
(Chapter 5). The controversy in the literature may be caused by number of factors 
including: the use of CSE/CBS inhibitors or H2S donors, the concentration of H2S, the 
time of administration, the stimulus utilised, the cell type, animal species, and the in 
vitro or in vivo conditions. Moreover, NaHS in the current study appears to exert a 
biphasic inflammatory effect which causes added complication to an already 
ambiguous situation. In addition, the effects of NaHS, particularly at millimolar 
concentrations, may be accounted for by its potential toxicity. To date, studies 
investigating the effects of the novel slow releasing H2S donor GYY4137 have been 
promising. This compound has shown to exert anti-inflammatory/protective effects in 
a model of endotoxic shock in vivo (Li, et al. 2009b), LPS stimulated RAW264.7 cells in 
vitro (Whiteman, et al. 2010c),  oxidative stress induced by H2O2, 4-HNE (4-
hydroxynonenal) and SIN-1 (3-morpholinosydnonimine) on human chondrocytes in 
vitro (Fox, et al. 2011), and this thesis supports a role for an anti-inflammatory nature 
for GYY4137 (Chapter 5). The need for more slow releasing H2S donors is necessary to 
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confirm a beneficial role for H2S in inflammation. Indeed, whether slow releasing H2S 
donors will be of therapeutic benefit is currently unknown due to limited data, but 
appears to be highly feasible (see later). 
 
iv) Organosulfur compounds  
In an attempt to assess a library of drugs that may potentially release H2S, an 
antioxidant was discovered, ZJ802. This compound exhibited greater antioxidant 
potential than NaHS and GYY4137 and was shown to also exert some beneficial anti-
inflammatory effects in vivo. Interestingly, other organosulfur compounds such as 
allicin and sulforaphane have antioxidant properties and may potentially exert their 
effects through the release of H2S (Chapter 6). Whether ZJ802 releases H2S is unclear 
as is the toxicological profile of this compound.  
  
7.1. Methods used to measure H2S 
Plasma H2S and H2S synthesising enzyme activity is elevated in a number of 
inflammatory diseases (Bhatia, et al. 2005, Li, et al. 2005, Whiteman, et al. 2010b). As a 
result H2S has been suggested to act as a biomarker for a number of conditions such as 
atherosclerotic peripheral arterial disease, (Kevil 2011)  and asthma (Wang, et al. 
2011a). However, the sensitivity and selectivity (for free, acid-liable or protein bound 
sulfur) of the different methods used to measure H2S is a limitation. The inconsistent 
plasma levels of H2S, ranging from 10-300 µM, likely results from different methods 
used to measure H2S (Whitfield, et al. 2008). The predominant methods used to 
measure H2S in the literature are the methylene blue colourimetric method and the 
ISE. The harsh chemical conditions exerted by both methods result in the release of 
H2S from acid-liable sulfur or protein bound sulfur, which may artificially elevate the 
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concentration of H2S detected (Chapter 3). In order to fully understand the 
physiological role of endogenously produced H2S and the effects of H2S donors, a 
reliable, sensitive method to directly measure H2S is required. Data presented within 
this thesis indicates that there may be some inherent problems with the methods that 
are currently available and this in turn may explain some of the variable/conflicting 
data published within the literature. This limitation of H2S direct measurement has 
prompted a number of alternative methods for measuring H2S as discussed below. 
The polarographic H2S sensor is an amperometric microsensor that estimates 
H2S gas indirectly from pH (Doeller, et al. 2005, Olson 2009). The polargraphic sensor 
has a reported sensitivity of 14 nM H2S gas and 100 nM total sulfide (Whitfield, et al. 
2008) contrasting the current study where the methylene blue and ISE method, in the 
current study, has a sensitivity of ~ 3 and 10 µM total sulfide respectively. Furthermore 
in contrast to the current methods which utilise harsh chemical conditions to ‘trap’ (or 
react with) H2S, the polarographic sensor measures sulfide in real time (Whitfield, et al. 
2008). Whether flaws exist with this microsensor remains to be elucidated. 
Gas chromatography has a reported sensitivity in the nM range with 0.1 nM 
H2S detected in blood and 15 nM H2S in the gas space above brain homogenates 
incubated with 1 mM cysteine (Furne, et al. 2008). This method is sensitive and specific 
for measuring H2S gas. However, in solution such as blood plasma, if H2S were to be 
generated endogenously, other forms of H2S (e.g. HS
- and possibly S2
-) are likely to 
exist in addition to molecular H2S.  
A group in Japan recently created a novel method to measure free H2S using 
silver (Ag) particles combined with gas chromatography (Ishigami, et al. 2009). In this 
assay, Ag powder was incubated with the supernatant of tissue homogenates to 
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convert sulfide into silver sulfide (AgS) (Ishigami, et al. 2009). The Ag powder was 
extracted and incubated with thiourea/H2SO4 to induce the release of H2S, which was 
subsequently quantitated using gas chromatography (Ishigami, et al. 2009). This 
method has the advantage, over conventional methods (methlyene blue) in that H2S 
from acid-liable from tissues will not be released. However, in this study the authors 
utilised a strong alkali buffer (borate buffer, pH 9) to homogenise their tissues which 
may induce the release of H2S from protein bound sulfur (Olson 2009). The reason for 
the use of alkali borate buffer is unclear, but may be utilised to preserve H2S in the S2
- 
form. Whether another buffer within a physiological pH range would be suitable for 
this assay, is something that requires further consideration. 
In a recent study, a sulfide derivatisation method was utilised to measure blood 
sulfide in human volunteers injected with Na2S (Toombs, et al. 2010). In this protocol, 
blood sulfide was incubated with monobromobimane to form sulfide dibimane, a 
fluorescent product which was extracted and separated by high-performance liquid 
chromatography (HPLC) and the fluorescence quantitated (Toombs, et al. 2010). This 
method can detect 0.4-0.9 µM sulfide in baseline rat blood (Wintner, et al. 2010).  The 
polarographic sensor and the monobromobimane assay appear to correlate when 
measuring H2S in buffer and human plasma spiked with Na2S in vitro (Wintner, et al. 
2010). However, the monobromobimane assay detects significantly more H2S than the 
polarographic sensor in whole blood spiked with Na2S in vitro (Wintner, et al. 2010). 
Moreover, the measurement of H2S from whole blood samples obtained from rats 
injected with Na2S (60 mg/kg/h) using the two independent methods demonstrated 
marked differences in absolute H2S concentrations (Wintner, et al. 2010). Less than 1 
µM H2S was detectable by the polarographic sensor and up to 30 µM H2S was 
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measured using the monobromobimane assay (Wintner, et al. 2010). Interestingly, in 
another study within 5 min of injecting radiolabled sulfide 35S (i.v.) into rats 70% of the 
35S was bound to proteins (half to plasma proteins and half to red blood cells) (Curtis, 
et al. 1972). The results from the latter study may suggest that upon administering H2S 
in vivo, H2S is quenched by proteins in the blood and any free H2S left will be minimal. 
Indeed, this may be a reason why injecting NaHS into animals only results in a transient 
(~30 sec) (Zhao, et al. 2001) drop in blood pressure. These latter studies may suggest 
that the monobromobimane assay is thus measuring protein bound sulfur in addition 
to free H2S.  
 Overall, it is likely that most of the methods used to measure H2S are not just 
measuring free H2S, but also sulfur from a source of protein. Therefore it is necessary 
to utilise more than one method when measuring H2S, or indeed not measuring 
endogenous blood or tissue H2S. There is currently no gold standard for measuring H2S 
and acknowledgement of the limitations associated with each method is necessary 
before making a full conclusion regarding concentrations of H2S. The most accurate 
measurement of H2S so far is probably the polarographic sensor which can measure 
free H2S in real time without chemical modification. Interestingly, this device cannot 
detect H2S in the plasma (Whitfield, et al. 2008) and this questions whether H2S exists 
as a freely circulating endogenous signalling molecule (discussed later).  
7.2. Biomarkers for H2S 
The methods for measuring H2S are not perfect. H2S itself is unstable (liable to 
phase transition) if not chemically modified. Biomarkers may be an alternative method 
to measure levels of H2S. H2S is endogenously detoxified to sulfate and may be utilised 
as a biomarker for H2S. However, sulfate in the urine may be derived from the 
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oxidation of cysteine by cysteine dioxygenase to form cysteine sulfinic acid (Wainer 
1965). The transamination of cysteine sulfinic acid results in the production of β-
sulfinylpyruvate which is cleaved to form pyruvate and sulfite (Singer and Kearney 
1956). Sulfite is then catalysed to sulfate by sulfite oxidase and excreted in the urine 
(Singer and Kearney 1956).  
Urinary thiosulfate levels have previously been used as a non-specific 
biomarker for the physiological production of H2S (Belardinelli, et al. 2001) and for 
individuals over-exposed to H2S (Kage, et al. 1997). Indeed, the primary route by which 
H2S is removed is predominately through conversion to sulfate or thiosulfate through 
the action of mitochondrial enzymes quinone oxidoreductase, sulfur dioxygenase and 
a sulfur transferase (Hildebrandt and Grieshaber 2008). However, thiosulfate is also a 
by-product of cysteine and methionine metabolism (Gast, et al. 1952) where cysteine 
can be directly converted to 3-mercaptopyruvate by CAT, which is subsequently 
converted to thiosulfate by 3-MST (Wrobel 2001, Mikami, et al. 2011a, Tanizawa 
2011). Although, sulfate and thiosulfate may not be entirely specific for H2S, currently 
no studies have demonstrated whether plasma H2S levels correlate with 
urinary/plasma sulfate or thiosulfate levels and/or whether dietary intake of cysteine 
correlates with plasma H2S levels in vivo.   
Lanthionine and homolanthionine has been suggested to act as a potential 
biomarker for H2S production (Chiku, et al. 2009). However, it is possible external 
factors e.g. lanthionine antibiotics (Parisot, et al. 2008) or internal infections from 
gram negative bacteria (Wadman, et al. 1978) may influence urinary lanthionine levels. 
Interestingly, homolanthionine is elevated in the urine of patients with homocystinuria 
(Perry, et al. 1966), which implies dysfunctional CBS may lead to elevated 
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homolanthionine in the urine. These authors suggested that the formation of 
homolanthionine was due to the condensation of homocysteine and homoserine 
(Perry, et al. 1966). Therefore urinary (and possibly plasma) homolanthionine may not 
be a suitable biomarker for CSE/CBS/H2S activity in vivo.   
 
7.1. H2S as an endogenous signalling mediator 
 
There has been some debate as to whether H2S is an endogenous signalling mediator. 
Indeed, the methods used to detect H2S have limitations and whether free H2S exists in 
the blood is controversial. Indeed, at some of the concentrations reported in blood 
plasma (~40 µM) one would expect the distinct smell of H2S to be clearly detectable. 
However, this is not the case. Moreover, the rapid binding of sulfide to blood proteins 
(Curtis, et al. 1972) as well as the short lasting action of NaHS on blood pressure (Zhao, 
et al. 2001) may suggest that free sulfide does not circulate in blood. However, H2S 
may exert its actions through other mechanisms. H2S can modify the functions of 
proteins through s-sulfhydration, that is, the reaction with a disulfide bond to form a 
persulfide R-SSH and thiol -SH (Mustafa, et al. 2009, Kabil and Banerjee 2010). It has 
also been suggested that the actions of sulfide are conducted by sulfane sulfur (Toohey 
2011). Sulfane sulfur atoms are reactive sulfur atoms with a valency of 0 or -1 and do 
not exist in the free form but are instead found covalently bound to other sulfur atoms 
(Westley, et al. 1983, Toohey 1989, Iciek and Wlodek 2001). Such sufane sulfur 
compounds include thiosulfate, elemental sulfur So, persulfides R-SSH, disulfides R-SS-
R and polysulfides R-Sn-R (Toohey 2011). The addition of exogenous H2S to a system 
also introduces sulfane sulfur which can itself induce the formation of persulfides from 
protein disulfide bonds (Toohey 2011). Moreover, CSE, 3MST and rhodanese 
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contribute to the formation of sulfane sulfur compounds during anaerobic cysteine 
metabolism  (Iciek and Wlodek 2001). Sodium thiosulfate has been described as an 
antioxidant and demonstrated to delay the vessel calcification process in humans 
(Adirekkiat, et al. 2010). H2S can indirectly increase endogenous thiosulfate levels 
(Hildebrandt and Grieshaber 2008). However, thiosulfate itself is also capable of 
increasing endogenous H2S (Sen, et al. 2008, Mikami, et al. 2011a). Whether H2S or 
thiosulfate is the active molecule requires further investigation. Indeed, further studies 
are required to determine the molecular mechanism by which H2S acts and whether 
the actions of CSE and H2S are through the production and action of s-sulfhydration, 
sulfane sulfur or possibly thiosulfate.  
Although it is questionable whether H2S is a free circulating gaseous mediator, 
the small diffusible membrane permeable property of H2S makes it a suitable 
endogenous signalling molecule. H2S can be released from bound sulfur sources in the 
presence of physiological sources of GSH (Ishigami, et al. 2009), and may therefore act 
as a signalling molecule during oxidative stress.  Furthermore, the transulfuration 
pathway is intimately connected to the GSH synthesising pathway, where L-cysteine is 
the rate limiting substrate for the synthesis of GSH (Shackebaei, et al. 2005). This 
means the transulfuration pathway, the predominant pathway for endogenous H2S 
generation, may also be responsible for driving the production of GSH which itself may 
promote release of H2S from protein bound sulfur sources. Interestingly, the 
transulfuration pathway is also up-regulated in response to oxidative stress (Persa, et 
al. 2004). Moreover, CBS is redox active, and oxidation increases its enzyme activity 
(Taoka, et al. 1998).  Indeed, during oxidative stress, H2S is capable of reacting with 
reactive oxygen species such as peroxynitrite in vitro (Whiteman, et al. 2004), and may 
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regulate endogenous levels of •NO through the formation of a biologically less reactive 
nitrosothiol (Whiteman, et al. 2006). Indeed, this thesis supports a role for H2S as an 
antioxidant in vitro (Chapter 6) and it is possible H2S acts as an endogenous signalling 
mediator during oxidative stress. 
 
7.2.  H2S donors and inhibitors 
H2S donors and CSE/CBS inhibitors have been useful tools in understanding the 
biological actions of what is currently known about H2S. CSE/CBS inhibitors elicit non-
selective effects (Pfeffer and Ressler 1967, Tanase and Morino 1976, Burnett, et al. 
1980, Loscher 1981, Hamel, et al. 1982), which has also been demonstrated in this 
thesis. The H2S synthesising enzyme activity utilised in the current studies is bias 
towards CSE activity (Chapter 4), yet AOAA inhibitor of CBS, could almost abolish rat 
liver H2S enzyme activity (Chapter 3) suggesting AOAA is non-selective. 
There are several commercially available H2S salts (e.g. NaHS, Na2S, calcium 
sulfide CaS) and Lawesson's reagent. However, the purity of these H2S donors is 
questionable. For example, the purity of NaHS is not usually greater than 70% and 
could also be another reason for the discrepancy in the literature when using H2S 
donors in vitro and in vivo (Whiteman and Winyard 2011). As described earlier in 
Chapter 5 of this thesis, there are several problems with these donors, namely they 
can cause cell death (Yang, et al. 2004, Cao, et al. 2006, Yang, et al. 2007). Moreover, 
these salts probably do not mimic the slower biological release of endogenous H2S. In 
contrast, the use of slow releasing H2S donors may provide a better insight into the 
roles of endogenous H2S and are less likely to induce cell death as a result of a rapid 
release of large concentrations of H2S. Organosulfur compound, GYY4137 has been 
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shown, to date, to consistently exert an anti-inflammatory effect both in vivo and in 
vitro (Chapter 5). Therefore, the progressive release of H2S from slow releasing donors, 
like GYY4137, may be of more therapeutic relevance and better tools to examine the 
effects of H2S than are conventional H2S salts.  
The beneficial effects of slow releasing H2S donors have been exemplified by 
H2S-NSAID hybrids. ADT-OH (anethol trithione, 5-(4-hydroxyphenyl)-3H-1,2-dithiol-3-
thione) is a H2S donor and in combination with NSAIDs such as diclofenac results in the 
slow release of H2S (Li, et al. 2007). Moreover, there is increasing evidence for a 
beneficial role for H2S-NSAID hybrids in limiting gastrointestinal damage induced by 
NSAIDs (Distrutti, et al. 2006b, Fiorucci, et al. 2007, Li, et al. 2007, Wallace, et al. 
2007a). So far, several ADT-OH-hybrid drugs have been produced, such drugs include: 
H2S-NSAID hybrids (e.g. aspirin ACS14, indomethacin ATB343, diclofenac ATB337 or 
ACS15, mesalamine ATB429); H2S anti-glaucoma hybrid (latanoprost-H2S hybrid 
ACS67); and H2S-phosphodiesterase hybrids (sildenafil ACS6). These H2S hybrids have 
provided further insight of the benefits of H2S administration and may provide an 
alternative means by which H2S can enhance the efficacy/drug tolerability of currently 
available drugs for human consumption. However, it has been suggested that the 
beneficial effects of ADT-OH may be as a result of the dithiolethione moiety itself 
rather than the release of H2S (Isenberg, et al. 2007), and is therefore an area that 
requires further evaluation.  
 Exogenous L-cysteine is thought to increase endogenous production of H2S and 
may be an alternative means for producing H2S. Cysteine analogues have been 
generated (e.g. S-allyl-l-cysteine SAC and S-propargyl-l-cysteine SPRC) (Wang, et al. 
2009a). However, the beneficial effects of these cysteine analogues over L-cysteine 
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itself, is unclear. None-the-less, these analogues have been demonstrated to promote 
endogenous H2S production (Wang, et al. 2009a) and have anti-cancer effects both in 
vitro and in vivo (Ma, et al. 2011). The addition of L-cysteine has previously been 
shown to up-regulate the expression of cysteine dioxygenase, the enzyme involved in 
taurine synthesis, and down-regulate γ-glutamylcysteine synthetase, the enzyme 
involved in GSH synthesis (Kwon and Stipanuk 2001). However, L-cysteine is the 
substrate for GSH production and may therefore potentially increase GSH production 
on increasing L-cysteine availability. Whether the effects of adding L-cysteine are due 
to changes in the anti-oxidants GSH or taurine, and/or H2S is more difficult to decipher. 
Therefore although added cysteine may lead to increases in endogenous H2S 
generation, other antioxidant systems are also likely to change as a result. 
Recently, a novel H2S donor has been described, based on the structure of N-
(benzoylthio)benzamide (Zhao, et al. 2011). These H2S donors release H2S in the 
presence of excess cysteine, which provides a mechanism for the controlled release of 
H2S (Zhao, et al. 2011). However, whether enough free cysteine exists in vivo to induce 
the release of H2S from these of N-(benzoylthio)benzamide based H2S donors requires 
further study (Zhao, et al. 2011). 
Meta analysis of clinical trials has demonstrated the benefits of using garlic 
derived compounds on blood pressure regulation in humans (Ried, et al. 2008). The 
mechanism behind the beneficial effects of garlic is unclear. However, garlic 
organosulfur compounds (diallyl disulfide, diallyl trisulfide) have been shown to release 
H2S in the presence of red blood cells under anoxic conditions (Benavides, et al. 2007). 
Whether these reactions take place in vivo require further examination. Indeed, other 
organosulfur compounds such as sulforaphane have cardiovascular and anti-
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inflammatory benefits (Vazquez-Prieto and Miatello 2010). Indeed, the potential 
benefits of oraganosulfur compounds have been demonstrated in Chapter 6 of this 
thesis. Whether these compounds are converted to H2S endogenously require further 
investigation. 
Overall there are several available compounds that can be utilised to examine 
the effects of H2S in vitro and in vivo. It is likely there will be increasing interest in the 
generation of slow releasing donors in the future. The use of different organosulfur 
compounds as a basis for H2S generation in vivo may be an ideal starting point for the 
generation of future slow releasing H2S donors. 
 
7.3. Future for H2S and the cardiovascular field 
Most of the actions of H2S in the cardiovascular system have focused on a very 
pharmacological approach to assessing the roles of H2S in the vascular system, using 
H2S donors or inhibitors of CSE/CBS.  However, the role for endogenous H2S signalling 
within the cardiovascular system remains largely unexplored. Although CSE/CBS 
inhibitors have provided insight into the endogenous roles of H2S, the effects of these 
inhibitors remain speculative due to their non-selective effects. However, transgenic 
mice will probably be a useful tool to increase knowledge regarding the function of 
endogenous H2S. However, KO mice have their flaws, such as potential compensatory 
mechanisms and in particular regard to CSE/CBS KO mice, the increase in plasma 
homocysteine. None-the-less, CSE-/- KO mice have a reduced plasma H2S and have 
provided an alternative insight to the endogenous functions of H2S dispite the 
setbacks. Indeed the development of CSE-/- mice has demonstrated a role for 
endogenous H2S in blood pressure regulation (Yang, et al. 2008), angiogenesis 
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(Papapetropoulos, et al. 2009),  O2 sensing in the carotid body (Peng, et al. 2010), 
vascular remodelling  (Yang, et al. 2010), and in the development of diabetes (Yang, et 
al. 2011b). Moreover, mice with a targeted over expression of CSE in the cardiac tissue 
are protected against left ventricular structural and functional impairment which may 
suggest a role for endogenous H2S in cardiac remodelling (Calvert, et al. 2010). To 
provide further evidence for a role of CSE in cardiac remodelling, it would be 
interesting to examine whether CSE-/- mice would be more prone to heart failure.  
In terms of inflammation, it would be interesting to examine whether 
differences in disease severity exist between CSE-/- and WT mice. The role of H2S in 
nociception is unclear and these KO mice may also be a useful tool to increasing the 
understanding of endogenous H2S in models of pain. There has been much interest in 
H2S-releasing NSAIDS and ability to promote gastric healing compared to the 
conventional NSAIDS. Indeed, it could be predicted that the extent of gastric 
damage/bleeding would be reduced in mice with a targeted over expression of CSE or 
CBS. Slow releasing H2S donor GYY4137 has been demonstrated to have anti-cancer 
effects as demonstrated by its ability to selectively induce apoptosis in cancer cell lines 
(e.g. HeLa, cervical carcinoma) but not non-cancer cell lines (e.g. WI-38, human 
fibroblast) (Lee, et al. 2011), and this questions whether low concentrations and slow 
rates of endogenous H2S production may also elicit anti-cancer effects. Indeed, it could 
be hypothesised that CSE-/- mice may be more prone tumour progression in cancer 
models. 
ApoE-/- injected with NaHS over 10 weeks exhibit  reduced atherosclerotic 
plaque formation (Wang, et al. 2009b). It would be interesting to assess whether ApoE-
/- mice also have a reduced H2S enzyme activity. Moreover, it could be predicted that 
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crossbreeding CSE-/- with ApoE-/- mice would accelerate vascular calcification and the 
atherosclerotic process and increase the risk of myocardial infarction and/or stroke. 
Indeed it would also be interesting to explore whether a targeted over expression of 
CSE in vascular endothelial cells would attenuate the atherosclerotic process in ApoE-/- 
mice.   
The general impression is that CBS is the predominant source of H2S in the 
central nervous system and CSE in the peripheral systems. Both CBS and CSE mRNA has 
been demonstrated to be expressed in HUVEC (Chapter 3). It is likely that both CBS and 
CSE work together to generate H2S. Indeed CBS is needed for the generation of 
cystathionine, a substrate of CSE, which in turn catalyses its conversion to cysteine. 
Although, it should be noted that both CSE and CBS appears to be promiscuous for 
their substrates (Singh, et al. 2009), therefore it is possible these enzymes can 
synthesise H2S independently of each other.  CBS is regulated by SAM and in the 
presence of this allosteric regulator may be the predominant source of H2S (Singh, et 
al. 2009). However, the distribution and concentration of SAM throughout bodily 
tissues have not been determined and is an area that requires further consideration in 
order to examine whether CSE or CBS is the predominant source of H2S in various 
organ systems. 
Apart from the transulfuration pathway of H2S biosynthesis, the CAT/3MST 
pathway may also be a source of H2S. Whether the CAT/3MST enzymatic pathway 
occurs at physiological pH requires further investigation. None-the-less, the global 
enzyme expression and activity of the CAT/3MST pathway of H2S generation has not 
been determined and is an area that requires further work. Moreover, the subcellular 
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generation of H2S, either the cytoplasm or mitochondria, through this pathway has not 
been determined.  
This thesis has explored the potential interaction between •NO and H2S using 
eNOS-/- mice. Whether chronic administration of L-NAME in rodents would increase 
H2S enzyme activity is an alternative method to assess potential crosstalk between 
these two gaseous mediators. Other than •NO and H2S, CO is another gasotransmitter 
and although the actions of CO was not examined in this thesis, it is an area that 
requires further exploration. Indeed, it would be interesting to explore whether CSE-/- 
KO mice have increased total NOS or HO activity, or whether HO KO mice also have 
increased NOS or H2S enzyme activity.  
There are a vast number of possibilities that requires exploration regarding 
endogenous H2S, particularly with the use of genetically modified mice. Indeed, this 
appears to be the most imminent way in assessing the role of endogenous H2S 
particularly with the recent generation of CSE-/- mice. 
 
7.4. Clinical perspective for H2S 
There has been increasing interest in the literature regarding the third gasotransmitter 
H2S. H2S has been demonstrated to have protective (and detrimental) effects in various 
pre-clinical models of inflammation, ischemia/reperfusion and remodelling. Already, 
within 10 years of active H2S research, Na2S has been administered into healthy human 
volunteers (total of 52 subjects, with 13 receiving placebo), as a phase I toxicology and 
tolerability trial (Toombs, et al. 2010). In this study, the administration of Na2S (0.005 – 
0.2 mg/kg i.v.) into humans did not exert any toxicological effects with no effects on 
the ECG (electrocardiogram), heart rate, blood pressure, temperature, respiration or 
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haematology, at the doses used (Toombs, et al. 2010). Although this gas did not have 
any toxicological effects in humans at the doses utilised (Toombs, et al. 2010) very 
little is known about the pharmacokinetics and pharmacodynamic profile of H2S 
donors. As described earlier, the methods used to measure H2S, although advancing, 
are still in its infancy. Moreover, there is increasing interest for the development of 
slow releasing H2S donors, and much of their toxicology and pharmacokinetic/dynamic 
profile have not been thoroughly investigated in vivo. Overall, the phase I safety trial in 
humans (Toombs, et al. 2010) provides further reason to advance scientific knowledge 
and technology within the H2S field.   
Although the use of H2S releasing drugs in the clinic are far from advance, H2S 
itself is a potential biomarker for disease severity in conditions such as: coronary heart 
disease (Jiang, et al. 2005), rheumatoid arthritis (Whiteman, et al. 2010b), obesity and 
type 2 diabetes (Whiteman, et al. 2010a), peripheral arterial disease (Kevil 2011), and 
asthma (Wang, et al. 2011a). However, whether the methods used to measure H2S 
truly reflect levels of H2S or alternative forms of sulfur are currently uncertain. 
 
7.5. Summary and conclusion 
In summary, in this rapidly advancing field it is necessary not to overlook critical 
factors in methods used to measure H2S, H2S enzyme activity, and keep in mind the 
limitations of the agents used to inhibit enzyme activity or donate H2S prior to making 
a full conclusion. There is the need for better methods of H2S detection and selective 
pharmacological modulators of H2S synthesising enzymes in order to advance the 
knowledge regarding the biological actions of endogenous H2S. The development of 
genetically modified CSE mice will particularly be beneficial in advancing our 
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knowledge about endogenous H2S produced by this enzyme. There appears to be a 
promising therapeutic role for exogenous H2S, particularly in ischemia/reperfusion and 
gastric healing. Slow releasing H2S donors such as GYY4137 will provide a greater 
insight into the benefits of H2S donors in inflammation. As the therapeutic role for H2S 
advances, there is the need for more detailed pharmacodynamic, pharmacokinetic and 
safety in vivo pharmacology data.  
Overall, this thesis has: emphasised the need for better methods in the H2S 
field particularly when assessing endogenous H2S release; demonstrated a role for 
potential endogenous crosstalk between eNOS and CSE; provided further evidence for 
an anti-inflammatory role for slow-releasing H2S donor GYY4137; and characterised a 






























Appendix A  
Gel composition for SDS-PAGE. Volumes were made up to 10 ml using H2O.  






Buffer 2.5ml 1.0M Tris 
pH 6.8 (Final: 
0.125mmol/L 
Tris-HCl, 0.1% 
SDS, pH 6.8) 
2.5 ml 1.5M Tris 
pH 8.8 (Final: 
0.375mmol/L 
Tris-HCl, 0.1% 
SDS, pH 8.8) 
2.5 ml 1.5M Tris 
pH 8.8 
2.5 ml 1.5M Tris 
pH 8.8 
Sodium dodecyl 
sulphate (SDS, 10%  
w/v) 
100 µl 100 µl 100 µl 100 µl 
Acrylamide 1.30 ml 2.5 ml 4 ml 5 ml 
Ammonium 
Persulphate (APS, 10%  
w/v)  
100 µl 50 µl 50 µl 50 µl 
N N N’ N’-
Tetramethylethylene-
diamine (TEMED) 
10 µl 5 µl 5 µl 5 µl 
 
Laemmli sample buffer (2x) 
 Volume 
Tris-HCl 0.5M 2.4 ml 
SDS 800 mg 
Glycerol 4 ml 
Bromophenol blue (0.01% w/v) 100 µl 
β2-mercaptoethanol 1 ml 





Western blot lysis buffer (Final concentration: EDTA 5mM, NaCl 150mM, Tris HCl 50 
mM, Triton x-100 1%, SDS 1%, PMSF 1mM) 
 Volume (µl) 
EDTA (0.5 M) 50  
NaCl (5 M) 150  
Tris HCl  (1 M) 250  
Triton x-100 (10% v/v) 500  
SDS (10% w/v) 500 
Phenylmethanesulfonyl fluoride (PMSF, 100 mM) 50  

















Primary antibodies (5% w/v non-fat milk, PBST) 
Primary 
antibody 
Dilution Origin/type Source 
β-actin (42 kDa) 1:5000 Mouse 
polyclonal 
Sigma (A5441) 
α-tubulin 1:2000 Rabbit 
polyclonal 
Cell Signaling Technology 
(#2144) 





CBS (75 kDa) 1:2000 Rabbit 
polyclonal 
Abnova (H00000875-D01P) 
COX-2 1:2000 Rabbit 
polyclonal 
Cayman (#160106) 
IκB-α 1:2000 Rabbit 
polyclonal 
Cell signalling (#9242) 
VCAM-1 1:500 
(5% w/v albumin,  
PBST) 
Goat polyclonal R&D systems (BBA19) 
ICAM-1 1:500 
(5% w/v albumin, 
PBST) 
Goat polyclonal R&D systems (BBA17) 
 
Secondary-HRP linked antibodies (5% w/v non-fat milk, PBST)  






1:2000 Cell Signaling Technology 
(#7074) 








Primers for PCR 
Human CSE (157 bp) reverse 3’ GTGGCTGCTAAACCTGAAGC 
forward 5’ CACTGTCCACCACGTTCAAG 
Human CBS (150 bp) reverse 3’ TTGGGGATTTCGTTCTTCAG  
forward 5’ TCATCGTGATGCCAGAGAAG 
Human α-tubulin (200 bp) reverse 3’ CACGTTTGGCATACATCAGG 
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